Chapter 23
Share-based payment

List of examples

Chapter 23
Share-based payment

1 INTRODUCTION

1.1 Background

Most share-based payment transactions undertaken by entities are awards of shares and options as remuneration to employees, in particular senior management and directors. One advantage of shares and options as remuneration is that they need not entail any cash cost to the entity. If an executive is entitled under a bonus scheme to a free share, the entity can satisfy this award simply by printing another share certificate, which the executive can sell, so that the cash cost of the award is effectively borne by shareholders rather than by the entity itself. However, this very advantage was the source of controversy surrounding share-based remuneration.

Investors became increasingly concerned that share-based remuneration was resulting in a significant cost to them, through dilution of their existing shareholdings. As a result, there emerged an increasing consensus among investors that awards of shares and share options should be recognised as a cost in the financial statements.

Accounting for share-based payment transactions is addressed in Section 26 – Share-based Payment. However, many of the requirements of Section 26 are virtually impossible to interpret without recourse to IFRS 2 – Share-based Payment – from which many of the requirements and definitions of Section 26 were ultimately derived.

The IASB published IFRS 2 in February 2004. There have been three subsequent sets of amendments to IFRS 2 as well as a number of clarifications through the IASB's Annual Improvements process. The most recent amendments to IFRS 2 were published in June 2016 and were mandatory for accounting periods beginning on or after 1 January 2018 for entities applying IFRS. These June 2016 amendments have not been incorporated into FRS 102 but are referred to, where relevant, in the discussions of IFRS 2 in this chapter.

1.2 Scope of Chapter 23 and referencing convention

This chapter generally discusses the requirements of Section 26 for entities applying FRS 102 in accounting periods beginning on or after 1 January 2019. It is based on the March 2018 version of FRS 102 which includes the amendments in 2017. Section 26 has had incremental improvements and clarifications made to it as a result of the Amendments to FRS 102 Triennial review 2017 – Incremental improvements and clarifications (Triennial review 2017), with retrospective effect. The March 2018 version of FRS 102 is referred to as ‘FRS 102’ throughout this chapter.

As noted at 1.1 above, the requirements of Section 26 are virtually impossible to interpret without recourse to IFRS 2, which contains extensive application and implementation guidance. Without this guidance, the practical application of the requirements of Section 26 is difficult and we therefore draw on the guidance in IFRS 2 as part of the explanation in this chapter, applying the hierarchy on selecting accounting policies as set out in Section 10 – Accounting Policies, Estimates and Errors (see Chapter 9 at 3.2).

The application of Section 26 – and IFRS 2 – to a variety of practical situations is unclear. Whilst this chapter addresses some of the complexities, other areas of discussion are beyond the scope of this publication. EY International GAAP 2019 includes a more detailed analysis in certain areas, as indicated later in this chapter.

1.3 Overview of accounting approach

The overall approach to accounting for share-based payment transactions is complex, in part because it is something of a hybrid. Essentially the total cost (i.e. measurement) of an award is calculated by determining whether the award is a liability or an equity instrument, using criteria somewhat different from those used in accounting for financial instruments but then applying measurement principles based on those generally applicable to financial liabilities or equity instruments. However the periodic allocation (i.e. recognition) of the cost1 is determined using something closer to a straight-line accruals methodology, which would not generally be used for financial instruments.

This inevitably has the result that, depending on its legal form, a transaction of equal value to the recipient can result in several different potential charges in profit or loss. Moreover, many of the requirements are rules derived from the ‘anti-avoidance’ approach of IFRS 2. This means that an expense often has to be recorded for transactions that either have no ultimate value to the counterparty or to which, in some cases, the counterparty actually has no entitlement at all.

1.3.1 Classification differences between share-based payments and financial instruments

As noted above, not only are there differences between the accounting treatment of liabilities or equity in a share-based payment transaction as compared with that of other transactions involving liabilities or equity instruments (Section 22 – Liabilities and Equity), but the classification of a transaction as a liability or equity transaction may differ.

The most important difference is that a share-based payment transaction involving the delivery of equity instruments is always accounted for as an equity transaction, whereas a similar transaction outside the scope of the share-based payment accounting requirements might well be classified as a liability if the number of shares to be delivered varies.

2 COMPARISON BETWEEN SECTION 26 AND IFRS

As a result of the Triennial review 2017 some of the principal differences between Section 26 and IFRS 2 have been eliminated through the incremental improvements and clarifications. This section summarises the remaining principal differences between Section 26 and the requirements of IFRS 2. In some of the areas referred to below, the difference between the standards is explicit but there are others where the lack of guidance or explanation in Section 26 means that it is unclear whether or not a different accounting treatment is intended.

Prior to the Triennial review 2017, Section 26 did not include a definition of ‘vesting conditions’ or make explicitly clear that service conditions and non-market performance conditions should not be taken into account in determining the fair value of equity-settled share-based payment transaction but in estimating the number of awards expected to vest. The Triennial review 2017 now provides a definition of ‘vesting conditions’ consistent with that in IFRS 2 and clarifies that service conditions and non-market performance conditions should not be taken into account when estimating the fair value of shares or share options.

All of the areas below, which set out the differences, are addressed in more detail in the remainder of this chapter, as indicated.

2.1 Scope

2.1.1 Definitions and transactions within scope

Unlike IFRS 2, Section 26 does not provide guidance or examples in areas such as:

  • the meaning of ‘goods’ in ‘goods and services’ when used in the definition of a share-based payment transaction;
  • vested transactions;
  • transactions with shareholders as a whole;
  • business combinations; or
  • the interaction with the requirements of FRS 102 relating to financial instruments.

The differences are discussed in more detail at 3.2 and 3.3 below and, in the case of replacement awards in a business combination, at 12 below.

2.2 Recognition

2.2.1 Accounting after vesting date

FRS 102 includes no guidance on accounting for awards after vesting whereas IFRS 2 specifically prohibits a reversal of expense (see 7.1.3 below).

2.3 Measurement of equity-settled share-based payment transactions

2.3.1 Non-vesting conditions

The Triennial review 2017 amended FRS 102 whereby reference to ‘non-vesting conditions’ has been replaced with ‘conditions that are not vesting conditions’. Neither of these terms are defined in FRS 102 or IFRS 2, but IFRS 2 includes examples of such conditions as part of its implementation guidance (see 4 and 7 below).

Section 26 of FRS 102 provides an example of a condition that is not a vesting condition, such as a condition that an employee contributes to a saving plan, which is one of the examples provided in the implementation guidance of IFRS 2 as a non-vesting condition. Therefore we believe that both terms, ‘non-vesting conditions’ and ‘conditions that are not vesting conditions’, are similar and we will refer to the terms interchangeably throughout this chapter.

2.3.2 Employees and others providing similar services

Both Section 26 and IFRS 2 distinguish between awards to employees (and others providing similar services) and those to other parties providing goods or services. The recognition and measurement of equity-settled share-based payment transactions differ according to whether the counterparty is treated as an employee.

Section 26 provides no additional guidance on the meaning of ‘others providing similar services’ whereas IFRS 2 defines/explains this term in Appendix A (see 6.2.1 below).

In dealing with the recognition and measurement of share-based payments, FRS 102 sometimes refers only to employees without specifying the treatment for non-employee awards. In such cases, we assume that a similar accounting treatment is intended for non-employee awards.

2.3.3 Valuation methodology

IFRS 2 requires the use of a market price or an option pricing model for the valuation of equity-settled share-based payment transactions. FRS 102 draws a more explicit distinction than IFRS 2 between the valuation of shares and the valuation of options and appreciation rights. Section 26 specifies the following valuation hierarchy:

  • observable market price,
  • entity-specific observable market data,
  • directors' valuation using a generally accepted methodology

and gives limited examples for both shares and options/appreciation rights of the type of approach that might be taken. [FRS 102.26.10-11]. Section 26 does not mandate the use of an option pricing model for the valuation of share options when market prices are unavailable; instead it allows use of a valuation methodology ‘such as an option pricing model’.

This approach to valuation was identified by the FRC in earlier versions of FRS 102 as a significant difference between FRS 102 and the IFRS for SMEs (and therefore IFRS 2). In practical terms, it is not entirely clear what alternatives to an option pricing model are likely to provide a reliable indication of the fair value (see 9.2 and 9.3 below).

IFRS 2 includes guidance in Appendix B about the selection and application of option pricing models, none of which is reproduced in FRS 102 (see 9 below).

2.3.4 Awards where fair value cannot be measured reliably

Section 26 assumes as part of its requirements relating to the measurement of equity-settled share-based payment transactions that it will always be possible to derive a fair value for the award (see 9.2 and 9.3 below). IFRS 2 includes an approach based on the intrinsic value of the equity instruments for the ‘rare cases’ in which an entity is unable to measure reliably the fair value of those instruments. [IFRS 2.24]. The intrinsic value approach is not addressed in this chapter.

2.3.5 Cancellation of awards

IFRS 2 makes clear that an award may be cancelled either by the entity or by the counterparty and also that a failure to meet non-vesting conditions should, in certain situations, be considered to amount to the cancellation of an award. Section 26 includes no explicit requirements to mirror those in IFRS 2 (see 7.4.3 and 8.4 below).

2.3.6 Settlement of awards

Section 26 states that a settlement of an unvested equity-settled share-based payment should be treated as an acceleration of vesting. It does not specify the treatment where the fair value of the settlement exceeds the fair value of the award being cancelled. Under IFRS 2, any incremental fair value is expensed at the date of settlement but any settlement value up to the fair value of the cancelled award is debited to equity.

Similarly, Section 26 contains no guidance on the repurchase of vested equity instruments whereas IFRS 2 requires any incremental fair value to be expensed as at the date of repurchase (see 8.4 below).

2.3.7 Replacement awards following a cancellation or settlement

Section 26 includes no guidance on the accounting treatment of equity-settled awards to replace an award cancelled during the vesting period and whether, as under IFRS 2, they may be accounted for on the basis of their incremental fair value rather than being treated as a completely new award (see 8.4.4 below).

2.4 Cash-settled share-based payment transactions

Until the publication of an amendment to IFRS 2 in June 2016, the treatment of service and non-market performance conditions in determining the fair value of a cash-settled share-based payment transaction was unclear. The amendment clarified that the approach should be similar to that for equity-settled share-based payment transactions rather than the probability of such conditions being reflected directly in measuring the fair value of the liability. In the absence of a similar clarification to the wording of paragraph 14 of Section 26, we believe that either interpretation remains valid for cash-settled arrangements under FRS 102 (see 10.3.2.C below).

2.5 Share-based payment transactions with cash alternatives

2.5.1 Entity or counterparty has choice of equity- or cash-settlement

Where the counterparty has a choice of settlement in equity or cash, Section 26 requires the entity to account for the transaction as wholly cash-settled unless the choice of settlement in cash has no commercial substance (in which case the transaction is accounted for as wholly equity-settled). IFRS 2 requires a split accounting approach (between a liability and equity) for such arrangements (see 11.2 below).

There are no significant differences between the requirements of Section 26 and those of IFRS 2 for transactions where the entity has a choice of equity or cash settlement.

2.5.2 Settlement in cash of award accounted for as equity-settled (or vice versa)

Section 26 contains no guidance on how to account for the settlement in cash of an award accounted for as equity-settled (or vice versa). This is specifically addressed in IFRS 2 and discussed at 11.1.1 below.

2.6 Group plans

2.6.1 Accounting by group entity with obligation to settle an award when another group entity receives goods or services

Section 26 makes clear that a group entity receiving goods or services, but with no obligation to settle the transaction with the provider of those goods or services, accounts for a share-based payment transaction as equity-settled. However, prior to the Triennial review 2017 the accounting treatment in the entity settling the transaction was not specified. The accounting has now been clarified to be consistent with IFRS 2 and makes clear that when the entity settles the share-based payment when another group entity receives the goods or services, the entity recognises the transaction as an equity-settled share-based payment transaction only if it is settled in its own equity instruments, otherwise the transaction should be recognised as a cash-settled share-based payment transaction. [FRS 102.26.2A]. This is discussed at 3.2.1 and 13.2 below.

2.6.2 Alternative accounting treatment for group plans

Where a share-based payment award is granted by an entity to the employees of one or more members of a group, those members are permitted – as an alternative to the general recognition and measurement requirements of Section 26 – to recognise and measure the share-based payment expense on the basis of a reasonable allocation of the group expense (see 3.2.1 and 13.2-3-A below). There is no corresponding alternative treatment in IFRS 2.

2.7 Government-mandated plans

2.7.1 Unidentifiable goods/services

For certain government-mandated plans where the goods/services received or receivable in exchange for equity instruments are not identifiable, Section 26 requires the award to be valued on the basis of the equity instruments rather than the goods or services. Under IFRS 2, the scope is not restricted to government-mandated plans.

The FRC appeared to address this inconsistency in the Triennial review 2017 by introducing similar wording to that in IFRS 2, where in the absence of specifically identifiable goods or services, other circumstances may indicate that goods or services have been (or will be) received, in which case Section 26 applies. [FRS 102.26.1]. However, as noted above, Section 26 appears to restrict the requirements of unidentifiable goods or services only to certain government arrangements, for the fact the requirements are placed within the section heading ‘Government-mandated plans’ in Section 26. Therefore, it still remains unclear whether entities applying Section 26 should apply the principle more widely (see 3.2.3 below).

2.8 Plans with net settlement for tax withholding obligations

The June 2016 amendment to IFRS 2 introduced an exception for transactions with a net settlement feature for tax withholding obligations. Following application of the amendment, awards meeting the exception criteria will be accounted for in their entirety as equity-settled rather than being separated into an equity-settled element and a cash-settled element. There is no comparable exception for entities applying FRS 102. See 15.3 below.

2.9 Disclosures

The disclosure requirements of Section 26 are generally derived from, but less extensive than, those of IFRS 2. However, Section 26 has three specific requirements that are not found in IFRS 2:

  • if a valuation methodology is used to determine the fair value of equity-settled awards, the entity is required to disclose both the method and reason for choosing it;
  • for cash-settled share-based payment transactions, an entity is required to disclose how the liability was measured; and
  • where the alternative accounting treatment is adopted for group plans, disclosure of this fact is required together with the basis of allocation.

More generally, unlike IFRS, FRS 102 includes exemptions from disclosure for certain entities.

The disclosure requirements are discussed at 14 below.

2.10 First-time adoption

The first-time adoption provisions of FRS 102 are set out in Section 35 – Transition to this FRS. The specific requirements relating to share-based payments are discussed at 17 below. Unlike IFRS 1 – First-time Adoption of International Financial Reporting Standards, Section 35 does not specify the accounting treatment of an award that was granted prior to transition but subsequently modified.

3 SCOPE OF SECTION 26

This section covers the scope of the share-based payment accounting requirements of Section 26 as follows:

  • definitions from Appendix I to FRS 102 that are relevant to determining whether transactions are within the scope of Section 26 (see 3.1 below);
  • a discussion of transactions that fall within the scope of Section 26 (see 3.2 below) including group arrangements (see 3.2.1 below), transactions with employee benefit trusts (EBTs) and similar vehicles (see 3.2.2 below) and transactions where the consideration received might not be clearly identifiable (see 3.2.3 below);
  • a discussion of transactions that fall outside the scope of Section 26 (see 3.3 below); and
  • some examples of situations commonly encountered in practice and a discussion of whether they are within scope of Section 26 (see 3.4 below).

3.1 Definitions

The following definitions from Appendix I: Glossary to FRS 102 are relevant to the scope of Section 26.

Term Definition
Cash-settled share-based payment transaction A share-based payment transaction in which the entity acquires goods or services by incurring a liability to transfer cash or other assets to the supplier of those goods or services for amounts that are based on the price (or value) of equity instruments (including shares and share options) of the entity or another group entity.
Equity (equity instrument is not defined) The residual interest in the assets of the entity after deducting all its liabilities.
Equity-settled share-based payment transaction A share-based payment transaction in which the entity:
  1. receives goods or services as consideration for its own equity instruments (including shares or share options); or
  2. receives goods or services but has no obligation to settle the transaction with the supplier.
Group (group entity is not defined) A parent and all its subsidiaries.
Share-based payment The equity instruments (including shares and share options), cash or other assets to which a counterparty may become entitled in a share-based payment transaction.
Share-based payment arrangement An agreement between the entity (or another group entity or any shareholder of any group entity) and another party (including an employee) that entitles the other party to receive:
  1. cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or
  2. equity instruments (including shares or share options) of the entity or another group entity,
  3. provided the specified vesting conditions, if any, are met.
Share-based payment transaction A transaction in which the entity:
  1. receives goods or services from the supplier of those goods or services (including an employee) in a share-based payment arrangement; or
  2. incurs an obligation to settle the transaction with the supplier in a share-based payment arrangement when another group entity receives those goods or services.
Share option A contract that gives the holder the right, but not the obligation, to subscribe to the entity's shares at a fixed or determinable price for a specific period of time.

The definition of a share-based payment transaction was revised as part of the Triennial review 2017 and is now consistent with IFRS 2.

It will be seen from these definitions that FRS 102 applies not only to awards of shares and share options but also to awards of cash (or other assets) of a value equivalent to the value, or a movement in the value, of a particular number of shares.

3.2 Transactions within the scope of Section 26

Subject to the exceptions noted at 3.3 below, Section 26 must be applied to all share-based payment transactions, including:

  1. equity-settled share-based payment transactions (discussed at 5 to 9 below);
  2. cash-settled share-based payment transactions (discussed at 10 below); and
  3. transactions where either the entity or the supplier of goods or services can choose whether the transaction is to be equity-settled or cash-settled (discussed at 11 below). [FRS 102.26.1].

Whilst the boundaries between these types of transaction are reasonably self-explanatory, there may be transactions – as discussed in more detail at 10 and 11 below – that an entity may intuitively regard as equity-settled which are in fact required to be treated as cash-settled.

Although the majority of share-based payment transactions are with employees, the scope of Section 26 is not restricted to employee transactions. For example, if an external supplier of goods or services, including another group entity, is paid in shares or share options, or cash of equivalent value, Section 26 must be applied.

A share-based payment transaction as defined in FRS 102 (see 3.1 above) requires goods or services to be received or acquired, but FRS 102 does not define ‘goods’ or give any additional guidance as to what might be included within such a term. IFRS 2 includes the following within its scope and it seems appropriate to use this guidance for the purposes of Section 26:

  • inventories;
  • consumables;
  • property, plant and equipment (PP&E);
  • intangibles; and
  • other non-financial assets. [IFRS 2.5].

It will be seen that ‘goods’ do not include financial assets, which raises some further issues (see 3.3.6 below).

Although not always explicitly stated, the scope of Section 26 extends to:

  • certain transactions by other group entities and by shareholders of group entities (see 3.2.1 below);
  • transactions with employee benefit trusts (‘EBTs’) and similar vehicles (see 3.2.2 below);
  • certain transactions where the identifiable consideration received appears to be less than the consideration given (see 3.2.3 below); and
  • ‘all employee’ share plans (see 3.2.4 below).

Section 26 is silent on certain other transactions or arrangements, including vested transactions (see 3.2.5 below), where it is unclear whether the transactions or arrangements fall within the scope of the share-based payment accounting requirements.

In the absence of specific guidance in FRS 102 we suggest that entities follow the requirements of IFRS 2, or general practice that has evolved through the application of IFRS 2, as set out in the sections below.

3.2.1 Transactions by other group entities and shareholders

The definition of ‘share-based payment transaction’ (see 3.1 above) and additional requirements in paragraph 1A of Section 26 have the effect that the scope of Section 26 is not restricted to transactions where the reporting entity acquires goods or services in exchange for providing its own equity instruments (or cash or other assets based on the cost or value of those equity instruments). Within a group of companies it is common for one member of the group (typically the parent) to have the obligation to settle a share-based payment transaction in which services are provided to another member of the group (typically a subsidiary). This transaction is within the scope of Section 26 for the entity receiving the services (even though it is not a direct party to the arrangement between its parent and its employee), the entity settling the transaction and the group as a whole.

Accordingly, Section 26 requires an entity to account for a transaction in which it either:

  • receives goods or services when another entity in the same group (or shareholder of any group entity) has the obligation to settle the share-based payment transaction; or
  • has an obligation to settle a share-based payment transaction when another entity in the same group receives the goods or services

unless the transaction is clearly for a purpose other than payment for goods or services supplied to the entity receiving them. [FRS 102.26.1A].

Moreover, the definition of ‘equity-settled share-based payment transaction’ (see 3.1 above) has the effect that the analysis of the transaction as equity-settled or cash-settled (and its accounting treatment) may differ when viewed from the perspective of the entity receiving the goods or services, the entity settling the transaction and the group as a whole depending on whether or not an entity is required to settle the award and whether that settlement is in its own equity instruments.

The Triennial review 2017 clarified that an entity settling a share-based payment transaction is required to account for that transaction as a cash-settled share-based payment transaction when:

  • another group entity is receiving the goods and services; and
  • the award is not settled with the equity instruments of the settling entity. [FRS 102.26.2A].
3.2.1.A Scenarios illustrating scope requirements for group entities

In this section we consider seven scenarios, all based on the simple structure in Figure 23.1. These scenarios are by no means exhaustive, but cover the situations most commonly seen in practice.

image

Figure 23.1: Scope of IFRS 2

It should be noted that the scenarios below are based on the scope requirements of Section 26 as set out at 3.2.1 above and do not reflect the additional exemption for members of group schemes. This exemption allows the group expense to be allocated between members of the group on a reasonable basis rather than requiring each group entity to recognise and measure its expense in accordance with the general requirements of Section 26. [FRS 102.26.16]. The exemption and the accounting treatment of group share schemes generally are discussed in more detail at 13 below.

The scenarios assume that:

  • the shareholder is not a group entity; and
  • the subsidiary is directly owned by the parent company (see also 13.2.1 below in relation to intermediate parent companies).

 

Scenario Who grants the award? Which entity receives the goods or services? Who settles the award? On which entity's shares is the award based? Award settled in shares or cash?
1 Parent Subsidiary Parent Parent Shares
2 Shareholder Subsidiary Shareholder Parent Shares
3 Subsidiary Subsidiary Subsidiary Parent Shares
4 Subsidiary Subsidiary Subsidiary Subsidiary Shares
5 Parent Subsidiary Parent Subsidiary Shares
6 Parent Subsidiary Parent Parent Cash
7 Shareholder Subsidiary Shareholder Parent Cash

Scenario 1

Parent awards equity shares in Parent to employees of Subsidiary in exchange for services to Subsidiary. Parent settles the award with the employees of Subsidiary.

  1. Consolidated financial statements of Parent

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. the Parent group] … receives goods or services … in a share-based payment arrangement …’. A share-based payment arrangement includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … equity instruments … of the entity …’.

    The transaction is classified as an equity-settled transaction because it is settled in an equity instrument of the group.

  2. Separate financial statements of Parent

    Parent does not receive the goods or services but it does have the obligation to settle. This is within the scope of paragraph 1A(b) of Section 26 as Parent ‘has an obligation to settle a share-based payment transaction when another entity in the same group receives the goods or services’. The transaction is classified as an equity-settled transaction because it is settled in an equity instrument of Parent. [FRS 102.26.2A].

  3. Subsidiary

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. Subsidiary] … receives goods or services … in a share-based payment arrangement …’. A ‘share-based payment arrangement’ includes ‘an agreement between … another group entity [i.e. Parent] … and another party (including an employee) that entitles the other party to receive … equity instruments of … another group entity’.

    The transaction is classified as an equity-settled transaction because Subsidiary ‘has no obligation to settle the transaction with the supplier’.

    Even if Subsidiary is not a party to the agreement with its employees, it nevertheless records a cost for this transaction. In effect, the accounting treatment is representing that Subsidiary has received a capital contribution from Parent, which Subsidiary has then ‘spent’ on employee remuneration. This treatment is often referred to as ‘push-down’ accounting – the idea being that a transaction undertaken by one group entity (in this case, Parent) for the benefit of another group entity (in this case, Subsidiary) is ‘pushed down’ into the financial statements of the beneficiary entity.

Scenario 2

Shareholder awards equity shares in Parent to employees of Subsidiary in exchange for services to Subsidiary. Shareholder settles the award with the employees of Subsidiary.

  1. Consolidated financial statements of Parent

    Paragraph 1A of Section 26 refers to awards settled by a shareholder of a group entity on behalf of the entity receiving the goods or services.

    The transaction is classified as an equity-settled transaction, because the Parent group ‘receives goods or services but has no obligation to settle the transaction with [the] supplier’.

  2. Separate financial statements of Parent

    Scenario 2 is not within the scope of Section 26 for the separate financial statements of Parent because Parent (as a separate entity) receives no goods or services, nor does it settle the transaction.

  3. Subsidiary

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. Subsidiary] … receives goods or services … in a share-based payment arrangement …’. A ‘share-based payment arrangement’ includes ‘an agreement between … another group entity [i.e. Parent] … and another party (including an employee) that entitles the other party to receive … equity instruments of … another group entity’.

    The transaction is classified as an equity-settled transaction because Subsidiary ‘has no obligation to settle the transaction with the supplier’.

Scenario 3

Subsidiary awards equity shares in Parent to employees of Subsidiary in exchange for services to Subsidiary. Subsidiary settles the award with its employees.

  1. Consolidated financial statements of Parent

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. the Parent group] … receives goods or services … in a share-based payment arrangement …’. A share-based payment arrangement includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … equity instruments … of the entity …’

    The transaction is classified as an equity-settled transaction because it is settled in an equity instrument of Parent. [FRS 102.26.2A].

  2. Separate financial statements of Parent

    Scenario 3 is not within the scope of Section 26 for the separate financial statements of Parent because Parent (as a separate entity) receives no goods or services, nor does it settle the transaction.

  3. Subsidiary

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. Subsidiary] … receives goods or services … in a share-based payment arrangement …’. A ‘share-based payment arrangement’ includes ‘an agreement between … another group entity [i.e. Parent] … and another party (including an employee) that entitles the other party to receive … equity instruments of … another group entity’.

    The transaction is classified as a cash-settled transaction because Subsidiary has the obligation to settle the award with equity instruments issued by Parent – i.e. a financial asset in Subsidiary's separate financial statements – rather than with Subsidiary's own equity instruments.

    However, for the approach in this Scenario to apply, it must be the case that Subsidiary grants the award as a principal rather than acting as agent for Parent. If Subsidiary appears to be granting an award but is really doing so only on the instructions of Parent, as will generally be the case for UK companies, then the approach in Scenario 1 above is more likely to apply. This is discussed in more detail at 13.2-5-B below.

Scenario 4

Subsidiary awards equity shares in Subsidiary to employees of Subsidiary in exchange for services to Subsidiary. Subsidiary settles the award with the employees of Subsidiary.

  1. Consolidated financial statements of Parent

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. the Parent group] … receives goods or services … in a share-based payment arrangement’. A share-based payment arrangement includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … equity instruments … of the entity …’.

    In the consolidated financial statements of Parent, shares of Subsidiary not held by Parent are a non-controlling interest.

    Separate financial statements of Parent

    Scenario 4 is not within the scope of Section 26 for the separate financial statements of Parent because Parent (as a separate entity) receives no goods or services, nor does it settle the transaction.

  2. Subsidiary

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. Subsidiary] … receives goods or services … in a share-based payment arrangement’. A share-based payment arrangement includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … equity instruments … of the entity …’.

    The transaction is classified as an equity-settled transaction because it is settled in an equity instrument of Subsidiary.

Scenario 5

Parent awards equity shares in Subsidiary to employees of Subsidiary in exchange for services to Subsidiary. Parent settles the award with the employees of Subsidiary.

  1. Consolidated financial statements of Parent

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. the Parent group] … receives goods or services … in a share-based payment arrangement’. A share-based payment arrangement includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … equity instruments of the entity …’.

    The transaction is classified as an equity-settled transaction because it is settled in an equity instrument of the group. In the consolidated financial statements of Parent, shares of Subsidiary not held by Parent are a non-controlling interest.

  2. Separate financial statements of Parent

    Parent does not receive the goods or services but it does have the obligation to settle. This is within the scope of paragraph 1A(b) of Section 26 as Parent ‘has an obligation to settle a share-based payment transaction when another entity in the same group receives the goods or services’. The transaction is classified as a cash-settled transaction as Parent is settling the award not in its own equity instrument but in an equity instrument issued by a subsidiary and held by Parent – i.e. a financial asset in Parent's separate financial statements. [FRS 102.26.2A].

  3. Subsidiary

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. Subsidiary] … receives goods or services … in a share-based payment arrangement’. A ‘share-based payment arrangement’ includes ‘an agreement between … another group entity [i.e. Parent] … and another party (including an employee) that entitles the other party to receive equity instruments of the entity…’.

    The transaction is classified as an equity-settled transaction, because Subsidiary ‘has no obligation to settle the transaction with the supplier’.

Scenario 6

Parent awards cash based on the value of shares in Parent to employees of Subsidiary in exchange for services to Subsidiary. Parent settles the award with the employees of Subsidiary.

  1. Consolidated financial statements of Parent

    Under the definition of ‘share-based payment transaction’, ‘the entity [i.e. the Parent group] … receives goods or services … in a share-based payment arrangement’. A ‘share-based payment arrangement’ includes ‘an agreement between the entity … and another party (including an employee) that entitles the other party to receive … cash … of the entity … based on the price (or value) of equity instruments … of the entity …’.

    The transaction is classified as a cash-settled transaction, because it is settled in cash of the group.

  2. Separate financial statements of Parent

    Parent does not receive the goods or services but it does have the obligation to settle. This is within the scope of paragraph 1A(b) of Section 26 as Parent ‘has an obligation to settle a share-based payment transaction when another entity in the same group receives the goods or services’. The transaction is classified as a cash-settled transaction, because it is settled not in an equity instrument issued by Parent, but in cash based on the value of shares in Parent.

  3. Subsidiary

    When the drafting of the definition of a ‘share-based payment transaction’ is examined closely, it is not absolutely clear that this arrangement is within the scope of Section 26 for Subsidiary. In order to be a share-based payment transaction (and therefore in the scope of Section 26) for the reporting entity, a transaction must also be a share-based payment arrangement. A share-based payment arrangement is defined as one in which the counterparty receives (our emphasis added):

    • cash or other assets of the entity; or
    • equity of the entity or any other group entity.
  4. As drafted, the definition has the effect that a transaction settled in equity is in the scope of Section 26 for a reporting entity, whether the equity used to settle the transaction is the entity's own equity or that of another group entity. Where a transaction is settled in cash, however, the definition has the effect that a transaction is in the scope of Section 26 for a reporting entity only when that entity's own cash (or other assets) is used in settlement, and not when another group entity settles the transaction.

When read with the general scope requirements in paragraphs 1 and 1A, we believe that the apparent omissions from the definition of ‘share-based payment transaction’ should be regarded as minor drafting errors and that the transaction should be classified as an equity-settled transaction by Subsidiary, because Subsidiary ‘receives goods or services but has no obligation to settle the transaction with the supplier’.

Scenario 7

Shareholder awards cash based on the value of shares in Parent to employees of Subsidiary in exchange for services to Subsidiary. Shareholder settles the award with the employees of Subsidiary.

This transaction is within the scope of paragraph 1A of Section 26 for the consolidated financial statements of Parent and for the separate financial Subsidiary as it is a transaction where the shareholder has an obligation to settle on behalf of the entity receiving the goods or services. However, it does not strictly meet the definitions in Appendix I. As noted at Scenario 6 above, the definitions of ‘share-based payment transaction’ and ‘cash-settled share-based payment transaction’ as drafted do not explicitly address any arrangement that is settled in cash by a party other than the reporting entity.

Nevertheless, we believe that the transaction should be treated as being within the scope of Section 26 for the consolidated financial statements of Parent and the separate financial statements of Subsidiary and the transaction accounted for as equity-settled.

3.2.2 Transactions with employee benefit trusts and similar vehicles

It is common for an entity to establish a trust to hold shares in the entity for the purpose of satisfying share-based awards to employees. In such cases, it is often the trust, rather than any entity within the legal group, that actually makes share-based awards to employees. Awards by EBTs and similar vehicles are within the scope of Section 26 and are discussed at 13.3 below.

3.2.3 Transactions where the identifiable consideration received appears to be less than the consideration given

3.2.3.A Government-mandated plans

A share-based payment transaction as defined (see 3.1 above) involves the receipt of goods or services. Nevertheless, Section 26 also applies to government-mandated plans ‘established under law by which equity investors (such as employees) are able to acquire equity without providing goods or services that can be specifically identified (or by providing goods or services that are clearly less than the fair value of the equity instruments granted). This indicates that other consideration has been or will be received (such as past or future employee services) …’. [FRS 102.26.17].

Such arrangements are treated as equity-settled share-based payment transactions under FRS 102 and the unidentifiable goods or services are measured as the difference between the fair value of the equity instrument and the fair value of any identifiable goods or services received (or to be received) measured at the grant date. [FRS 102.26.17]. The determination of the grant date is addressed at 6.3 below.

Section 26 offers no further explanation or guidance as to the type of arrangement that is expected to fall within the scope of this paragraph. The reference to employees and employee services is somewhat puzzling since share-based payment transactions with employees are always measured at the fair value of the share-based payment rather than the fair value of the employee services, identifiable or otherwise.

What is also not made explicitly clear in paragraph 17 is that, in this situation, the fair value of a share-based payment with a non-employee would need to be that of the equity instruments rather than that of the goods or services (as would normally be the case for an award to a non-employee – see 6.1 and 6.4 below).

As Section 26 refers only to ‘programmes mandated under law’ beneath the heading ‘Government-mandated plans’, it appears that the standard does not require an entity to apply the requirements of paragraph 17 to other transactions with non-employees in which the value of goods or services received or receivable falls short of the fair value of the equity instruments or cash transferred.

IFRS 2 includes a similar requirement for transactions with non-employees where no specifically identifiable goods or services have been (or will be) received but does not restrict the scope to government-mandated plans. [IFRS 2.2]. Section 26 as a result of the Triennial review 2017 clarifications, contains similar wording and requirements in paragraph 26.1 of Section 26 to that of paragraph 2 of IFRS 2, but then goes on to restrict the requirement to government mandated plans.

IFRS 2 asserts that, if the identifiable consideration received (if any) appears to be less than the fair value of consideration given in any share-based payment arrangement, the implication is that, in addition to the identifiable goods and services acquired, the entity must also have received some unidentifiable consideration equal to the difference between the fair value of the share-based payment and the fair value of any identifiable consideration received. Accordingly, the cost of the unidentified consideration must be accounted for in accordance with IFRS 2. [IFRS 2.13A].

For example, if an entity agrees to pay a supplier of services with a clearly identifiable market value of £1,000 by issuing shares with a value of £1,500, IFRS 2 requires the entity to recognise an expense of £1,500. This is notwithstanding the normal requirement of IFRS 2 that an equity-settled share-based payment transaction with a non-employee be recognised at the fair value of the goods or services received (see 6.1 and 6.4 below).

3.2.3.B Other transactions

In rare circumstances a transaction may occur in which no goods or services are received by the entity. For example, a principal shareholder of an entity, for reasons of estate planning, may transfer shares to a relative. In the absence of indications that the relative has provided, or is expected to provide, goods or services to the entity in exchange for the shares, such a transfer would be outside the scope of Section 26 as a transaction clearly for a purpose other than payment for goods or services supplied to the entity. [FRS 102.26.1A].

3.2.4 ‘All employee’ share plans

Many countries, including the UK, encourage wider share-ownership by allowing companies to award a limited number of free or discounted shares to employees without either the employee or the employer incurring tax liabilities which would apply if other benefits in kind to an equivalent value were given to employees.

There is no exemption from the scope of Section 26 for such plans (unless they are immaterial).

3.2.5 Vested transactions

Section 26 does not specifically address the accounting treatment of awards once they have vested. Drawing on the requirements of IFRS 2, a transaction accounted for as a share-based payment does not necessarily cease to be within the scope of Section 26 once it has vested in the counterparty (see 4 below). This is made clear by the numerous provisions of IFRS 2 referring to the accounting treatment of vested awards.

Once equity shares have been unconditionally delivered or beneficially transferred to the counterparty (e.g. as the result of the vesting of an award of ordinary shares, or the exercise of a vested option over ordinary shares), the holder of those shares will often be in exactly the same position as any other holder of ordinary shares and the shares should generally be accounted for under Section 22, rather than under Section 26.

If, however, the holder of a share or vested option enjoys rights not applicable to all holders of that class of share, such as a right to put the share or the option to the entity for cash, or holds a special class of share with rights that do not apply to other classes of equity, the share or option might remain in the scope of Section 26 as long as any such rights continue to apply. The same is true of modifications made after vesting which add such rights to a vested share or option or otherwise alter the life of the share-based payment transaction. The special terms or rights will often be linked to the holder's employment with the entity but could also apply to an arrangement with a non-employee.

The significance of this is that accounting and disclosure requirements could be very different depending on whether or not transactions are considered to be within the scope of Section 26.

3.3 Transactions not within the scope of Section 26

Section 26 simply states that share-based transactions that are clearly for a purpose other than payment to the entity for goods or services are not within its scope. [FRS 102.26.1A]. It does not include any more specific examples of transactions that are outside the scope of its requirements. IFRS 2 includes some specific scope exemptions and we imagine that similar exemptions are intended to apply in the application of Section 26. The following transactions are outside the scope of IFRS 2:

  • transactions with shareholders as a whole and with shareholders in their capacity as such (see 3.3.1 below);
  • transfers of assets in certain group restructuring arrangements (see 3.3.2 below);
  • business combinations (see 3.3.3 below);
  • combinations of businesses under common control and the contribution of a business to form a joint venture (see 3.3.4 below); and
  • transactions in the scope of IAS 32 – Financial Instruments: Presentation – and IAS 39 – Financial Instruments: Recognition and Measurement – or IFRS 9 – Financial Instruments – or Section 22 (see 3.3.5 below). In addition, the scope exemptions in IFRS 2 combined with those in IAS 32 and IAS 39 (or IFRS 9) appear to have the effect that there is no specific guidance in IFRS for accounting for certain types of investments when acquired in return for shares (see 3.3.6 below).

However, as noted at 3.2.4 above, there is no exemption for share schemes aimed mainly at lower- and middle-ranking employees, referred to in different jurisdictions by terms such as ‘all-employee share schemes’, ‘employee share purchase plans’ and ‘broad-based plans’.

3.3.1 Transactions with shareholders in their capacity as such

IFRS 2 does not apply to transactions with employees (and others) purely in their capacity as shareholders. For example, an employee may already hold shares in the entity as a result of previous share-based payment transactions. If the entity then raises funds through a rights issue, whereby all shareholders (including the employee) can acquire additional shares for less than the current fair value of the shares, such a transaction is not a ‘share-based payment transaction’ for the purposes of IFRS 2. [IFRS 2.4].

3.3.2 Transfer of assets in group restructuring arrangements

In some group restructuring arrangements, one entity will transfer a group of net assets, which does not meet the definition of a business, to another entity in return for shares. Careful consideration of the precise facts and circumstances is needed in order to determine whether, for the separate or individual financial statements of any entity affected by the transfer, such a transfer meets the definition of a share-based payment transaction. If the transfer is considered primarily to be a transfer of goods by their owner in return for payment in shares then, in our view, this should be accounted for as a share-based payment transaction. However, if the transaction is for another purpose and is driven by the group shareholder in its capacity as such, the transaction may be outside the scope of share-based payment accounting (see 3.3.1 above).

Accounting for intra-group asset transfers in return for shares is considered further in Chapter 8 at 4.4.2.B.

3.3.3 Business combinations

IFRS 2 does not apply to share-based payments to acquire goods (such as inventories or property, plant and equipment) in the context of a business combination to which IFRS 3 – Business Combinations – applies. We assume that shares issued as consideration for business combinations under Section 19 – Business Combinations and Goodwill – are similarly outside the scope of Section 26.

Equity instruments granted to the employees of the acquiree in their capacity as employees (e.g. in return for continued service following the business combination) do not form part of the consideration for the business combination and are therefore within the scope of Section 26 as a share-based payment transaction, as are the cancellation, replacement or modification of a share-based payment transaction as the result of a business combination or other equity restructuring.

If a vendor of an acquired business remains as an employee of that business following the business combination and receives a share-based payment for transferring control of the entity and for remaining in continuing employment, it is necessary to determine how much of the share-based payment relates to the acquisition of control (and therefore forms part of the consideration for the business combination) and how much relates to the provision of future services (which is a post-combination operating expense). There is further discussion on this issue in Chapter 17 at 3.6.4.

3.3.4 Common control transactions and formation of joint arrangements

IFRS 2 also does not apply to a combination of entities or businesses under common control or the contribution of a business on the formation of a joint venture as defined by IFRS 11 – Joint Arrangements. [IFRS 2.5].

It should be noted that the contribution of non-financial assets (which do not constitute a business) to a joint venture in return for shares is within the scope of IFRS 2.

IFRS 2 does not directly address other types of transactions involving joint ventures or transactions involving associates, particularly arrangements relating to the employees of associates or joint ventures (see 13 below).

3.3.5 Transactions in the scope of IAS 32, IAS 39 and IFRS 9 or Section 22 (financial instruments)

IFRS 2 does not apply to transactions within the scope of IAS 32, IAS 39 or IFRS 9. Therefore, if an entity enters into a transaction to purchase, in return for shares, a commodity surplus to its production requirements or with a view to short-term profit taking, the contract is treated as a financial instrument under IAS 32 and IAS 39 or IFRS 9 rather than a share-based payment transaction under IFRS 2. [IFRS 2.6].

Some practical examples of scope issues involving IFRS 2 and IAS 32 / IAS 39 / IFRS 9 are discussed at 3.4 below.

Whilst Section 26 has no specific corresponding reference to financial assets or liabilities, Section 22 excludes from its scope financial instruments, contracts and obligations under share-based payment transactions (except for the classification requirements that relate to treasury shares) and refers users to Section 26. [FRS 102.22.2(d)].

3.3.6 Transactions relating to investments in subsidiaries, associates and joint ventures

As noted at 3.2 above, IFRS 2 applies to share-based payment transactions involving goods or services, with ‘goods’ defined so as to exclude financial assets. This means that, when (as is commonly the case) an entity acquires an investment in a subsidiary, associate or joint venture for the issue of equity instruments, there is no explicit guidance as to the required accounting in the separate financial statements of the investor when it chooses to apply a policy of ‘cost’ under paragraph 24 of Section 9 – Consolidated and Separate Financial Statements (see Chapter 8 at 4.4.2.B).

3.4 Some practical applications of the scope requirements

This section addresses the application of the scope requirements of Section 26 to a number of situations frequently encountered in practice. The situations are not specifically addressed in Section 26 but the following sections draw on the requirements of Section 26 together with related guidance in IFRS 2 and our experience of the practical application of IFRS 2:

  • remuneration in non-equity shares and arrangements with put rights over equity shares (see 3.4.1 below);
  • an increase in the counterparty's ownership interest with no change in the number of shares held (see 3.4.2 below);
  • awards for which the counterparty has paid ‘fair value’ (see 3.4.3 below);
  • a cash bonus which depends on share price performance (see 3.4.4 below);
  • cash-settled awards based on an entity's ‘enterprise value’ or other formula (see 3.4.5 below); and
  • holding own shares to satisfy or ‘hedge’ awards (see 3.4.6 below).

The following aspects of the scope requirements are covered elsewhere in this chapter:

  • employment taxes on share-based payment transactions (see 15 below); and
  • instruments such as limited recourse loans that sometimes fall within the scope of the share-based payment, rather than financial instruments, requirements because of the link both to the entity's equity instruments and to goods or services received in exchange (see 16.2 below).

3.4.1 Remuneration in non-equity shares and arrangements with put rights over equity shares

A transaction is within the scope of Section 26 only where it involves the delivery of an equity instrument, or cash or other assets based on the price or value of ‘equity instruments (including shares and share options) of the entity or another group entity’ (see 3.1 above).

There can sometimes be advantages to giving an employee, in lieu of a cash payment, a share that carries a right to a ‘one-off’ dividend, or is mandatorily redeemable, at an amount equivalent to the intended cash payment. Such a share would almost certainly be classified as a liability (based on Section 22). Payment in such a share would not fall in the scope of Section 26 since the consideration paid by the entity for services received is a financial liability rather than an equity instrument (see the definitions at 3.1 above).

If, however, the amount of remuneration delivered in this way were equivalent to the value of a particular number of equity instruments issued by the entity, then the transaction would be in scope of Section 26 as a cash-settled share-based payment transaction, since the entity would have incurred a liability (i.e. by issuing the redeemable shares) for an amount based on the price of its equity instruments.

Similarly, if an entity grants an award of equity instruments to an employee together with a put right whereby the employee can require the entity to purchase those shares for an amount based on their fair value, both elements of that transaction are in the scope of Section 26 as a single cash-settled transaction (see 10 below). This is notwithstanding the fact that, in other circumstances, the share and the put right might well be analysed as a single synthetic instrument and classified as a liability with no equity component.

3.4.2 Increase in ownership interest with no change in number of shares held

An increasingly common arrangement, typically found in entities with venture capital investors, is one where an employee (often part of the key management) subscribes initially for, say, 1% of the entity's equity with the venture capitalist holding the other 99%. The employee's equity interest will subsequently increase by a variable amount depending on the extent to which certain targets are met. This is achieved not by issuing new shares but by cancelling some of the venture capitalist's shares. In our view, such an arrangement falls within the scope of Section 26 as the employee is rewarded with an increased equity stake in the entity if certain targets are achieved. The increased equity stake is consistent with the definition of equity as ‘a residual interest’ notwithstanding the fact that no additional shares are issued.

In such arrangements, it is often asserted that the employee has subscribed for a share of the equity at fair value. However, the subscription price paid must represent a fair value using a Section 26 valuation basis in order for there to be no additional Section 26 expense to recognise (see 3.4.3 below).

3.4.3 Awards for which the counterparty has paid ‘fair value’

In certain situations, such as where a special class of share is issued, the counterparty might be asked to subscribe a certain amount for the share which is agreed as being its ‘fair value’ for taxation or other purposes. This does not mean that such arrangements fall outside the scope of Section 26, either for measurement or disclosure purposes, if the arrangement meets the definition of a share-based payment transaction. In many cases, the agreed ‘fair value’ will be lower than a fair value measured in accordance with Section 26 because it will reflect the impact of service and non-market performance vesting conditions which are excluded from a Section 26 fair value (see 7 and 9 below). This is addressed in more detail at 16.4.5 below.

3.4.4 Cash bonus dependent on share price performance

An entity might agree to pay its employees a £100 cash bonus if its share price remains at £10 or more over a given period. Intuitively, this does not appear to be in the scope of Section 26, since the employee is not being given cash of equivalent value to a particular number of shares. However, it could be argued that it does fall within the scope of Section 26 on the basis that the entity has incurred a liability, and the amount of that liability is ‘based on’ the share price (in accordance with the definition of a cash-settled share-based payment transaction) – it is nil if the share price is below £10 and £100 if the share price is £10 or more. In our view, either interpretation is acceptable.

3.4.5 Cash-settled awards based on an entity's ‘enterprise value’ or other formula

As noted at 3.1 above, Section 26 includes within its scope transactions in which the entity acquires goods or services by incurring a liability ‘based on the price (or value) of equity instruments (including shares and share options) of the entity or another group entity’. Employees of an unquoted entity may receive a cash award based on the value of the equity of that entity. Such awards are typically, but not exclusively, made by venture capital investors to the management of entities in which they have invested and which they aim to sell in the medium term. Further discussion of the accounting implications of awards made in connection with an exit event may be found at 16.4 below.

More generally, where employees of an unquoted entity receive a cash award based on the value of the equity, there is no quoted share price and an ‘enterprise value’ has therefore to be calculated as a surrogate for it. This begs the question of whether such awards are within the scope of Section 26 (because they are based on the value of the entity's equity) or that of Section 28 – Employee Benefits.

In order for an award to be within the scope of Section 26, any calculated ‘enterprise value’ must represent the fair value of the entity's equity. Where the calculation uses techniques recognised by Section 26 as yielding a fair value for equity instruments (as discussed at 9 below), we believe that the award should be regarded as within the scope of Section 26.

An unquoted entity may have calculated the value of its equity based on net assets or earnings (see 9.3 below). In our view, this may be appropriate in some cases.

Where, however, the enterprise value is based on a constant formula, such as a fixed multiple of earnings before interest, tax, depreciation and amortisation (EBITDA), in our view it is unlikely that this will represent a good surrogate for the fair value of the equity on an ongoing basis, even if it did so at the inception of the transaction. It is not difficult to imagine scenarios in which the fair value of the equity of an entity could be affected with no significant change in EBITDA, for example as a result of changes in interest rates and effective tax rates, or a significant impairment of assets. Alternatively, there might be a significant shift in the multiple of EBITDA equivalent to fair value, for example if the entity were to create or acquire a significant item of intellectual property.

The accounting treatment of awards based on the ‘market price’ of an unquoted entity raises similar issues, as discussed more fully at 7.3.7 below.

3.4.6 Holding own shares to satisfy awards

Entities often seek to ‘hedge’ the cost of share-based payment transactions by buying their own equity instruments in transactions with existing shareholders. For example, an entity could grant an employee options over 10,000 shares and buy 10,000 of its own shares into treasury, or into its employee benefit trust, at the date that the award is made. If the award is share-settled, the entity will deliver the shares to the counterparty. If it is cash-settled, it may be in a position to sell the shares to raise the cash it is required to deliver to the counterparty. In either case, the cash cost of the award is capped at the amount paid for the shares at the date the award is made, less any amount paid by the employee on exercise. It could of course be argued that such an arrangement only ‘hedges’ an increase in the price of the shares. If the share price goes down so that the option is never exercised, the entity is left holding 10,000 of its own shares that cost more than they are now worth.

Whilst these strategies may cap the cash cost of share-based payment transactions that are eventually exercised, they will not have any effect on the charge to profit or loss required by Section 26 for such transactions. This is because purchases and sales of own shares are accounted for as movements in equity and are therefore never included in profit or loss, i.e. the recognition of an expense under Section 26 for the share-based payment transaction and accounting for movements in own shares are two completely distinct areas which should be treated separately for accounting purposes (see 5.1 below).

4 GENERAL RECOGNITION PRINCIPLES

The recognition rules in Section 26 are based on a so-called ‘service date model’. In other words, an entity is required to recognise the goods or services received or acquired in a share-based payment transaction when it obtains the goods or as the services are received. [FRS 102.26.3]. For awards to employees (or others providing similar services), this contrasts with the measurement rules, which normally require a share-based payment transaction to be measured as at the date on which the transaction was entered into, which may be some time before or after the related services are received – see 5 to 8 below.

Where the goods or services received or acquired in exchange for a share-based payment transaction do not qualify for recognition as assets they should be expensed. [FRS 102.26.4]. Typically, services will not qualify as assets and should therefore be expensed immediately, whereas goods will generally be initially recognised as assets and expensed later as they are consumed. However, some payments for services may be capitalised (e.g. as part of the cost of PP&E or inventories) and some payments for goods may be expensed immediately (e.g. where they are for items included within development costs written off as incurred).

The corresponding credit entry is, in the case of an equity-settled transaction, an increase in equity and, in the case of a cash-settled transaction, a liability (or decrease in cash or other assets). [FRS 102.26.3].

The primary focus of the discussion in the remainder of this chapter is the application of these rules to transactions with employees, with the accounting treatment of transactions with non-employees addressed at 3.2.3 above and 6.1 and 6.4 below.

4.1 Vesting and vesting conditions

Under Section 26, the point at which a cost is recognised for goods or services depends on the concept of ‘vesting’.

A share-based payment to a counterparty is said to vest when it becomes an entitlement of the counterparty. The term is further defined as follows:

‘Under a share-based payment arrangement, a counterparty's right to receive cash, other assets or equity instruments of the entity vests when the counterparty's entitlement is no longer conditional on the satisfaction of any vesting conditions.’ [FRS 102 Appendix I].

This definition refers only to equity instruments of the entity and omits any reference to equity instruments of other group entities. This appears to be a drafting oversight given that the scope of Section 26 and the definitions of equity- and cash-settled share-based payment transactions in Appendix I to FRS 102 all refer to the equity instruments of the entity and other group entities.

The definition above refers to ‘vesting conditions’. Prior to the Triennial review 2017 this term was not defined in FRS 102. However, the standard now defines the term and is consistent with IFRS 2. Vesting conditions are defined as ‘conditions that determines whether the entity receives the services that entitle the counterparty to receive cash, other assets or equity instruments of the entity, under a share-based payment arrangement. Vesting conditions are either service conditions or performance conditions.’ [FRS 102 Appendix I].

The definition of vesting conditions emphasises the receipt of services by the entity. The recognition principles in FRS 102 using this approach set out the differing accounting treatments, discussed further below, depending on whether the share-based payment transaction includes a service condition. A service condition is, ‘a vesting condition that requires the counterparty to complete a specified period of service during which services are provided to the entity. If the counterparty, regardless of the reason, ceases to provide service during the vesting period, it has failed to satisfy the condition. A service condition does not require a performance target to be met.’ [FRS 102 Appendix I].

The absence of a service requirement means that an award will vest, or be deemed to vest, immediately as there is no service to be rendered before the counterparty becomes unconditionally entitled to the award. This concept of immediate vesting is reinforced by the fact that FRS 102 requires an entity to presume, in the absence of evidence to the contrary, that services rendered by the counterparty (for example, an employee) as consideration for the share-based payments have already been received. Where there is immediate vesting, the entity is required to recognise the services received, i.e. the cost of the award, in full on the grant date of the award with a corresponding credit to equity or liabilities. [FRS 102.26.5].

If, as will generally be the case for employee awards, the share-based payments do not vest until the counterparty completes a specified period of service, the entity should presume that the services to be rendered by the counterparty as consideration for those share-based payments will be received in the future, during the vesting period, i.e. the period over which the services are being rendered in order for the award to vest. The entity is required to account for those services as they are rendered by the counterparty during the vesting period, with a corresponding increase in equity or liabilities. [FRS 102.26.6]. For example, if an employee is granted a share option with a service condition of remaining in employment with an entity for three years, the award vests three years after the date of grant. Accordingly, if the employee is still employed by the entity the cost of the award will be recognised over that three-year period.

As mentioned above, the vesting of awards might also be conditional on performance conditions which require both the counterparty to complete a specified period of service and specified performance targets to be met. Following the amendment to FRS 102 from the Triennial review 2017, the standard includes the following definition of a ‘performance condition’ consistent with IFRS 2:

‘A vesting condition that requires:

  1. the counterparty to complete a specified period of service (i.e. a service condition); the service requirement can be explicit or implicit; and
  2. specified performance target(s) to be met while the counterparty is rendering the service required in (a).

The period of achieving the performance target(s):

  1. shall not extend beyond the end of the service period; and
  2. may start before the service period on the condition that the commencement date of the performance target is not substantially before the commencement of the service period;

A performance target is defined by reference to:

  1. the entity's own operations (or activities) or the operations or activities of another entity in the same group (i.e. a non-market condition); or
  2. the price (or value) of the entity's equity instruments or the equity instruments of another entity in the same group (including shares and share options) (i.e. a market condition).

A performance target might relate either to the performance of the entity as a whole or to some part of the entity (or part of the group), such as a division or an individual employee.' [FRS 102 Appendix I].

Examples of performance conditions are a specified increase in the entity's profit over a specified period of time (a non-market condition – see 7.2 below) or a specified increase in the entity's share price (a market condition – see 7.3 below). [FRS 102.26.9]. As discussed more fully at 4.2 below, performance conditions refer to performance by an employee (such as a personal sales target) or performance by the entity (or part of the entity), rather than an external performance indicator, such as a general stock market index.

Thus a condition that an award vests if, in three years' time, earnings per share have increased by 10% and the employee is still in employment, is a performance condition. If, however, the award becomes unconditional in three years' time if earnings per share have increased by 10%, irrespective of whether the employee is still in employment, that condition is not a performance condition, but a ‘non-vesting’ condition because there is no associated service requirement (see 4.2 below).

In addition to the general discussion above and in the remainder this section, specific considerations relating to awards that vest on a flotation or change of control (or similar exit event) are addressed at 16.4 below.

4.2 Non-vesting conditions (conditions that are neither service conditions nor performance conditions)

Some share-based payment transactions are dependent on the satisfaction of conditions that are neither service conditions nor performance conditions. For example, an employee might be given the right to 100 shares in three years' time, subject only to the employee not working in competition with the reporting entity during that time. An undertaking not to work for another entity does not include a requirement for the counterparty to complete a specified period of service with the entity – the employee could sit on a beach for three years and still be entitled to collect the award. Accordingly, such a condition is not regarded as a vesting condition for the purposes of Section 26, but is instead referred to as a ‘condition that is not a vesting condition’. [FRS 102.26.9]. Alternatively IFRS 2 refers to such a condition as a ‘non-vesting condition’. Throughout this chapter we will refer to a ‘condition that is not a vesting condition’ as a ‘non-vesting condition’ (see 2.3.1 above).

Section 26 introduces the concept of a non-vesting condition when discussing the measurement of equity-settled awards, providing an example of a condition when an employee contributes to a saving plan as a condition that is not vesting condition, but does not otherwise define the term. [FRS 102.26.9]. Given the similarities of approach to recognition and measurement in IFRS 2 and Section 26, we presume that the concept of a non-vesting condition under FRS 102 is intended to be the same as that under IFRS 2 and this is the approach adopted in this chapter. The accounting impact of non-vesting conditions is discussed in detail at 7.4 below.

Although IFRS 2 contains a little more explanation about non-vesting conditions than is found in FRS 102, it does not explicitly define a ‘non-vesting condition’ but uses the term to describe a condition that is neither a service condition nor a performance condition. However, the concept of the ‘non-vesting’ condition is not entirely clear and the identification of such conditions is not always straightforward. This has sometimes resulted in differing views on the appropriate classification of certain types of condition depending on whether or not they were considered to be measures of the entity's performance or its activities and hence performance vesting conditions.

As noted at 4.1 above, FRS 102 and IFRS 2 define a vesting condition as a condition that determines whether the entity receives the services that entitle the counterparty to receive payment in equity or cash. Performance conditions are those that require the counterparty to complete a specified period of service and specified performance targets to be met (such as a specified increase in the entity's profit over a specified period of time).

The Basis for Conclusions to IFRS 2 adds that the feature that distinguishes a performance condition from a non-vesting condition is that the former has an explicit or implicit service requirement and the latter does not. [IFRS 2.BC171A].

In issuing its Annual Improvements to IFRSs 2010-2012 Cycle in December 2013 the IASB considered whether a definition of ‘non-vesting condition’ was needed. It decided that ‘the creation of a stand-alone definition … would not be the best alternative for providing clarity on this issue’. [IFRS 2.BC364]. Instead, it sought to provide further clarification in the Basis for Conclusions to IFRS 2, as follows:

‘…the Board observed that the concept of a non-vesting condition can be inferred from paragraphs BC170-BC184 of IFRS 2, which clarify the definition of vesting conditions. In accordance with this guidance it can be inferred that a non-vesting condition is any condition that does not determine whether the entity receives the services that entitle the counterparty to receive cash, other assets or equity instruments of the entity under a share-based payment arrangement. In other words, a non-vesting condition is any condition that is not a vesting condition.’ [IFRS 2.BC364].

For a condition to be a performance vesting condition, it is not sufficient for the condition to be specific to the performance of the entity. There must also be an explicit or implied service condition that extends to the end of the performance period. For example, a condition that requires the entity's profit before tax or its share price to reach a minimum level, but without any requirement for the employee to remain in employment throughout the performance period, is not a performance condition, but a non-vesting condition.

Specific examples of non-vesting conditions given by IFRS 2 include:

  • a requirement to make monthly savings during the vesting period;
  • a requirement for a commodity index to reach a minimum level;
  • restrictions on the transfer of vested equity instruments; or
  • an agreement not to work for a competitor after the award has vested – a ‘non-compete’ agreement. [IFRS 2.BC171B, IG24].

The IASB has also clarified that a condition related to a share market index target (rather than to the specific performance of the entity's own shares) is a non-vesting condition because a share market index reflects not only the performance of an entity but also that of other entities outside the group. Even where an entity's share price makes up a substantial part of the share market index, the IASB confirmed that this would still be a non-vesting condition because it reflects the performance of other, non-group, entities. [IFRS 2.BC354-358].

Thus, whilst conditions that are not related to the performance of the entity are always, by their nature, non-vesting conditions, conditions that relate to the performance of the entity may or may not be non-vesting conditions depending on whether there is also a requirement for the counterparty to render service.

As noted at 4.1 above, FRS 102 and IFRS 2 define a performance condition. The definition clarifies the extent to which the period of achieving the performance target(s) needs to coincide with the service period and states that this performance period:

  1. shall not extend beyond the end of the service period; and
  2. may start before the service period on the condition that the commencement date of the performance target is not substantially before the commencement of the service period.

There clearly remains an element of judgement in the interpretation of ‘substantially’ as used in the definition.

There is further discussion of the accounting treatment of non-vesting conditions at 7.4 below.

4.3 Vesting period

As noted at 4.1 above, the vesting period is the period during which all the specified vesting conditions of a share-based payment arrangement are to be satisfied. This is not the same as the exercise period or the life of the option, as illustrated by Example 23.1 below.

It is also important to distinguish between vesting conditions and other restrictions on the exercise of options and / or trading in shares, as illustrated by Example 23.2 below.

The accounting implications of vesting conditions, non-vesting conditions and vesting periods for equity-settled transactions are discussed at 5 to 8 below and for cash-settled transactions at 10 below.

5 EQUITY-SETTLED TRANSACTIONS – OVERVIEW

5.1 Summary of accounting treatment

The provisions relating to accounting for equity-settled transactions are complex, even when supplemented by additional guidance as is found in the appendices and implementation guidance to IFRS 2. As noted at 1.2 above, FRS 102 does not replicate this guidance and so we have referred to IFRS 2 to supplement the requirements of FRS 102.

The key points can be summarised as follows.

  1. All equity-settled transactions are measured at fair value. However, transactions with employees are measured using a ‘grant date model’ (i.e. the transaction is recorded at the fair value of the equity instrument at the date when it is originally granted), whereas transactions with non-employees are normally measured using a ‘service date model’ (i.e. the transaction is recorded at the fair value of the goods or services received at the date they are received). As noted at 4 above, all transactions, however measured, are recognised using a ‘service date model’ (see 6 below).
  2. Where an award is made subject to future fulfilment of conditions, a ‘market condition’ (i.e. one related to the market price (or value) of the entity's equity instruments) or a ‘non-vesting condition’ (i.e. one that is neither a service condition nor a performance condition) is taken into account in determining the fair value of the award. However, the effect of conditions other than market and non-vesting conditions is ignored in determining the fair value of the award (see 4 above and 7 below).
  3. Where an award is made subject to future fulfilment of service or performance vesting conditions, its cost is recognised over the period during which the service condition is fulfilled (see 4 above and 7 below). The corresponding credit entry is recorded within equity (see 5.2 below).
  4. Until an equity instrument has vested (i.e. the entitlement to it is no longer conditional on future service) any amounts recorded are in effect contingent and will be adjusted if more or fewer awards vest than were originally anticipated to do so. However, an equity instrument awarded subject to a market condition or a non-vesting condition is considered to vest irrespective of whether or not that market or non-vesting condition is fulfilled, provided that all other vesting conditions are satisfied (see 7 below).
  5. No adjustments are made, either before or after vesting, to reflect the fact that an award has no value to the employee or other counterparty e.g. in the case of a share option, because the option exercise price is above the current market price of the share (see 7.1.1 and 7.1.3 below).
  6. If an equity instrument is cancelled, whether by the entity or the counterparty (see (g) below) before vesting, any amount remaining to be expensed is charged in full at that point (see 8.4 below). If an equity instrument is modified before vesting (e.g. in the case of a share option, by changing the performance conditions or the exercise price), the financial statements must continue to show a cost for at least the fair value of the original instrument, as measured at the original grant date, together with any excess of the fair value of the modified instrument over that of the original instrument, as measured at the date of modification (see 8.3 below).
  7. Where an award lapses during the vesting period due to a failure by the counterparty to satisfy a non-vesting condition within the counterparty's control, or a failure by the entity to satisfy a non-vesting condition within the entity's control, the lapse of the award is accounted for as if it were a cancellation (see (f) above and 7.4.3 below).
  8. In determining the cost of an equity-settled transaction, whether the entity satisfies its obligations under the transaction with a fresh issue of shares or by purchasing its own shares in the financial markets or from private company shareholders is completely irrelevant to the charge in profit or loss, although there is clearly a difference in the cash flows. Where own shares are purchased, they are accounted for as treasury shares (see 3.4.6 above).

The requirements summarised in (d) to (g) above can have the effect that an entity is required to record a cost for an award that is deemed to vest for accounting purposes but ultimately has no value to the counterparty because the award either does not vest or vests but is not exercised. These rather counter-intuitive requirements are in part ‘anti-abuse’ provisions to prevent entities from applying a ‘selective’ grant date model, whereby awards that increase in value after grant date remain measured at grant date while awards that decrease in value are remeasured. This is discussed further in the detailed analysis at 6 to 8 below.

5.2 The credit entry

As noted at (c) in the summary at 5.1 above, the basic accounting entry for an equity-settled share-based payment transaction is: [FRS 102.26.3]

    • Dr Profit or loss for the period (employee costs)
      • Cr Equity.

FRS 102 does not prescribe whether the credit should be to a separate reserve or, if the entity chooses to treat it as such, how it should be described. Under the Companies Act 2006, an entity is permitted to credit a separate ‘other reserve’ rather than the credit being allocated initially to the profit and loss reserve. The ‘other reserve’ is generally labelled as ‘shares to be issued’ or ‘share-based payment reserve’ with the share-based payment credit held within this reserve until the award vests (if an award of free shares), is exercised or lapses (an award of options). When such trigger events occur, it will be appropriate for the entity to make a transfer between reserves.

The FRS 102 credit is not taken to share capital and share premium as these are used to record the legal proceeds of a share issue.

Overall, there will be a net nil impact on equity arising from the FRS 102 accounting as the profit and loss expense is ultimately reflected in the profit and loss reserve and offset by the credit taken directly to equity. The impact on distributable profits of employee share schemes depends on whether or not the reporting entity is a public company. Whilst FRS 102 is not specifically addressed, the effect of the similar accounting requirements of IFRS 2 is discussed in Section 7 of TECH 02/17BL: Guidance on Realised and Distributable Profits under the Companies Act 2006 (TECH 02/17BL). [TECH 02/17BL.7].

Occasionally there will be a credit to profit or loss (see for instance Example 23.12 at 7.2.4 below) and a corresponding reduction in equity.

6 EQUITY-SETTLED TRANSACTIONS – COST OF AWARDS

6.1 Cost of awards – overview

The general measurement rule in FRS 102 is that an entity must measure the goods or services received, and the corresponding increase in equity, directly, at the fair value of the goods or services received, unless that fair value cannot be estimated reliably. If the fair value of the goods or services received cannot be estimated reliably, the entity must measure their value, and the corresponding increase in equity, indirectly, by reference to the fair value of the equity instruments granted. [FRS 102.26.7].

‘Fair value’ is defined in Appendix I to FRS 102 as ‘the amount for which an asset could be exchanged, a liability settled, or an equity instrument granted could be exchanged, between knowledgeable, willing parties in an arm's length transaction’. The definition goes on to make clear that, in the absence of more specific guidance within individual sections of FRS 102, the Appendix to Section 2 – Concepts and Pervasive Principles – should be used in determining fair value. Therefore, where the fair value of a share-based payment is based on the fair value of the goods or services, the Section 2 Appendix guidance should be used. Where the share-based payment is measured on the basis of the fair value of the equity instruments rather than the goods or services, Section 26 has its own specific rules in relation to determining the fair value which differ from the more general fair value measurement requirements of FRS 102 (see 6.5 below).

On their own, the general measurement principles of paragraph 7 of Section 26 might suggest that the reporting entity must determine in each case whether the fair value of the equity instruments granted or that of the goods or services received is more reliably determinable. However, paragraph 7 goes on to clarify that, in the case of transactions with employees and others providing similar services, the fair value of the equity instruments must always be used ‘because typically it is not possible to estimate reliably the fair value of the services received’ (see 6.2 below). [FRS 102.26.7].

Moreover, transactions with employees and others providing similar services are measured at the date of grant (see 6.2 below), whereas those with non-employees are measured at the date when the entity obtains the goods or the counterparty renders service (see 6.4 below). [FRS 102.26.8].

The overall position can be summarised by the following matrix.

Counterparty Measurement basis Measurement date Recognition date
Employee Fair value of equity instruments awarded Grant date Service date
Non-employee Fair value of goods or services received or, if goods or services not reliably measurable, fair value of equity instruments awarded Service date Service date

One effect of a grant date measurement model is that, applied to a grant of share options that is eventually exercised, it ‘freezes’ the accounting cost at the (typically) lower fair value at the date of grant. This excludes from the post-grant financial statements the increased cost and volatility that would be associated with a model that constantly remeasured the award to fair value until exercise date.

The price to be paid in accounting terms for the grant date model is that, when an award falls in value after grant date, it continues to be recognised at its higher grant date value. It is therefore quite possible that, during a period of general economic downturn, financial statements will show significant costs for options granted in previous years, but which are currently worthless.

6.2 Transactions with employees and others providing similar services

These will comprise the great majority of transactions accounted for as equity-settled share-based payments under Section 26 and include all remuneration in the form of shares, share options and any other form of reward settled in equity instruments of the entity or a member of its group.

6.2.1 Who is an ‘employee’?

Given the difference between the accounting treatment of equity-settled transactions with employees and with non-employees, it is obviously important to understand what is meant by ‘employees and others providing similar services’. [FRS 102.26.7]. FRS 102 does not provide a definition but IFRS 2 defines ‘employees and others providing similar services’ as individuals who render personal services to the entity and either:

  1. the individuals are regarded as employees for legal or tax purposes;
  2. the individuals work for the entity under its direction in the same way as individuals who are regarded as employees for legal or tax purposes; or
  3. the services rendered are similar to those rendered by employees.

The term encompasses all management personnel, i.e. those persons having authority and responsibility for planning, directing and controlling the activities of the entity, including non-executive directors. [IFRS 2 Appendix A].

The implication of (a) and (b) above is that it is not open to an entity to argue that an individual who is not an employee as a matter of law is therefore automatically a non-employee for the purposes of IFRS 2 and FRS 102.

The implication of (b) and (c) above is that, where a third party provides services pursuant to a share-based payment transaction that could be provided by an employee (e.g. where an external IT consultant works alongside an in-house IT team), that third party is treated as an employee rather than a non-employee for the purposes of IFRS 2 and FRS 102.

Conversely, however, where an entity engages a consultant to undertake work for which there is not an existing in-house function, the implication is that such an individual is not regarded as an employee. In other words, in our view, the reference in (c) to ‘services … similar to those rendered by employees’ is to services rendered by employees that the entity actually has, rather than to employees that the entity might have if it were to recruit them. Otherwise, the distinction in IFRS 2 and FRS 102 between employees and non-employees would have no effect, since it would always be open to an entity to argue that it could employ someone to undertake any task instead of engaging a contractor.

Exceptionally, there might be cases where the same individual is engaged in both capacities. For example, a director of the entity might also be a partner in a firm of lawyers and be engaged in that latter capacity to advise the entity on a particular issue. It might be more appropriate to regard payment for the legal services as made to a non-employee rather than to an employee.

6.2.2 Basis of measurement

As noted above, equity-settled transactions with employees must be measured by reference to the fair value of the equity instruments granted at ‘grant date’ (see 6.3 below). [FRS 102.26.8]. FRS 102 offers no explanation as to why this should be the case, but IFRS 2 asserts that this approach is necessary because shares, share options and other equity instruments are typically only part of a larger remuneration package, such that it would not be practicable to determine the value of the work performed in consideration for the cash element of the total package, the benefit-in-kind element, the share option element and so on. [IFRS 2.12].

In essence, this is really an anti-avoidance provision. The underlying concern is that, if an entity were able to value options by reference to the services provided for them, it might assert that the value of those services was zero, on the argument that its personnel are already so handsomely rewarded by the non-equity elements of their remuneration package (such as cash and health benefits), that no additional services are (or indeed could be) obtained by granting options.

6.3 Grant date

The determination of grant date is critical to the measurement of equity-settled share-based transactions with employees, since grant date is the date at which such transactions must be measured (see 6.2 above). Grant date is defined as:

‘The date at which the entity and another party (including an employee) agree to a share-based payment arrangement, being when the entity and the counterparty have a shared understanding of the terms and conditions of the arrangement. At grant date the entity confers on the counterparty the right to cash, other assets or equity instruments of the entity, provided the specified vesting conditions, if any, are met. If that agreement is subject to an approval process (for example, by shareholders), grant date is the date when that approval is obtained.’ [FRS 102 Appendix I].

In practice, it is not always clear when a shared understanding of the award (and, therefore, grant date) has occurred. Issues of interpretation can arise as to:

  • how precise the shared understanding of the terms of the award must be; and
  • exactly what level of communication between the reporting entity and the counterparty is sufficient to ensure the appropriate degree of agreement and ‘shared understanding’.

As a consequence, the determination of the grant date is often difficult in practice. We discuss the following issues in more detail in the sections below:

  • basic determination of grant date (see 6.3.1 below);
  • the communication of awards to employees and the rendering of services in advance of grant date (see 6.3.2 below);
  • awards where the exercise price or performance target depends on a formula or on a future share price (see 6.3.3 below);
  • awards where the exercise price is paid in shares – net settlement of award (see 6.3.4 below);
  • an award of equity instruments to a fixed monetary value (see 6.3.5 below);
  • awards with multiple service and performance periods (see 6.3.6 below);
  • awards subject to modification or discretionary re-assessment by the entity after the original grant date (see 6.3.7 below); and
  • mandatory or discretionary awards to ‘good leavers’ (see 6.3.8 below).

Some arrangements give rise to significant issues of interpretation in relation to the determination of grant date and the appropriate accounting treatment. For example:

  • automatic full or pro rata entitlement to awards on cessation of employment (see 6.3.8.C below); and
  • awards over a fixed pool of shares (including ‘last man standing’ arrangements) (see 6.3.9 below).

An outline of the nature of these arrangements is given in this chapter but a detailed discussion is beyond the scope of this publication.

6.3.1 Determination of grant date

The definition of ‘grant date’ in Appendix I to FRS 102 (see 6.3 above) emphasises that a grant occurs only when all the conditions are understood and agreed by the parties to the arrangement and any required approval process has been completed. This is reinforced by the implementation guidance accompanying the same definition in IFRS 2 which, in our view, should also be considered by an entity applying FRS 102.

For example, if an entity makes an award ‘in principle’ to an employee of options whose terms are subject to review or approval by a remuneration committee or the shareholders, ‘grant date’ is the later date when the necessary formalities have been completed. [FRS 102 Appendix I, IFRS 2.IG1-3].

The implementation guidance to IFRS 2 emphasises that the word ‘agree’ is ‘used in its usual sense, which means that there must be both an offer and an acceptance of that offer’. Therefore, there cannot be a grant unless an offer by one party has been accepted by the other party. The guidance notes that agreement will be explicit in some cases (e.g. if an agreement has to be signed), but in others it might be implicit, such as when an employee starts to deliver services for the award. [IFRS 2.IG2]. Determination of when the counterparty has agreed to an offer will often be an area of judgement that depends on the precise facts and circumstances of a particular situation.

The implementation guidance to IFRS 2 further notes that employees may begin rendering services in consideration for an award before it has been formally ratified. For example, a new employee might join an entity on 1 January and be granted options relating to performance for a period beginning on that date, but subject to formal approval by the remuneration committee at its next quarterly meeting on 15 March. In that case, the entity would typically begin expensing the award from 1 January based on a best estimate of its fair value, but would subsequently adjust that estimate so that the ultimate cost of the award was its actual fair value at 15 March (see 6.3.2 below). [IFRS 2.IG4]. This reference to formal approval could be construed as indicating that, in fact, FRS 102 and IFRS 2 require not merely that there is a mutual understanding of the award (which might well have been in existence since 1 January), but also that the entity has completed all processes necessary to make the award a legally binding agreement.

In practice, many situations are much less clear-cut than the examples given in the implementation guidance. Some of the practical interpretation issues are considered further below.

6.3.2 Communication of awards to employees and services in advance of grant date

As discussed at 6.3.1 above, the definition of grant date in FRS 102 together with the implementation guidance to IFRS 2 indicate that, in order for a grant to have been made, there must not merely be a mutual understanding of the terms – including the conditions attached to the award – but there must also be a legally enforceable arrangement. Thus, if an award requires board or shareholder approval for it to be legally binding on the reporting entity, it has not been granted until such approval has been given, even if the terms of the award are fully understood at an earlier date. However, if services are effectively being rendered for an award from a date earlier than the grant date as defined in IFRS 2, the cost of the award should be recognised over a period starting with that earlier date. [IFRS 2.IG4].

In some situations the employee will have a valid expectation of an award, and the entity will have a corresponding obligation, based on an earlier commitment by the entity. However, it might be the case that not all of the precise terms and conditions have been finalised. In our view, provided it is possible to estimate the fair value of the arrangement, an estimated cost for services should be recognised in advance of grant date in such cases as well as in those situations where formal approval does not take place until a later date.

The implications of this approach are illustrated in Example 23.3 below for a situation where formal approval of an award is delayed. It is important, however, to retain a sense of proportion in considering the overall impact on the financial statements. For example, in cases where the share price or value is not particularly volatile, whether the grant date is, say, 1 January or 1 April may not make a great difference to the valuation of the award, particularly when set beside the range of acceptable valuations resulting from the use of estimates in the valuation process.

Examples of situations where an employee might render service in advance of the formal grant date because the precise conditions of an award are outstanding are considered at 6.3.3 to 6.3.6 and at 16.4.1 below.

6.3.3 Exercise price or performance target dependent on a formula or future share price

Some share plans define the exercise price not in absolute terms, but as a factor of the share price. For example, the price might be expressed as:

  • a percentage of the share price at exercise date; or
  • a percentage of the lower of the share price at grant date and at exercise date.

The effect of this is that, although the actual exercise price is not known until the date of exercise, both the entity and the counterparty already have a shared understanding of how the price will be calculated and it is possible to estimate the outcome on an ongoing basis without the need for additional approval or inputs.

A similar approach might be applied in the setting of performance targets, i.e. they are set by reference to a formula rather than in absolute terms and so do not require further input by the entity or its shareholders.

In order for there to be a shared understanding and a grant date, the formula or method of determining the outcome needs to be sufficiently clear and objective to allow both the entity and the counterparty to make an estimate of the outcome of the award during the vesting period. Accordingly, in our view, grant date is the date on which the terms and conditions (including the formula for calculating the exercise price or performance target) are determined sufficiently clearly and agreed by the entity and the counterparty, subject to the matters discussed at 6.3.2 above.

6.3.4 Exercise price paid in shares (net settlement of award)

Some share awards allow the exercise price to be paid in shares. In practical terms, this means that the number of shares delivered to the counterparty will be the total ‘gross’ number of shares awarded less as many shares as have, at the date of exercise, a fair value equal to the exercise price.

In our view, this situation is analogous to that described at 6.3.3 above in that, whilst the absolute ‘net’ number of shares awarded will not be known until the date of exercise, the basis on which that ‘net’ number will be determined is established in advance. Accordingly, in our view, grant date is the date on which the terms and conditions (including the ability to surrender shares to a fair value equal to the exercise price) are determined and agreed by the entity and the counterparty, subject to the matters discussed at 6.3.2 above.

Such a scheme could be analysed as a share-settled share appreciation right (whereby the employee receives shares to the value of the excess of the value of the shares given over the exercise price), which is accounted for as an equity-settled award.

Awards settled in shares net of a cash amount to meet an employee's tax liability are considered further at 15.3 below.

6.3.5 Award of equity instruments to a fixed monetary value

Some entities may grant awards to employees of shares to a fixed value. For example, an entity might award as many shares as are worth £10,000, with the number of shares being calculated by reference to the share price as at the vesting date. The number of shares ultimately received will not be known until the vesting date. This begs the question of whether such an award can be regarded as having been granted until that date, on the argument that it is only then that the number of shares to be delivered – a key term of the award – is known, and therefore there cannot be a ‘shared understanding’ of the terms of the award until that later date.

In our view, however, this situation is analogous to those in 6.3.3 and 6.3.4 above in that, whilst the absolute number of shares awarded will not be known until the vesting date, the basis on which that number will be determined is established in advance in a manner sufficiently clear and objective as to allow an ongoing estimate by the entity and by the counterparty of the number of awards expected to vest. Accordingly, in our view, grant date is the date on which the terms and conditions are determined sufficiently clearly and agreed by the entity and the counterparty, subject to the matters discussed at 6.3.2 above.

FRS 102 does not address the valuation of such awards and IFRS 2 does not address it directly. Intuitively, it might seem obvious that an award which promises (subject to vesting conditions) shares to the value of £10,000 must have a grant date fair value of £10,000, adjusted for the time value of money, together with market conditions and non-vesting conditions. However, matters are not so clear-cut, as Example 23.4 illustrates:

Whilst there are hints in the Basis for Conclusions to IFRS 2 that the IASB thought that the two awards should be similarly valued, this treatment is not made explicitly clear.

Some argue that an award of shares to a given monetary amount contains a market condition, since the number of shares ultimately delivered (and therefore vesting) depends on the market price of the shares on the date of delivery. This allows the award to be valued at a fixed amount at grant date. We acknowledge that a literal reading of the definition of ‘market condition’ in FRS 102 and IFRS 2 supports this view, but question whether this can really have been intended. In our view, the essential feature of a share-based payment transaction subject to a market condition must be that the employee's ultimate entitlement to the award depends on the share price rather than the share price simply being used to determine the number of shares.

In our view, the principal question is whether the measurement of the transaction should be based on the overall award or on each share or share equivalent making up the award. In the absence of clear guidance as to the appropriate unit of account, entities may take a number of views on how to value awards of shares to a given value, but should adopt a consistent approach for all such awards.

6.3.6 Awards with multiple service and performance periods

Entities frequently make awards that cover more than one reporting period, but with different performance conditions for each period, rather than a single cumulative target for the whole vesting period. In such cases, the grant date may depend on the precision with which the terms of the award are communicated to employees, as illustrated by Example 23.5 below.

A variation on the above two scenarios which is seen quite frequently in practice is an award where the target is quantified for the first year and the targets for subsequent years depend on a formula-based increase in the year 1 target. The formula is set at the same time as the year 1 target. Whether the accounting treatment for scenario 1 above or scenario 2 above is the more appropriate in such a situation is, in our view, a matter of judgement depending on the precise terms of the arrangement (see 6.3.3 above).

6.3.7 Awards subject to modification by entity after original grant date

Some employee share awards are drafted in terms that give the entity discretion to modify the detailed terms of the scheme after grant date. Some have questioned whether this effectively means that the date originally determined as the ‘grant date’ is not in fact the grant date as defined in FRS 102, on the grounds that the entity's right to modify means that the terms are not in fact understood by both parties in advance.

In our view, this is very often not an appropriate analysis. If it were, it could mean that significant numbers of share-based awards to employees (including most in the UK) would be required to be measured at vesting date, which clearly is not intended under the grant date model in Section 26.

However, the assessment of whether or not an intervention by the entity after grant date constitutes a modification is often difficult. Some situations commonly encountered in practice are considered in the sections below.

6.3.7.A Significant equity restructuring or transactions

Many schemes contain provisions designed to ensure that the value of awards is maintained following a major capital restructuring (such as a share split or share consolidation – see 8.7 below) or a major transaction with shareholders as a whole (such as a major share buyback or the payment of a special dividend). These provisions will either specify the adjustments to be made in a particular situation or, alternatively, may allow the entity to make such discretionary adjustments as it sees fit in order to maintain the value of awards. In some cases the exercise of such discretionary powers may be relatively mechanistic (e.g. the adjustment of the number of shares subject to options following a share split). In other cases, more subjectivity will be involved (e.g. in determining whether a particular dividend is a ‘special’ dividend for the purposes of the scheme).

In our view, where the scheme rules specify the adjustments to be made or where there is a legal requirement to make adjustments in order to remedy any dilution that would otherwise arise, the implementation of such adjustments would not result in the recognition of any incremental fair value. This assumes that the adjustment would simply operate on an automatic basis to put the holders of awards back to the position that they would have been in had there not been a restructuring and hence there would be no difference in the fair value of the awards before and after the restructuring (or other specified event).

However, where there is no such explicit requirement in the scheme rules or under relevant legislation, we believe that there should be a presumption that the exercise of the entity's discretionary right to modify is a ‘modification’ as outlined in FRS 102. In such a situation, the fair values before and after the modification may differ and any incremental fair value should be expensed over the remaining vesting period (see 8.3 below).

6.3.7.B Interpretation of general terms

More problematic might be the exercise of any discretion by the entity to interpret the more general terms of a scheme in deciding whether performance targets have been met and therefore whether, and to what extent, an award should vest. In this case, there might be more of an argument that the entity's intervention constitutes a modification.

If such an intervention were not regarded as a modification, then the results might be different depending on the nature of the award and the conditions attached to it. Where an award is subject to a market condition, or to a non-vesting condition, an expense might well have to be recognised in any event, if all the non-market vesting conditions (e.g. service) were satisfied – see 7.3 and 7.4 below.

However, suppose that an award had been based on a non-market performance condition, such as a profit target, which was met, but only due to a gain of an unusual, non-recurring nature. The Board of Directors concludes that this should be ignored, with the effect that the award does not vest. If this is regarded as the exercise of a pre-existing right to ensure that the award vests only if ‘normal’ profit reaches a given level, then there has been no modification. On this analysis, the award has not vested, and any expense previously recognised would be reversed. If, however, the Board's intervention is regarded as a modification, it would have no impact on the accounting treatment in this case, as the effect would not be beneficial to the employee and so the modification would be ignored under the general requirements of FRS 102 relating to modifications (see 8.3.2 below).

6.3.7.C Discretion to make further awards

Some schemes may contain terms that give the entity the power to increase an award in circumstances where the recipient is considered to have delivered exceptional performance, or some such similar wording. In our view, unless the criteria for judging such exceptional performance are so clear as to be, in effect, performance conditions, the presumption should be that any award made pursuant to such a clause is granted, and therefore measured, when it is made. There may be circumstances where an award described as ‘discretionary’ may not truly be so, since the entity has created an expectation amounting to an obligation to make the award. However, we believe that it would be somewhat contradictory to argue that such expectations had been created in the case of an award stated to be for (undefined) exceptional performance only.

6.3.8 ‘Good leaver’ arrangements

It is common for awards to contain a so-called ‘good leaver’ clause. A ‘good leaver’ clause is one which makes provision for an employee who leaves before the end of the full vesting period of an award nevertheless to receive some or all of the award on leaving (see 6.3.8.A below).

In other cases, the original terms of an award will either make no reference to ‘good leavers’ or will not be sufficiently specific to allow the accounting treatment on cessation of employment to be an automatic outcome of the original terms of the scheme. In such cases, and in situations where awards are made to leavers on a fully discretionary basis, the accounting approach differs from that required where the original terms are clear about ‘good leaver’ classification and entitlement (see 6.3.8.B below).

We refer throughout this section on ‘good leavers’ to an employee leaving employment, but similar considerations apply when an individual automatically becomes entitled to an award before the end of the original vesting period due to other reasons specified in the terms of the agreement, e.g. attaining a certain age or achieving a specified length of service, even if the individual remains in employment after the relevant date. In these situations, the date of full entitlement is the date on which any services – and therefore expense recognition – cease for the purposes of Section 26.

Arrangements for a good leaver to receive all, or part, of an award on leaving employment should be distinguished from a situation where an employee leaves with no award and where forfeiture accounting is likely to apply (see 8.4.1.A below).

6.3.8.A Provision for ‘good leavers’ made in original terms of award

In some cases the types of person who are ‘good leavers’ may be explicitly defined in the original terms of the arrangement (common examples being persons who die or reach normal retirement age before the end of the full vesting period, or who work for a business unit that is sold or closed during the vesting period). In other cases, the entity may have the discretion to determine on a case-by-case basis whether a person should be treated as a ‘good leaver’.

In addition, some schemes may specify the entitlement of a ‘good leaver’ on leaving (e.g. that the leaver receive a portion of the award pro-rata to the extent that the performance conditions have been met as at the date of leaving), whereas others leave the determination of the award to the entity at the time that the employee leaves.

Whichever situation applies, any expense relating to an award to a good leaver must be fully recognised by the leaving date (or date of unconditional entitlement, if earlier than the usual vesting date) because, at that point, the good leaver ceases to provide any services to the entity for the award and any remaining conditions attached to the award will be treated as non-vesting rather than vesting conditions (see 4.2 above).

In our view, an award which vests before the end of the original vesting period due to the operation of a ‘good leaver’ clause is measured at the original grant date only where, under the rules of the scheme as understood by both parties at the original grant date, the award is made:

  • to a person clearly identified as a ‘good leaver’; and
  • in an amount clearly quantified or quantifiable.

Where, as outlined above, the rules of the scheme make clear the categories of ‘good leaver’ and their entitlement, the entity should assess at grant date how many good leavers there are likely to be and to what extent the service period for these particular individuals is expected to be shorter than the full vesting period. The grant date fair value of the estimated awards to good leavers should be separately determined, where significant, and the expense relating to good leavers recognised over the expected period between grant date and leaving employment (or date of unconditional entitlement). In this situation the entity would re-estimate the number of good leavers and adjust the cumulative expense at each reporting date. This would be a change of estimate rather than a modification of the award as it would all be in accordance with the original terms and would require no discretionary decisions on the part of the entity. We would not generally expect an entity to have significant numbers of good leavers under such an arrangement.

6.3.8.B Discretionary awards to ‘good leavers’

Awards where the arrangements for leavers are clear as at the original grant date of the award are discussed at 6.3-8-A above. However, it is often the case that the entity determines only at, or near, the time that the employee leaves either that the employee is a ‘good leaver’ or the amount of the award. In such cases, grant date or modification date (see further below) should be taken as the later of the date on which such determination is made, or the date on which the award is notified to the employee. This is because the employee had no clear understanding at the original grant date of an automatic entitlement to equity instruments other than through full vesting of the award at the end of the full service period.

In our view, an entity should assess the appropriate accounting treatment based on the particular facts and circumstances and the extent to which the discretionary award is linked to the original award. The discretionary award at the time of leaving is considered to be either a modification of an original award in the employee's favour (for example, where vesting conditions are waived to allow an individual to keep an award) or the forfeiture of the original award and the granting of a completely new award on a discretionary basis (see 8.3 and 8.5 below).

In some cases, a good leaver will be allowed, on a discretionary basis, to keep existing awards that remain subject to performance conditions established at the original grant date. In this situation, any conditions that were previously treated as vesting conditions will become non-vesting conditions following the removal of the service requirement (see 4.1 and 4.2 above). This will be the case whether the discretionary arrangement is accounted for as the forfeiture of the old award plus a new grant or as a modification of the original award.

The non-vesting conditions will need to be reflected in the measurement of the fair value of the award as at the date of modification or new grant (although the non-vesting conditions alone will not result in any incremental fair value). Any fair value that is unrecognised as at the date of the good leaver ceasing employment will need to be expensed immediately as there is no further service period over which to recognise the expense.

There is further discussion of modifications at 8.3 below and of replacement and ex gratia awards granted on termination of employment at 8.5 below.

6.3.8.C Automatic full or pro rata entitlement on cessation of employment

In some cases, entities establish schemes where a significant number of the participants will potentially leave employment before the end of the full vesting period and will be allowed to keep a pro rata share of the award.

Such arrangements are encountered relatively infrequently and mostly outside the UK. Accordingly, a detailed discussion of the accounting treatment is beyond the scope of this publication. There is further detail available in EY International GAAP 2019.

6.3.9 Awards over a fixed pool of shares (including ‘last man standing’ arrangements)

An award over a fixed pool of shares is sometimes granted to a small group of, typically senior, employees. Such awards might involve an initial allocation of shares to each individual but also provide for the redistribution of each employee's shares to the other participants should any individual leave employment before the end of the vesting period. This is often referred to as a ‘last man standing’ arrangement.

The accounting requirements for such an arrangement are unclear and discussion of the various approaches seen in practice is beyond the scope of this publication. In the absence of specific guidance, several interpretations are possible and these are discussed in EY International GAAP 2019.

6.4 Transactions with non-employees

In accounting for equity-settled transactions with non-employees, the starting point is that the value of the goods or services received provides the more reliable indication of the fair value of the transaction. The fair value to be used is that at the date on which the goods are obtained or the services rendered. [FRS 102.26.3, 7-8]. This implies that, where the goods or services are received on a number of dates over a period, the fair value at each date should be used, although in the case of a relatively short period there may be no great fluctuation in fair value.

If the entity rebuts the presumption that the goods or services provide the more reliable indication of fair value, it may use as a surrogate measure the fair value of the equity instruments granted, but as at the date when the goods or services are received, not the original grant date. However, where the goods or services are received over a relatively short period and the share price does not change significantly, an average share price can be used in calculating the fair value of equity instruments granted.

6.4.1 Effect of change of status from employee to non-employee (or vice versa)

Neither FRS 102 nor IFRS 2 gives specific guidance on how to account for an award when the status of the counterparty changes from employee to non-employee (or vice versa) but, in all other respects, the award remains unchanged. In our view, the accounting following the change of status will depend on the entity's assessment of whether or not the counterparty is performing the same or similar services before and after the change of status.

If it is concluded that the counterparty is providing the same or similar services before and after the change of status, the measurement approach remains unchanged. However, if the services provided are substantially different, the accounting following the change of status will be determined by the counterparty's new status.

A change of status is rare in practice. A detailed discussion is beyond the scope of this publication but the matter is addressed in EY International GAAP 2019.

6.5 Determining the fair value of equity instruments

As discussed at 6.2 and 6.4 above, FRS 102 requires the following equity-settled transactions to be measured by reference to the fair value of the equity instruments issued rather than that of the goods or services received:

  • all transactions with employees; and
  • transactions with non-employees where, in rare cases, the entity rebuts the presumption that the fair value of goods or services provided is more reliably measurable.

There will also be situations where the identifiable consideration received (if any) from non-employees appears to be less than the fair value of consideration given. In such cases, an entity will need to determine the fair value of the equity instruments (see 3.2.3 above).

For all transactions measured by reference to the fair value of the equity instruments granted, fair value should be measured at the ‘measurement date’ – i.e. grant date in the case of transactions with employees and service date in the case of transactions with non-employees. [FRS 102.26.8]. Fair value should be based on market prices if available. [FRS 102.26.10-11]. In the absence of market prices or other entity-specific market data, a valuation method should be used to estimate what the market price would have been on the measurement date in an arm's length transaction between knowledgeable and willing parties. The technique used should be a generally recognised valuation methodology for valuing equity instruments that is appropriate to the circumstances of the entity and uses market data to the greatest extent possible. [FRS 102.26.10-11].

Paragraphs 10 to 11 of Section 26 contain outline requirements on valuation and are discussed at 9 below, supplemented by guidance from the appendices and implementation guidance to IFRS 2. As noted elsewhere in this chapter, the ‘fair value’ of equity instruments under Section 26 takes account of some, but not all, conditions attached to an award rather than being a ‘true’ fair value (see 7.3 and 7.4 below on the treatment of market and non-vesting conditions).

7 EQUITY-SETTLED TRANSACTIONS – ALLOCATION OF EXPENSE

7.1 Overview

Equity-settled transactions, particularly those with employees, raise particular accounting problems since they are often subject to vesting conditions (see 4.1 above) that can be satisfied only over an extended vesting period.

An award of equity instruments that vests immediately is presumed, in the absence of evidence to the contrary, to relate to services that have already been rendered, and is therefore expensed in full at grant date. [FRS 102.26.5]. This may lead to the immediate recognition of an expense for an award to which the employee may not be legally entitled for some time, as illustrated in Example 23.6.

Where equity instruments are granted subject to vesting conditions (as in many cases they will be, particularly where payments to employees are concerned), FRS 102 creates a presumption that they are a payment for services to be received in the future, during the ‘vesting period’, with the transaction being recognised during that period, as illustrated in Example 23.7. [FRS 102.26.6, 9].

In practice, the calculations required by FRS 102 are unlikely to be as simple as that in Example 23.7. In particular:

  • the final number of awards that vest cannot be known until the vesting date (because employees may leave before the vesting date, or because relevant performance conditions may not be met); and/or
  • the length of the vesting period may not be known in advance (since vesting may depend on satisfaction of a performance condition with no, or a variable, time-limit on its attainment).

In order to deal with such issues, FRS 102 requires a continuous re-estimation process as summarised at 7.1.1 below.

7.1.1 The continuous estimation process of Section 26

The overall objective is that, at the end of the vesting period, the cumulative cost recognised in profit or loss (or, where applicable, included in the carrying amount of an asset), should represent the product of:

  • the number of equity instruments that have vested, or would have vested, but for the failure to satisfy a market condition (see 7.3 below) or a non-vesting condition (see 7.4 below); and
  • the fair value (excluding the effect of any non-market vesting conditions, but including the effect of any market conditions or non-vesting conditions) of those equity instruments at the date of grant.

It is essential to appreciate that the ‘grant date’ measurement model in FRS 102 seeks to capture the value of the contingent right to shares promised at grant date, to the extent that the promise becomes (or is deemed to become – see 7.1.2 below) an entitlement of the counterparty, rather than the value of any shares finally delivered. Therefore, if an option vests, but is not exercised because it would not be in the counterparty's economic interest to do so, FRS 102 still recognises a cost for the award.

In order to achieve this outcome, FRS 102 requires the following process to be applied:

  1. at grant date, the fair value of the award (excluding the effect of any service and non-market performance vesting conditions, but including the effect of any market conditions or non-vesting conditions (conditions that are not vesting conditions)) is determined;
  2. at each subsequent reporting date until vesting, the entity calculates a best estimate of the cumulative charge to profit or loss at that date, being the product of:
    1. the grant date fair value of the award determined in (a) above;
    2. the current best estimate of the number of awards that will vest (see 7.1.2 below); and
    3. the expired portion of the vesting period;
  3. the charge (or credit) to profit or loss for the period is the cumulative amount calculated in (b) above less the amounts already charged in previous periods. There is a corresponding credit (or debit) to equity; [FRS 102.26.3-9]
  4. once the awards have vested, no further accounting adjustments are made to the cost of the award, except in respect of certain modifications to the award – see 8 below; and
  5. if a vested award is not exercised, an entity may (but need not) make a transfer between reserves – see 7.1.3 below.

The overall effect of this process is that a cost is recognised for every award that is granted, except when it is forfeited for failure to meet a vesting condition (see 7.1.2 below). [FRS 102.26.9].

It is stated above, service conditions and non-market performance vesting conditions are not taken into account in determining the fair value of an equity-settled share-based payment transaction. This approach was clarified in the Triennial review 2017 in paragraph 9 of Section 26 which requires market conditions and conditions that are not vesting conditions being reflected in the fair value of awards and other vesting conditions being taken into account in estimating the number of awards expected finally to vest.

7.1.2 Vesting and forfeiture

In normal English usage, and in many share scheme documents, an award is described as ‘vested’ when all the conditions needed to earn it have been met, and as ‘forfeited’ where it lapses before vesting because one or more of the conditions has not been met.

IFRS 2 uses the term ‘forfeiture’ in a much more restricted sense to refer to an award that does not vest in IFRS 2 terms. FRS 102 takes a similar approach although it does not specifically refer to ‘forfeiture’ of an award. Essentially the approach is as follows:

  • where an award is subject only to vesting conditions other than market conditions, failure to satisfy any one of the conditions is treated as a forfeiture (and any cumulative expense recognised to date is reversed);
  • where an award is subject to both
    • vesting conditions other than market conditions, and
    • market conditions and/or non-vesting conditions,

    failure to satisfy any one of the vesting conditions other than market conditions is treated as a forfeiture. Otherwise (i.e. where all the vesting conditions other than market conditions are satisfied), the award is deemed to vest even if the market conditions and/or non-vesting conditions have not been satisfied; and

  • where an award is subject only to non-vesting conditions, it is always deemed to vest.

Where an award has been modified (see 8.3 below) so that different vesting conditions apply to the original and modified elements of an award, forfeiture will not apply to the original award if the service and non-market performance conditions attached to that element have been met. This will be the case even if the service and non-market performance conditions attached to the modified award have not been met and so the modified award is considered to have been forfeited (resulting in the reversal of any incremental expense relating to the modification). Examples 23.24 and Examples 23.25 at 8.3 below illustrate this point.

As a result of the interaction of the various types of condition, the reference in the summary at 7.1.1 above to the ‘best estimate of the number of awards that will vest’ really means the best estimate of the number of awards for which it is expected that all non-market vesting conditions will be met.

In practice, however, it is not always clear how that best estimate is to be determined, and in particular what future events may and may not be factored into the estimate. This is discussed further at 7.2 to 7.4 and 8.6 below.

7.1.3 Accounting after vesting

FRS 102 does not address specifically the treatment of share-based payment transactions once they have vested but it seems appropriate to adopt the approach required by IFRS 2.

Once an equity-settled transaction has vested (or, in the case of a transaction subject to one or more market or non-vesting conditions, has been treated as vested – see 7.1.2 above), no further accounting entries are made to reverse the cost already charged, even if the instruments that are the subject of the transaction are subsequently forfeited or, in the case of options, are not exercised. However, the entity may make a transfer between different components of equity. [IFRS 2.23]. For example, an entity's accounting policy might be to credit all amounts recorded for share-based transactions to a separate reserve such as ‘Shares to be issued’. Where an award lapses after vesting, it would then be appropriate to transfer an amount equivalent to the cumulative cost for the lapsed award from ‘Shares to be issued’ to another component of equity, usually the profit and loss reserve.

This prohibition against ‘truing up’ (i.e. reversing the cost of vested awards that lapse) is controversial, since it has the effect that a cost is still recognised for options that are never exercised, typically because they are ‘underwater’ (i.e. the current share price is lower than the option exercise price), so that it is not in the holder's interest to exercise the option.

7.2 Vesting conditions other than market conditions

7.2.1 Awards with service conditions

Most share-based payment transactions with employees are subject to explicit or implied service conditions. Examples 23.8 and Examples 23.9 below illustrate the application of the allocation principles discussed at 7.1 above to awards subject only to service conditions which are based on the implementation guidance to IFRS 2. [IFRS 2.IG11].

In Example 23.9 above, the number of employees that leave during year 1 and year 2 is not directly relevant to the calculation of cumulative expense in those years, but would naturally be a factor taken into account by the entity in estimating the likely number of awards finally vesting.

7.2.2 Equity instruments vesting in instalments (‘graded’ vesting)

An entity may make share-based payments that vest in instalments (sometimes referred to as ‘graded’ vesting). For example, an entity might grant an employee 600 options, 100 of which vest if the employee remains in service for one year, a further 200 after two years and the final 300 after three years. In today's more mobile labour markets, such awards are often favoured over awards which vest only on an ‘all or nothing’ basis after an extended period.

It is consistent with the overall recognition approach of Section 26 (and with the implementation guidance to IFRS 2) to treat such an award as three separate awards, of 100, 200 and 300 options, on the grounds that the three different vesting periods will mean that the three tranches of the award have different fair values. This may well have the effect that, compared to the expense for an award with a single ‘cliff’ vesting, the expense for an award vesting in instalments will be for a different amount in total and require accelerated recognition of the expense in earlier periods, as illustrated in Example 23.10 below.

Provided all conditions are clearly understood at the outset, the accounting treatment illustrated in Example 23.10 would apply even if the vesting of shares in each year also depended on a performance condition unique to that year (e.g. that profit in that year must reach a given minimum level), as opposed to a cumulative performance condition (e.g. that profit must have grown by a minimum amount by the end of year 1, 2 or 3). This is because all tranches of the arrangement have the same service commencement date and so for the awards that have a performance condition relating to year 2 or year 3 there is a service condition covering a longer period than the performance condition. In other words, an award that vests at the end of year 3 conditional on profitability in year 3 is also conditional on the employee providing service for three years from the date of grant in order to be eligible to receive the award. This is discussed further at 6.3.6 above.

7.2.3 Transactions with variable vesting periods due to non-market performance vesting conditions

An award may have a vesting period which is subject to variation. For example, the award might be contingent upon the achievement of a particular performance target (such as achieving a given level of cumulative earnings) within a given maximum period, but vesting immediately once the target has been reached. Alternatively, an award might be contingent on levels of earnings growth over a period, but with vesting occurring more quickly if growth is achieved more quickly. Also some plans provide for ‘re-testing’, whereby an original target is set for achievement within a given vesting period, but if that target is not met, a new target and/or a different vesting period are substituted.

FRS 102 has no specific requirements in respect of variable vesting periods – it simply refers to revising the number of awards expected to vest if new information indicates that the number of equity instruments expected to vest differs from previous estimates. [FRS 102.26.9(a)]. However, it seems appropriate to follow the requirements of IFRS 2 in this area. Therefore, in such cases, the entity needs to estimate the length of the vesting period at grant date, based on the most likely outcome of the performance condition. Subsequently, it is necessary continuously to re-estimate not only the number of awards that will finally vest, but also the date of vesting, as shown by Example 23.11. [IFRS 2.15(b), IG12]. This contrasts with the IFRS 2 treatment of awards with market conditions and variable vesting periods, where the initial estimate of the vesting period may not be revised (see 7.3.4 below).

In Example 23.11, which is based on IG Example 2 in the implementation guidance to IFRS 2, it is assumed that the entity will pay no dividends (to any shareholders) throughout the maximum possible three year vesting period. This has the effect that the fair value of the shares to be awarded is equivalent to their market value at the date of grant.

If dividends were expected to be paid during the vesting period, this would no longer be the case. Employees would be better off if they received shares after two years rather than three, since they would have a right to receive dividends from the end of year two.

One solution might be to use the approach in IG Example 4 in the implementation guidance to IFRS 2 (the substance of which is reproduced as Example 23.13 at 7.2.5 below). That Example deals with an award whose exercise price is either £12 or £16, dependent upon various performance conditions. Because vesting conditions other than market conditions are ignored in determining the value of an award, the approach is in effect to treat the award as the simultaneous grant of two awards, whose value, in that case, varies by reference to the different exercise prices.

The same principle could be applied to an award of shares that vests at different times according to the performance conditions, by determining different fair values for the shares (in this case depending on whether they vest after one, two or three years). The cumulative charge during the vesting period would be based on a best estimate of which outcome will occur, and the final cumulative charge would be based on the grant date fair value of the actual outcome (which will require some acceleration of expense is the actual vesting period is shorter than the previously estimated vesting period).

Such an approach appears to be taking account of non-market vesting conditions in determining the fair value of an award, contrary to the basic principle of paragraph 9 of Section 26 (see 7.1.1 above). However, it is not the vesting conditions that are being taken into account per se, but the fact that the varying vesting periods will give rise to different lives for the award (which are generally required to be taken into account – see 8.2 and 9 below). That said, the impact of the time value of the different lives on the fair value of the award will, in many cases, be insignificant and it will therefore be a matter of judgement as to how precisely an entity switches from one fair value to another.

Economically speaking, the entity in Example 23.11 has made a single award, the true fair value of which must be a function of the weighted probabilities of the various outcomes occurring. However, under the accounting model for share-settled awards, the probability of achieving non-market performance conditions is not taken into account in valuing an award. If this is required to be ignored, the only approach open is to proceed as in Example 23.11 above and treat the arrangement as if it consisted of the simultaneous grant of three awards.

Some might object that this methodology is not relevant to the award in Example 23.11 above, since it is an award of shares rather than, in the case of Example 23.13 below, an award of options. However, an award of shares is no more than an award of options with an exercise price of zero. Moreover, the treatment in the previous paragraph is broadly consistent with the IFRS 2 treatment of an award vesting in instalments (see 7.2.2 above).

In Example 23.11 above, the vesting period, although not known, is at least one of a finite number of known possibilities. The vesting period for some awards, however, may be more open-ended, such as is frequently the case for an award that vests on a trade sale or flotation of the business. Such awards are discussed further at 16.4 below.

7.2.4 Transactions with variable number of equity instruments awarded depending on non-market performance vesting conditions

More common than awards with a variable vesting period are those where the number of equity instruments awarded varies, typically increasing to reflect the margin by which a particular minimum target is exceeded. In accounting for such awards, the entity must continuously revise its estimate of the number of shares to be awarded in line with the requirement to revise the estimate of the number of equity instruments expected to vest if new information indicates that this number differs from previous estimates. [FRS 102.26.9(a)]. This is illustrated in Example 23.12 below (which is based on IG Example 3 in the implementation guidance to IFRS 2).

This Example reinforces the point that it is quite possible for an equity-settled transaction to give rise to a credit to profit or loss for a particular period during the period to vesting.

7.2.5 Transactions with variable exercise price due to non-market performance vesting conditions

Another mechanism for delivering higher value to the recipient of a share award so as to reflect the margin by which a particular target is exceeded might be to vary the exercise price depending on performance. IFRS 2 requires such an award to be dealt with, in effect, as more than one award and we believe that it is appropriate to adopt a similar approach under FRS 102. The fair value of each award is determined, and the cost during the vesting period based on the best estimate of which award will actually vest, with the final cumulative charge being based on the actual outcome. [IFRS 2.IG12, IG Example 4].

This is illustrated in Example 23.13 below.

At first sight this may seem a rather surprising approach. In reality, is it not the case that the entity in Example 23.13 made a single award, the fair value of which must lie between £12 and £16, as a function of the weighted probabilities of either outcome occurring? Economically speaking, this is indeed the case. However, under the accounting model for equity-settled share-based payments in IFRS 2 and FRS 102, the probability of achieving non-market performance conditions is not taken into account in valuing an award. If this is required to be ignored, the only approach open is to proceed with the ‘two award’ analysis as above.

7.3 Market conditions

7.3.1 What is a ‘market condition’?

The Glossary to FRS 102 defines the term ‘market vesting condition’, whereas paragraph 9 of Section 26 refers to ‘market conditions’ and ‘market vesting conditions’ which sets out the principles of measuring an equity-settled share-based payment. We believe that the terms are synonymous and from here on we will refer to the condition as a market condition. A market condition is defined as ‘a condition upon which the exercise price, vesting or exercisability of an equity instrument depends that is related to the market price of the entity's equity instruments, such as attaining a specified share price or a specified amount of intrinsic value of a share option, or achieving a specified target that is based on the market price of the entity's equity instruments relative to an index of market prices of equity instruments of other entities’. [FRS 102 Appendix I]. In order for a market condition to be treated as a performance vesting condition rather than as a non-vesting condition, there must also be an implicit or explicit service condition (see 4.2 above).

The ‘intrinsic value’ of a share option is defined as ‘the difference between the fair value of the shares to which the counterparty has the (conditional or unconditional) right to subscribe or which it has the right to receive, and the price (if any) the counterparty is (or will be) required to pay for those shares’. [FRS 102 Appendix I]. In other words, an option to acquire for £8 a share with a fair value of £10 has an intrinsic value of £2. A performance condition based on the share price and one based on the intrinsic value of the option are effectively the same, since the values of each will obviously move in parallel.

Section 26 includes a specified increase in the entity's share price as an example of a market condition. [FRS 102.26.9]. A market condition often seen in practice, although more common in a listed entity and not specifically mentioned in FRS 102, is a condition based on total shareholder return (TSR). TSR is a measure of the increase or decrease in a given sum invested in an entity over a period on the assumption that all dividends received in the period had been used to purchase further shares in the entity. The market price of the entity's shares is an input to the calculation.

However, a condition linked to a purely internal financial performance measure such as profit or earnings per share is not a market condition. Such measures will affect the share price or value, but are not directly linked to it, and hence are not market conditions.

A condition linked solely to a general market index is not a market condition, but a non-vesting condition (see 4.2 above and 7.4 below), because the reporting entity's own share price is not relevant to the satisfaction of the condition.

However, if the condition were that the entity's own share price had to outperform a general index of shares, that condition would be a market condition because the reporting entity's own share price is then relevant to the satisfaction of the condition.

7.3.2 Summary of accounting treatment

The key feature of the accounting treatment of an equity-settled transaction subject to a market condition is that the market condition is taken into account in valuing the award at the date of grant, ‘with no subsequent adjustment to the estimated fair value, irrespective of the outcome of the market condition or condition that is not a vesting condition, provided that all other vesting conditions are satisfied’. [FRS 102.26.9(b)]. In other words, an award is treated as vesting irrespective of whether the market condition is satisfied, provided that all other service and non-market performance vesting conditions are satisfied. The requirements relating to market conditions can have rather controversial consequences, as illustrated by Example 23.14.

Therefore, an award is sometimes treated as vesting (and a cost is recognised for that award) when it does not actually vest in the natural sense of the word. See also Example 23.16 at 7.3.4 below.

This treatment is clearly significantly different from that for transactions involving a non-market vesting condition, where no cost would be recognised where the conditions were not met. As discussed at 7.2 above, the methodology prescribed for transactions with a vesting condition other than a market condition is to determine the fair value of the option ignoring the condition and then to multiply that fair value by the estimated (and ultimately the actual) number of awards expected to vest based on the likelihood of that non-market vesting condition being met.

In any event, it appears that it may be possible to soften the impact of the rules for market conditions relatively easily by introducing a non-market vesting condition closely correlated to the market condition. For instance, the option in Example 23.14 above could be modified so that exercise was dependent not only upon the £7 target share price and continuous employment, but also on a target growth in earnings per share. Whilst there would not be a perfect correlation between earnings per share and the share price, it would be expected that they would move roughly in parallel, particularly if the entity has historically had a fairly consistent price/earnings ratio. Thus, if the share price target were not met, it would be highly likely that the earnings per share target would not be met either. This would allow the entity to show no cumulative cost for the option, since only one (i.e. not all) of the non-market related vesting conditions would have been met.

Similarly, entities in sectors where the share price is closely related to net asset value (e.g. property companies and investment trusts) could incorporate a net asset value target as a non-market performance condition that would be highly likely to be satisfied only if the market condition was satisfied.

The matrices below illustrate the interaction of market conditions and vesting conditions other than market conditions. Matrix 1 summarises the possible outcomes for an award with the following two vesting conditions:

  • the employee remaining in service for three years (service condition); and
  • the entity's share price increasing by 10% over the vesting period (share price target).
Matrix 1
Service condition met? Share price target (market condition) met? Section 26 expense?
1 Yes Yes Yes
2 Yes No Yes
3 No Yes No
4 No No No

It will be seen that, to all intents and purposes, the ‘Share price target (market condition) met?’ column is redundant, as this is not relevant to whether or not the award is treated as vesting for accounting purposes. The effect of this is that the entity would recognise an expense for outcome 2, even though no awards truly vest.

Matrix 2 summarises the possible outcomes for an award with the same conditions as in Matrix 1, plus a requirement for earnings per share to grow by a general inflation index plus 10% over the period (‘EPS target’).

Matrix 2
Service condition met? Share price target (market condition) met? EPS target (non-market condition) met? Section 26 expense?
1 Yes Yes Yes Yes
2 Yes No Yes Yes
3 Yes Yes No No
4 Yes No No No
5 No Yes Yes No
6 No No Yes No
7 No Yes No No
8 No No No No

Again it will be seen that, to all intents and purposes, the ‘Share price target (market condition) met?’ column is redundant, as this is not relevant to whether or not the award is treated as vesting. The effect of this is that the entity would recognise an expense for outcome 2, even though no awards truly vest. However, no expense would be recognised for outcome 4, which is, except for the introduction of the EPS target, equivalent to outcome 2 in Matrix 1, for which an expense is recognised. This illustrates that the introduction of a non-market vesting condition closely related to a market condition may mitigate the impact of the accounting requirements.

Examples of the application of the accounting treatment for transactions involving market conditions are given at 7.3.3 and 7.3.4 below.

7.3.3 Transactions with market conditions and known vesting periods

Following on from the discussion at 7.3.2 above, the accounting for these transactions is essentially the same as that for transactions without market conditions but with a known vesting period (including ‘graded’ vesting – see 7.2.2 above), except that adjustments are made to reflect the changing probability of the achievement of the non-market vesting conditions only, as illustrated by Example 23.15 below (based partly on IG Example 5 in the implementation guidance to IFRS 2). [FRS 102.26.9].

7.3.4 Transactions with variable vesting periods due to market conditions

Where a transaction has a variable vesting period due to a market condition, a best estimate of the most likely vesting period will have been used in determining the fair value of the transaction at the date of grant. IFRS 2 requires the expense for that transaction to be recognised over an estimated expected vesting period consistent with the assumptions used in the valuation, without any subsequent revision. [IFRS 2.15(b), IG14]. FRS 102 does not specify the accounting treatment in this situation but it seems consistent with the general requirement in paragraph 9 of Section 26 that there should be ‘no subsequent adjustment to the estimated fair value, irrespective of the outcome of the market condition’ to adopt a similar approach to that required by IFRS 2.

This may mean, for example, that if the actual vesting period for an employee share option award turns out to be longer than that anticipated for the purposes of the initial valuation, a cost is nevertheless recorded in respect of all employees who reach the end of the anticipated vesting period, even if they do not reach the end of the actual vesting period, as shown by Example 23.16 below, which is based on IG Example 6 in the implementation guidance in IFRS 2.

IFRS 2 does not specifically address the converse situation, namely where the award actually vests before the end of the anticipated vesting period. In our view, where this occurs, any expense not yet recognised at the point of vesting should be immediately accelerated. We consider that this treatment is most consistent with the overall requirement of IFRS 2 – and FRS 102 – to recognise an expense for share-based payment transactions ‘as the services are received’. [IFRS 2.7, FRS 102.26.3]. It is difficult to regard any services being received for an award after it has vested.

Moreover, the prohibition in paragraph 15 of IFRS 2 on adjusting the vesting period as originally determined refers to ‘the estimate of the expected vesting period’. In our view, the acceleration of vesting that we propose is not the revision of an estimated period, but the substitution of a known vesting period for an estimate.

Suppose in Example 23.16 above, the award had in fact vested at the end of year 4. We believe that the expense for such an award should be allocated as follows:

Year Calculation of cumulative expense Cumulative expense (£) Expense for period (£)
1 8 employees × 10,000 options × £25 × 1/5 400,000 400,000
2 8 employees × 10,000 options × £25 × 2/5 800,000 400,000
3 8 employees × 10,000 options × £25 × 3/5 1,200,000 400,000
4 8 employees × 10,000 options × £25 × 4/4 2,000,000 800,000

7.3.5 Transactions with multiple outcomes depending on market conditions

In practice, it is very common for an award subject to market conditions to give varying levels of reward that increase depending on the extent to which a ‘base line’ market performance target has been exceeded. Such an award is illustrated in Example 23.17 below.

It can be seen that the (perhaps somewhat counterintuitive) impact of this is that an equity-settled share-based payment where the number of shares increases in line with increases in the entity's share price may nevertheless have a fixed grant date value irrespective of the number of shares finally awarded.

7.3.6 Transactions with independent market conditions, non-market vesting conditions or non-vesting conditions

7.3.6.A Independent market and non-market vesting conditions

The discussion at 7.3.2 above addressed the accounting treatment of awards with multiple conditions that must all be satisfied, i.e. a market condition and a non-market vesting condition. However, entities might also make awards with multiple conditions, only one of which need be satisfied, i.e. the awards vest on satisfaction of either a market condition or a non-market vesting condition. Neither FRS 102 nor IFRS 2 provides any explicit guidance on the treatment of such awards and the requirements are far from clear, as illustrated by Example 23.18 below.

7.3.6.B Independent market conditions and non-vesting conditions

Arrangements are also seen where a share-based payment transaction vests on the satisfaction of either a market condition or a non-vesting condition.

In our view, an entity granting an award on the basis of a service condition (and any other non-market vesting conditions) plus either a market condition or a non-vesting condition should measure the fair value of the award at grant date taking into account the probability that either the market condition or the non-vesting condition will be met. The fact that there are two alternative conditions on which the award might vest means that, unless the two conditions are perfectly correlated, the grant date fair value of such an award will be higher than that of an award where there is only one possible basis on which the award might vest. Irrespective of whether the market and/or non-vesting conditions are met, the entity will recognise the grant date fair value provided all other service and non-market vesting conditions are met (i.e. the expense recognition is consistent with that of any award with market and/or non-vesting conditions).

7.3.7 Awards based on the market value of a subsidiary or business unit

Awards with a market condition are frequently based on the market value of the (typically quoted) equity instruments of the parent entity. However, some entities implement share-based remuneration schemes which aim to reward employees by reference to the market value of the equity of the business unit for which they work. The detail of such schemes varies, but the general effect is typically as follows:

  • at grant date, the employee is allocated a (real or notional) holding in the equity of the employing subsidiary, the market value of which is measured at grant date; and
  • the employee is granted an award of as many shares of the listed parent as have a value, at a specified future date (often at, or shortly after, the end of the vesting period but sometimes at a later date), equal to the increase over the vesting period in the market value of the employee's holding in the equity of the employing subsidiary.

Some take the view that such a scheme contains a market condition, since it depends on the fair value of the subsidiary's shares, with the result that the grant date fair value per share:

  • reflects this market condition (see 7.3.2 above); and
  • is fixed, irrespective of how many parent company shares are finally issued, since the entity has effectively issued a market-based award with multiple outcomes based on the market value of the equity of a subsidiary (see 7.3.5 above).

In our view, however, the required accounting treatment of such schemes is not as straightforward as suggested by this analysis. A fundamental issue is whether any award dependent on the change in value of the equity of an unquoted entity contains a market condition at all. A market condition is defined (see 7.3.1 above) as one dependent on the ‘market price’ of the entity's equity. Prima facie, if there is no market, there is no market price.

Notwithstanding the absence of a market, some argue that there are generally accepted valuation techniques for unquoted equities which can yield a fair value as a surrogate for market value. The difficulty with that argument, in our view, is that the definition of ‘market condition’ refers to ‘market price’ and not to ‘fair value’. The latter term is, of course, used extensively elsewhere in Section 26 (and in IFRS 2), which suggests that the two terms were not considered to be interchangeable. This concern is reinforced by that fact that, in the ‘valuation hierarchy’ for the measurement of share awards in paragraph 10 of Section 26, a quoted market price is given as the preferred (but not the only) method of arriving at fair value (see 9 below).

An entity implementing such an award must therefore make an assessment, in any particular situation, of whether the basis on which the subsidiary equity is valued truly yields a market price (or value) or merely a fair value according to a hypothetical valuation model.

Furthermore, in order for there to be a market condition there needs to be a specified performance target. It is not always clear in such situations that there is such a target if the various outcomes depend on an exchange of shares regardless of the level of market price or value achieved by the subsidiary.

If it is considered that there is no market condition within the arrangement and there is simply an exchange of shares – in effect, using one entity's shares as the currency for the other – then the arrangement might nonetheless be viewed as containing a non-vesting condition (similar to when an arrangement depends on the performance of an index for example (see 4.2 above and 7.4 below)). Like a market condition, a non-vesting condition would be taken into account in determining the fair value of the award and would result in a fixed grant date fair value irrespective of the number of shares finally delivered.

7.3.7.A Awards with a condition linked to flotation price

The situations discussed above and at 3.4.5 above relate to ongoing conditions linked to the calculated value of an unlisted entity's equity instruments and therefore differ from those where the condition is linked to the market price at which a previously unlisted entity floats. On flotation there is clearly a market and a market price for the entity's equity instruments and the achievement of a specific price on flotation would, in our view, be a market condition when accompanied by a corresponding service requirement (see 16.4 below).

7.4 Non-vesting conditions

Prior to the Triennial review 2017, Section 26 and IFRS 2 referred to ‘non-vesting conditions’. Section 26 has been amended whereby the term has now been deleted and replaced with ‘conditions that are not vesting conditions’, neither terms are defined in FRS 102 or IFRS 2. However, FRS 102 provides an example of a condition that is not a vesting condition, such as a condition that an employee contributes to a saving plan, which is one of the examples provided in the implementation guidance of IFRS 2 as a non-vesting condition. [FRS 102.26,9(b), IFRS 2.IG24]. Therefore we believe that both terms, ‘non-vesting conditions’ and ‘conditions that are not vesting conditions’, are similar and we will refer to the term as a non-vesting condition in this section. FRS 102 does not specify the accounting treatment for non-vesting conditions other than to state that ‘… conditions that are not vesting conditions shall be taken into account when estimating the fair value of the equity instruments granted at the measurement date, with no subsequent adjustment to the estimated fair value, irrespective of the outcome of the … condition that is not a vesting condition, provided that all other vesting conditions are satisfied’. [FRS 102.26.9(b)].

The accounting treatment for awards with non-vesting conditions has some similarities to that for awards with market conditions in that:

  • the fair value of the award at grant date is reduced to reflect the impact of the condition; and
  • an expense is recognised for the award irrespective of whether the non-vesting condition is met, provided that all vesting conditions (other than market conditions) are met.

However, in some situations under IFRS 2 – and, in the absence of specific guidance, FRS 102 – the accounting for non-vesting conditions differs from that for market conditions as regards the timing of the recognition of expense if the non-vesting condition is not satisfied (see 7.4.3 below).

7.4.1 Awards with no conditions other than non-vesting conditions

Any award that has only non-vesting conditions (e.g. an option award to an employee that may be exercised on a trade sale or IPO of the entity, irrespective of whether the employee is still in employment at that time) must be expensed in full at grant date. This is discussed further at 4.2 above and at 16.4 below, and illustrated in Example 23.6 at 7.1 above.

7.4.2 Awards with non-vesting conditions and variable vesting periods

Neither FRS 102 nor IFRS 2 explicitly addresses the determination of the vesting period for an award with a non-vesting condition but a variable vesting period (e.g. an award which delivers 100 shares when the price of gold reaches a given level, but without limit as to when that level must be achieved, so long as the employee is still in employment when the target is reached). However, given the close similarity between the required treatment for awards with non-vesting conditions and that for awards with market conditions, we believe that entities should follow the guidance for awards with market conditions and variable vesting periods (see 7.3.4 above).

7.4.3 Failure to meet non-vesting conditions

As noted above, the accounting under IFRS 2 – and, in the absence of specific guidance, FRS 102 – for non-vesting conditions sometimes differs from that for market conditions in the timing of the recognition of expense if the non-vesting condition is not satisfied. The treatment depends on the nature of the non-vesting condition, as follows:

  • if a non-vesting condition within the control of the counterparty (e.g. making monthly savings in an SAYE scheme) is not satisfied during the vesting period, the failure to satisfy the condition is treated as a cancellation (see 8.4 below), with immediate recognition of any expense for the award not previously recognised; [IFRS 2.28A, IG24]
  • if a non-vesting condition within the control of the entity (e.g. continuing to operate the scheme) is not satisfied during the vesting period, the failure to satisfy the condition is treated as a cancellation (see 8.4 below), with immediate recognition of any expense for the award not previously recognised; [IFRS 2.28A, IG24] but
  • if a non-vesting condition within the control of neither the counterparty nor the entity (e.g. a financial market index reaching a minimum level) is not satisfied, there is no change to the accounting and the expense continues to be recognised over the vesting period, unless the award is otherwise treated as forfeited by IFRS 2. [IFRS 2.BC237A, IG24]. In our view, the reference to the vesting period would include any deemed vesting period calculated as described in 7.4.2 above.

If an award is forfeited due to a failure to satisfy a non-vesting condition after the end of the vesting period (e.g. a requirement for an employee not to work for a competitor for a two year period after vesting), no adjustment is made to the expense previously recognised, consistent with the general provisions for accounting for awards in the post-vesting period (see 7.1.3 above). This would be the case even if shares previously issued to the employee were required to be returned to the entity.

8 EQUITY-SETTLED TRANSACTIONS – MODIFICATION, CANCELLATION AND SETTLEMENT

8.1 Background

It is quite common for equity instruments to be modified or cancelled before or after vesting. Typically this is done where the conditions for an award have become so onerous as to be virtually unachievable, or (in the case of an option) where the share price has fallen so far below the exercise price of an option that it is unlikely that the option will ever be ‘in the money’ to the holder during its life. An entity may take the view that such equity awards are so unattainable as to have little or no motivational effect, and accordingly replace them with less onerous alternatives. Conversely, and more rarely, an entity may make the terms of a share award more onerous (possibly because of shareholder concern that targets are insufficiently demanding). In addition an entity may ‘settle’ an award, i.e. cancel it in return for cash or other consideration.

The provisions in FRS 102 relating to modification, cancellation and settlement are derived from those in IFRS 2 and, where necessary, we have drawn on the guidance in IFRS 2 to supplement and explain the FRS 102 requirements. The provisions in both standards (like the summary of them below) are framed in terms of share-based payment transactions with employees. IFRS 2 and FRS 102 (as a result of the Triennial review 2017) indicates that the provisions are equally applicable to transactions with parties other than employees that are measured by reference to the fair value of the equity instruments granted (see 6.4 above). [FRS 102.26.12]. For transactions with parties other than employees, however, all references to ‘grant date’ should be taken as references to the date on which the third party supplied goods or rendered service.

In the discussion below, any reference to a ‘cancellation’ is to any cancellation, whether instigated by the entity or the counterparty. As well as more obvious situations where an award is cancelled by either the entity or the counterparty, cancellations include:

  • a failure by the entity to satisfy a non-vesting condition within the control of the entity; and
  • a failure by the counterparty to satisfy a non-vesting condition within the control of the counterparty (see 7.4.3 above).

The basic principles of the rules for modification, cancellation and settlement, which are discussed in more detail at 8.3 and 8.4 below, can be summarised as follows:

  • As a minimum, the entity must recognise the amount that would have been recognised for the award if it remained in place on its original terms.
  • If the value of an award to an employee is reduced (e.g. by reducing the number of equity instruments subject to the award or, in the case of an option, by increasing the exercise price), there is no reduction in the cost recognised in profit or loss.
  • However, if the value of an award to an employee is increased (e.g. by increasing the number of equity instruments subject to the award or, in the case of an option, by reducing the exercise price), the incremental fair value must be recognised as a cost. The incremental fair value is the difference between the fair value of the original award and that of the modified award, both measured at the date of modification. [FRS 102.26.12].

8.2 Valuation requirements when an award is modified, cancelled or settled

These provisions have the important practical consequence that, when an award is modified, cancelled or settled, the entity must obtain a fair value not only for the modified award, but also for the original award, updated to the date of modification. If the award had not been modified, there would have been no need to obtain a valuation for the original award after the date of grant.

Any modification of a performance condition clearly has an impact on the ‘real’ value of an award but it may have no direct effect on the value of the award for accounting purposes. As discussed at 7.2 to 7.4 above, this is because market vesting conditions and non-vesting conditions are taken into account in valuing an award whereas non-market vesting conditions are not. Accordingly, by implication, a change to a non-market performance condition will not necessarily affect the expense recognised for the award.

For example, if an award is contingent upon sales of a given number of units and the number of units required to be sold is decreased, the ‘real’ value of the award is clearly increased. However, as the performance condition is a non-market condition, and therefore not relevant to the original determination of the value of the award, there is no incremental fair value required to be accounted for. However, if the change in the condition results in an increase in the estimated number of awards expected to vest, the change of estimate will however give rise to an accounting charge (see 7.1 to 7.4 above).

If an award is modified by changing the service period, the situation is more complex. A service condition does not of itself change the fair value of the award for the purposes of FRS 102 and IFRS 2, but a change in service period may indirectly change the life of the award, which is relevant to its value (see 9 below). Similar considerations apply where performance conditions are modified in such a way as to alter the anticipated vesting date.

The valuation requirements relating to cancelled and settled awards are considered further at 8.4 below.

8.3 Modification

When an award is modified, the entity must as a minimum recognise the cost of the original award as if it had not been modified (i.e. based on the original grant date fair value, spread over the original vesting period, and subject to the original vesting conditions). [FRS 102.26.12(b)].

In addition, a further cost must be recognised for any modifications that increase the fair value of the award. If the modification occurs during the vesting period, this additional cost is spread over the period from the date of modification until the vesting date of the modified award, which might not be the same as that of the original award. [FRS 102.26.12(a)]. Although not explicitly stated in Section 26, but nevertheless consistent with its requirements, where a modification is made after the original vesting period has expired, and is subject to no further vesting conditions, any incremental fair value should be recognised immediately. [IFRS 2 Appendix B.43].

Whether a modification increases or decreases the fair value of an award is determined as at the date of modification, as illustrated by Example 23.19. [FRS 102.26.12].

This treatment ensures that movements in the fair value of the original award are not reflected in the entity's profit or loss, consistent with the accounting treatment of other equity instruments.

Appendix B and the implementation guidance to IFRS 2 provide further detailed guidance on these requirements as set out in the following sections.

8.3.1 Modifications that increase the value of an award

8.3.1.A Increase in fair value of equity instruments granted

If the modification increases the fair value of the equity instruments granted, (e.g. by reducing the exercise price or changing the exercise period), the incremental fair value, measured at the date of modification, must be recognised over the period from the date of modification to the date of vesting for the modified instruments, as illustrated in Example 23.20 below (which is based on IG Example 7 in the implementation guidance to IFRS 2). [FRS 102.26.12(a), IFRS 2 Appendix B.43(a)].

In effect, the original award and the incremental value of the modified award are treated as if they were two separate awards.

A similar treatment to that in Example 23.20 above is adopted where the fair value of an award subject to a market condition has its value increased by the removal or mitigation of the market condition. [IFRS 2 Appendix B.43(c)]. Where a vesting condition other than a market condition is changed, the treatment set out at 8.3-1-C below is adopted. The standards do not specifically address the situation where the fair value of an award is increased by the removal or mitigation of a non-vesting condition. It seems appropriate, however, to account for this increase in the same way as for a modification caused by the removal or mitigation of a market condition – i.e. as in Example 23.20 above.

8.3.1.B Increase in number of equity instruments granted

Paragraph 12 of Section 26 on modification of awards begins by referring solely to modifications to the conditions on which equity instruments were granted rather than the number of equity instruments granted. However, in discussing the related accounting treatment, paragraph 12 goes on to refer both to the fair value of an award and to the number of equity instruments granted. If the modification increases the number of equity instruments granted, the fair value of the additional instruments, measured at the date of modification, must be recognised over the period from the date of modification to the date of vesting for the modified instruments. [FRS 102.26.12(a)]. Although not explicitly stated, it follows that if there is no further vesting period for the modified instruments, the incremental cost should be recognised immediately.

It is often the case, however, that a change in the number of equity instruments granted is combined with other modifications to the award – such situations are considered further at 8.3.2 and 8.3.4 below.

8.3.1.C Removal or mitigation of non-market related vesting conditions

Where a vesting condition, other than a market condition, is modified in a manner that is beneficial to the employee, the modified vesting condition should be taken into account when applying the general requirements of FRS 102 as discussed at 7.1 to 7.4 above – in other words, the entity would continuously estimate the number of awards likely to vest and/or the vesting period. This is consistent with the general principle that vesting conditions, other than market conditions, are not taken into account in the valuation of awards, but are reflected by recognising a cost for those instruments that ultimately vest on achievement of those conditions. See also the discussion at 8.2 above.

The standards do not provide an example that addresses this point specifically, but we assume that the intended approach is as in Example 23.21 below. In this Example, the entity modifies an award in a way that is beneficial to the employee even though the modification does not result in any incremental fair value. The effect of the modification is therefore recognised by basing the expense on the original grant date fair value of the awards and an assessment of the extent to which the modified vesting conditions will be met.

The difference between the accounting consequences for different methods of enhancing an award could cause confusion in some cases. For example, it may sometimes not be clear whether an award has been modified by increasing the number of equity instruments or by lowering the performance targets, as illustrated in Example 23.22.

Profit growth Number of options
5%-10% 100
10%-15% 200
over 15% 300

During the vesting period, the entity concludes that the criteria are too demanding and modifies them as follows.

Profit growth Number of options
5%-10% 200
over 10% 300

This raises the issue of whether the entity has changed:

  1. the performance conditions for the vesting of 200 or 300 options; or
  2. the number of equity instruments awarded for achieving growth of 5%-10% or growth of over 10%.

In our view, the reality is that the change is to the performance conditions for the vesting of 200 or 300 options, and should therefore be dealt with as in 8.3-1-C above rather than 8.3-1-B above. Suppose, however, that the conditions had been modified as follows.

Profit growth Number of options
5%-10% 200
10%-15% 300
over 15% 400

In that case, there has clearly been an increase in the number of equity instruments subject to an award for a growth increase of over 15%, which would have to be accounted for as such (i.e. under 8.3-1-B above rather than 8.3-1-C above). In such a case, it might seem more appropriate to deal with the changes to the lower bands as changes to the number of shares awarded rather than changes to the performance conditions.

8.3.2 Modifications that decrease the value of an award

This type of modification does not occur very often, as the effect would be somewhat demotivating and, in some cases, contrary to local labour regulations. However, there have been occasional examples of an award being made more onerous – usually in response to criticism by shareholders that the original terms were insufficiently demanding.

The general requirement of FRS 102 and of IFRS 2 (as outlined at 8.3 above) is that, where an award is made more onerous (and therefore less valuable), the financial statements must still recognise the cost of the original award. This rule is in part an anti-avoidance measure since, without it, an entity could reverse the cost of an out-of-the-money award by modifying it so that it was unlikely to vest (for example, by adding unattainable non-market performance conditions) rather than cancelling the award and triggering an acceleration of expense as at 8.4 below.

8.3.2.A Decrease in fair value of equity instruments granted

If the modification decreases the fair value of the equity instruments granted (e.g. by increasing the exercise price or reducing the exercise period), the decrease in value is effectively ignored and the entity continues to recognise a cost for services as if the awards had not been modified. [FRS 102.26.12(b), IFRS 2 Appendix B.44(a)]. This approach also applies to reductions in the fair value of an award by the addition of a market condition or by making an existing market condition more onerous. [IFRS 2 Appendix B.44(c)]. Although the standards have no specific guidance on this point, we assume that reductions in the fair value resulting from the addition or amendment of a non-vesting condition are similarly ignored, as illustrated in Example 23.23 below.

It can be seen that the only expense reversal relates to those employees who have forfeited their options by failing to fulfil the employment condition. There is no reversal of expense for those employees who met the service condition but whose options did not vest (in real terms) because the market condition was not met. In FRS 102 terms the options of those eight employees vested because all non-market conditions were met and so the entity has to recognise the grant date fair value for those awards. This is the case even though the original grant date fair value did not take account of the effect of the market condition (unlike an award with a market condition specified from grant date). This outcome is the result of the different treatment of market and non-market conditions within Section 26, and the requirement to recognise an expense for an award with a market condition provided all other conditions have been met (see further discussion at 7.3.2 above).

8.3.2.B Decrease in number of equity instruments granted

If the modification reduces the number of equity instruments granted, IFRS 2 requires the reduction to be treated as a cancellation of that portion of the award (see 8.4 below). [IFRS 2 Appendix B.44(b)]. Essentially this has the effect that any previously unrecognised cost of the cancelled instruments is immediately recognised in full, whereas the cost of an award whose value is reduced by other means continues to be spread in full over the remaining vesting period.

In situations where a decrease in the number of equity instruments is combined with other modifications so that the total fair value of the award remains the same or increases, it is unclear whether the approach required is one based on the value of the award as a whole or, as in the previous paragraph, one based on each equity instrument as the unit of account. This is considered further at 8.3.4 below.

8.3.2.C Additional or more onerous non-market related vesting conditions

Where a non-market vesting condition is modified in a manner that is not beneficial to the employee, again it is ignored and a cost recognised as if the original award had not been modified, as shown by Example 23.24 (which is based on IG Example 8 in the implementation guidance to IFRS 2). [IFRS 2 AppendixB.44(c), IG15, IG Example 8].

It is noted in IG Example 8 that the same accounting result would have occurred if the entity had increased the service requirement rather than modifying the performance target. Because such a modification would make it less likely that the options would vest, which would not be beneficial to the employees, the entity would take no account of the modified service condition when recognising the services received. Instead, it would recognise the services received from the twelve employees who remained in service for the original three year vesting period. Other modifications to vesting periods are discussed below.

8.3.3 Modifications with altered vesting period

Where an award is modified so that its value increases, FRS 102 and IFRS 2 require the entity to continue to recognise an expense for the grant date fair value of the unmodified award over its original vesting period, even where the vesting period of the modified award is longer (see 8.3.1 above). This appears to have the effect that an expense may be recognised for awards that do not actually vest, as illustrated by Example 23.25 (which is based on Example 23.20 above).

Year Calculation of cumulative expense
Original award
Modified award Cumulative expense (£) Expense for period (£)
1 390 employees × 100 options × £15 × 1/3 195,000 195,000
2 395 employees × 100 options × £15 × 2/3 365 employees × 100 options × £2 × 1/3 419,333 224,333
3 397 employees × 100 options × £15 377 employees × 100 options × £2 × 2/3 645,767 226,434
4 397 employees × 100 options × £15 372 employees × 100 options × £2 669,900 24,133

It may seem strange that a cost is being recognised for the original award in respect of the 25 employees who leave during year 4, who are never entitled to anything. However, in our view, this is consistent with:

  • the overall requirement of FRS 102 and IFRS 2 that the minimum cost of a modified award should be the cost that would have been recognised if the award had not been modified; and
  • IG Example 8 in IFRS 2 (the substance of which is reproduced in Example 23.24 above) where an expense is clearly required to be recognised to the extent that the original performance conditions would have been met if the award had not been modified.

Moreover, as Examples 23.24 and 23.25 illustrate, the rule in FRS 102 and IFRS 2 requiring recognition of a minimum expense for a modified award (i.e. as if the original award had remained in place) applies irrespective of whether the effect of the modification is that an award becomes less valuable to the employee (as in Example 23.24) or more valuable to the employee (as in Example 23.25).

Where a modified vesting period is shorter than the original vesting period, all of the expense relating to both the original and modified elements of the award should, in our view, be recognised by the end of the modified vesting period as no services will be rendered beyond that date.

8.3.4 Modifications that reduce the number of equity instruments granted but maintain or increase the value of an award (‘value for value’ exchanges and ‘give and take’ modifications)

As discussed at 8.3-2-B above, IFRS 2 requires cancellation accounting to be applied to a reduction in the number of equity instruments when a modification reduces both the number of equity instruments granted and the total fair value of the award. [IFRS 2 Appendix B.44(b)]. FRS 102 is silent on the accounting treatment of such arrangements and we therefore suggest that entities follow the IFRS 2 requirements. The IFRS 2 approach is consistent with the fact that part of the award has been removed without compensation to the employee. However, a modification of this kind is rarely seen in practice because of the demotivating effect and, in some jurisdictions, a requirement to pay compensation to the counterparty. An entity is more likely to modify an award so that the overall fair value remains the same, or increases, even if the number of equity instruments is reduced. These types of modification, sometimes known as ‘value for value’ exchanges or ‘give and take’ modifications, are considered below.

Where an entity reduces the number of equity instruments but also makes other changes so that the total fair value of the modified award remains the same as, or exceeds, that of the original award as at the modification date, it is unclear whether the unit of account for accounting purposes should be an individual equity instrument or the award as a whole. Examples 23.26 and 23.27 below illustrate the two situations and the two approaches.

Given the lack of clarity, we believe that an entity may make an accounting policy choice as to whether it considers the unit of account to be an individual equity instrument or an award as a whole. Further detail on the arguments underpinning each of the two approaches is given in EY International GAAP 2019 but is beyond the scope of this publication.

Once made, the accounting policy choice should be applied consistently to all modifications that reduce the number of equity instruments but maintain or increase the overall fair value of an award. Whatever the policy choice, the entity will still need to determine whether or not the amendments to the arrangement are such that it is appropriate to account for the changes as a modification rather than as a completely new award (see 8.4.2 and 8.4.4 below).

8.3.5 Modification of award from equity-settled to cash-settled (and vice versa)

Occasionally an award that was equity-settled when originally granted is modified so as to become cash-settled, or an originally cash-settled award is modified so as to become equity-settled. FRS 102 provides no explicit guidance on such modifications. IFRS 2 provides no explicit guidance on modifications from equity-settled to cash-settled but the June 2016 amendment clarified IFRS 2 to provide more specific guidance on modifications of awards from cash-settled to equity-settled. In the absence of specific guidance in FRS 102 we believe that it is possible to arrive at a reasonable approach by analogy to the provisions of IFRS 2 in respect of:

  • the modification of equity-settled awards during the vesting period (see 8.3 above);
  • the addition of a cash-settlement alternative to an equity-settled award after grant date (as illustrated in IG Example 9 in the implementation guidance to IFRS 2);
  • the settlement of equity-settled awards in cash (see 8.4 below); and
  • the settlement in equity of awards where the entity has a choice of settlement, but which have been accounted for as cash-settled during the vesting period (see 11.1.1.A below).

A detailed discussion of this topic is beyond the scope of this publication but the subject is addressed more fully in EY International GAAP 2019.

8.4 Cancellation and settlement

Paragraph 13 of Section 26 is headed ‘cancellations and settlements’ but, whilst its treatment of cancellations is consistent with the basic requirement of IFRS 2 (as set out in (a) below), it does not specify the accounting treatment of a settlement (i.e. an award cancelled with some form of compensation). Section 26 also does not address the treatment of replacement awards following a cancellation.

In the absence of specific guidance in FRS 102, we consider it appropriate to follow the full guidance in IFRS 2, as outlined below, for the cancellation, replacement or settlement of an award other than by forfeiture for failure to satisfy the vesting conditions.

When an award accounted for under FRS 102 is settled, it is perhaps debatable whether any incremental amount paid in settlement is required to be expensed, as for IFRS 2 (see (b) below) or whether any difference could be accounted for in equity as would be the case with the repurchase of equity instruments outside a share-based payment transaction. In our view, an approach consistent with that of IFRS 2 is appropriate given the extent to which the requirements of Section 26 generally are derived from those of IFRS 2.

IFRS 2 requires the following approach:

  1. if the cancellation or settlement occurs during the vesting period, it is treated as an acceleration of vesting, and the entity recognises immediately the amount that would otherwise have been recognised for services received over the remainder of the vesting period; [FRS 102.26.13, IFRS 2.28-29]
  2. where the entity pays compensation for a cancelled award:
    1. any compensation paid up to the fair value of the award at cancellation or settlement date (whether before or after vesting) is accounted for as a deduction from equity, as being equivalent to the redemption of an equity instrument;
    2. any compensation paid in excess of the fair value of the award at cancellation or settlement date (whether before or after vesting) is accounted for as an expense in profit or loss; and
    3. if the share-based payment arrangement includes liability components, the fair value of the liability is remeasured at the date of cancellation or settlement. Any payment made to settle the liability component is accounted for as an extinguishment of the liability; and
  3. if the entity grants new equity instruments during the vesting period and, on the date that they are granted, identifies them as replacing the cancelled or settled instruments, the entity is required to account for the new equity instruments as if they were a modification of the cancelled or settled award. Otherwise it accounts for the new instruments as an entirely new award. [IFRS 2.28-29].

It should be noted that the calculation of any additional expense in (b) above depends on the fair value of the award at the date of cancellation or settlement, not on the cumulative expense already charged. This has the important practical consequence that, when an entity pays compensation on cancellation or settlement of an award, it must obtain a fair value for the original award, updated to the date of cancellation or settlement. If the award had not been cancelled or settled, there would have been no need to obtain a valuation for the original award after the date of grant.

These requirements raise some further detailed issues of interpretation on a number of areas, as follows:

  • the distinction between ‘cancellation’ and ‘forfeiture’ (see 8.4.1 below);
  • the distinction between ‘cancellation’ and ‘modification’ (see 8.4.2 below);
  • the calculation of the expense on cancellation (see 8.4.3 below); and
  • replacement awards (see 8.4.4 and 8.5 below).

8.4.1 Distinction between cancellation and forfeiture

The provisions of IFRS 2 apply when an award of equity instruments is cancelled or settled ‘other than a grant cancelled by forfeiture when the vesting conditions are not satisfied’. [IFRS 2.28]. The significance of this is that the terms of many share-based awards provide that they are, or can be, ‘cancelled’, in a legal sense, on forfeiture. IFRS 2 is clarifying that, where an award is forfeited (within the meaning of that term in IFRS 2 – see 7.1.2 above), the entity should apply the accounting treatment for a forfeiture (i.e. reversal of expense previously recognised), even if the award is legally cancelled as a consequence of the forfeiture. FRS 102 does not have such an explicit distinction but we presume that a similar treatment is intended.

8.4.1.A Termination of employment by entity

In some cases, it might not always be immediately clear whether cancellation or forfeiture has occurred, particularly where options lapse as the result of a termination of employment by the entity. For example, an entity might grant options to an employee at the beginning of year 1 on condition of his remaining in employment until the end of year 2. During year 1, however, economic conditions require the entity to make a number of its personnel, including that employee, redundant, as a result of which his options lapse. Is this lapse a forfeiture or a cancellation for accounting purposes?

The uncertainty arises because it could be argued either that the employee will be unable to deliver the services required in order for the options to vest (suggesting a forfeiture) or that the options lapse as a direct result of the employer's actions (suggesting a cancellation).

Any failure to meet a service condition, regardless of the reason, is accounted for under IFRS 2 as a forfeiture rather than as a cancellation. Therefore a situation where the entity terminates the employment contract should be accounted for as a forfeiture and a similar approach should be followed by entities applying FRS 102 as the definition of a service condition is consistent with that in IFRS 2. [FRS 102 Appendix I].

8.4.1.B Surrender of award by employee

It is sometimes the case that an employee, often a member of senior management, will decide – or be encouraged by the entity – to surrender awards during the vesting period. The question arises as to whether this should be treated as a cancellation or forfeiture for accounting purposes. FRS 102 and IFRS 2 allow forfeiture accounting, and the consequent reversal of any cumulative expense, only in situations where vesting conditions are not satisfied. A situation where the counterparty voluntarily surrenders an award and therefore ‘fails’ to meet the service condition does not, in our view, meet the criteria for treatment as a forfeiture and should be treated as a cancellation of the award by the employee.

8.4.2 Distinction between cancellation and modification

One general issue raised by the approach to modification and cancellation in FRS 102 and IFRS 2 is where the boundary lies between ‘modification’ of an award in the entity's favour and outright cancellation of the award. As a matter of legal form, the difference is obvious. However, if an entity were to modify an award in such a way that there was no realistic chance of it ever vesting (for example, by introducing a requirement that the share price increase 1,000,000 times by vesting date), some might argue that this amounts to a de facto cancellation of the award. The significance of the distinction is that, whereas the cost of a ‘modified’ award continues to be recognised on a periodic basis over the vesting period (see 8.3 above), the remaining cost of a cancelled award is recognised immediately.

8.4.3 Calculation of the expense on cancellation

The basic accounting treatment for a cancellation and settlement is illustrated in Example 23.28 below.

Example 23.28 illustrates the basic calculation of the required cancellation ‘charge’. In more complex situations, however, the amount of the ‘charge’ may not be so clear-cut, due to an ambiguity in the drafting of paragraph 28(a) of IFRS 2 and paragraph 13 of Section 26, which state that an entity:

‘shall account for the cancellation or settlement … as an acceleration of vesting, and therefore shall recognise immediately the amount that otherwise would have been recognised for services received over the remainder of the vesting period.’ [FRS 102.26.13, IFRS 2.28(a)].

There is something of a contradiction within this requirement as illustrated by Example 23.29.

In extreme cases, the entity's best estimate, as at the date of cancellation, might be that no awards are likely to vest. In this situation, no cancellation expense would be recognised. However, there would need to be evidence that this was not just a rather convenient assessment made as at the date of cancellation. Typically, the previous accounting periods would also have reflected a cumulative expense of zero on the assumption that the awards would never vest.

An effect of these requirements is that they create an accounting arbitrage between an award that is ‘out of the money’ but not cancelled (the cost of which continues to be spread over the remaining period to vesting) and one which is formally cancelled (the cost of which is recognised immediately). Entities might well prefer to opt for cancellation so as to create a ‘one-off’ charge to earnings rather than continue to show, particularly during difficult trading periods, significant periodic costs for options that no longer have any real value. However, such early cancellation of an award precludes any chance of the cost of the award being reversed through forfeiture during, or at the end of, the vesting period if the original vesting conditions are not met.

8.4.4 Replacement awards

FRS 102 contains no specific requirements or guidance in relation to replacement awards and so we consider it appropriate to draw on those in IFRS 2. The remainder of this section therefore reflects the IFRS 2 requirements. Whilst the requirements relating to accounting for replacement awards are generally clear under IFRS 2, there are nevertheless some issues of interpretation.

As set out at 8.4 above, a new award that meets the criteria in paragraph 28(c) of IFRS 2 to be treated as a replacement of a cancelled or settled award is accounted for as a modification of the original award and any incremental value arising from the granting of the replacement award is recognised over the vesting period of that replacement award. Where the criteria are not met, the new equity instruments are accounted for as a new grant (in addition to accounting for the cancellation or settlement of the original arrangement). The requirements are discussed in more detail below.

8.4.4.A Designation of award as replacement award

Whether or not an award is a ‘replacement’ award (and therefore recognised at only its incremental, rather than its full, fair value) is determined by whether or not the entity designates it as such on the date that it is granted.

Entities need to ensure that designation occurs on grant date as defined by IFRS 2 (and FRS 102) (see 6.3 above). For example, if an entity cancels an award on 15 March and notifies an employee in writing on the same day of its intention to ask the remuneration committee to grant replacement options at its meeting in two months on 15 May, such notification (although formal and in writing) may not strictly meet the requirement for designation on grant date (i.e. 15 May). However, in our view, what is important is that the entity establishes a clear link between the cancellation of the old award and the granting of a replacement award even if there is later formal approval of the replacement award following the communication of its terms to the counterparty at the same time as the cancellation of the old award.

As drafted, IFRS 2 gives entities an apparently free choice to designate any newly granted awards as replacement awards. In our view, however, such designation cannot credibly be made unless there is evidence of some connection between the cancelled and replacement awards. This might be that the cancelled and replacement awards involve the same counterparties, or that the cancellation and replacement are part of the same arrangement.

8.4.4.B Incremental fair value of replacement award

Where an award is designated as a replacement award, any incremental fair value must be recognised over the vesting period of the replacement award. The incremental fair value is the difference between the fair value of the replacement award and the ‘net fair value’ of the cancelled or settled award, both measured at the date on which the replacement award is granted. The net fair value of the cancelled or settled award is the fair value of the award, immediately before cancellation, less any compensation payment that is accounted for as a deduction from equity. [IFRS 2.28(c)]. Thus the ‘net fair value’ of the original award can never be less than zero (since any compensation payment in excess of the fair value of the cancelled award would be accounted for in profit or loss, not in equity – see Example 23.28 at 8.4.3 above).

There is some confusion within IFRS 2 as to whether a different accounting treatment is intended to result from, on the one hand, modifying an award and, on the other hand, cancelling it and replacing it with a new award on the same terms as the modified award. This is explored in the discussion of Example 23.30 below, which is based on the same fact pattern as Example 23.20 at 8.3-1-A above.

Year Calculation of cumulative expense
Original award
Replacement award Cumulative expense (£) Expense for period (£)
1 390 employees × 100 options × £15 585,000 585,000
2 390 employees × 100 options × £15 390 employees × 100 options × £3 × 1/2
5 employees × 100 options × £8 × 1/2
645,500 60,500
3 390 employees × 100 options × £15 390 employees × 100 options × £3
7 employees × 100 options × £8
707,600 62,100

By contrast, the accounting treatment implied by the Basis for Conclusions is as follows (see Example 23.20 above):

Year Calculation of cumulative expense Cumulative expense (£) Expense for period (£)
Original award (a) Modified award (b) (a+b)
1 390 employees × 100 options × £15 × 1/3 195,000 195,000
2 395 employees × 100 options × £15 × 2/3 395 employees × 100 options × £3 × 1/2 454,250 259,250
3 397 employees × 100 options × £15 397 employees × 100 options × £3 714,600 260,350

It can be seen that both the periodic allocation of expense and the total expense differ under each interpretation. This is because, under the first interpretation, the cost of the original award is accelerated at the end of year 1 for all 390 employees expected at that date to be in employment at the end of the vesting period, whereas under the second interpretation a cost is recognised for the 397 employees whose awards finally vest. The difference between the two total charges of £7,000 (£714,600 – £707,600) represents 397 – 390 = 7 employees @ £1,000 (100 options × £10 (£15 + £3 – £8)) each = £7,000.

In practice, the second (modification accounting) approach tends to be seen more frequently. However, we believe that either interpretation is valid, and an entity should adopt one or other consistently as a matter of accounting policy.

In Example 23.30 above, we base the cancellation calculations on 390 employees (the number expected to be employed at the end of the vesting period as estimated at the cancellation date) rather than on 460 employees (the number in employment at the cancellation date). As discussed in Example 23.29 at 8.4.3 above, either approach may be adopted but the selected approach should be applied consistently.

The discussion above relates to situations in which awards are cancelled and replaced for reasons other than expected, or actual, failure by the counterparty to meet a service condition. Changes to awards in contemplation, or as a consequence, of cessation of employment are considered at 6.3-8-B above and at 8.5 and 8.6 below.

8.4.4.C Replacement of vested awards

The rules for replacement awards summarised in paragraph (c) at 8.4 above apply ‘if a grant of equity instruments is cancelled or settled during the vesting period …’. [IFRS 2.28]. FRS 102 does not explicitly state that its requirements relate solely to awards cancelled or settled during the vesting period but this seems to be implied by the references to ‘an acceleration of vesting’ and ‘the remainder of the vesting period’. [FRS 102.26.13]. However, if the original award has already vested when a replacement award is granted, there is no question of accelerating the cost of the cancelled award, as it has already been recognised during the vesting period. The issue is rather the treatment of the new award itself. Whilst neither IFRS 2 nor FRS 102 explicitly addresses this point, it appears that such a replacement award should be treated as if it were a completely new award. In other words, its full fair value should be recognised immediately or, if there are any vesting conditions for the replacement award, over its vesting period.

By contrast, the rules in IFRS 2 for modification of awards (discussed in 8.3 above) apply whether the award has vested or not. Paragraphs 26 and 27 of IFRS 2 (modifications) are not restricted to events ‘during the vesting period’ in contrast to paragraph 28 (cancellation and settlement, including replacement awards), which is restricted to events ‘during the vesting period’. [IFRS 2.26-28]. In FRS 102, any such distinction is less clear because the paragraph on modifications is written in the context of a modification of vesting conditions and, whilst it refers explicitly to the accounting treatment of modifications during the vesting period, it is silent on the modification of vested awards. [FRS 102.26.12]. In the absence of explicit guidance, we believe that it is appropriate to follow the accounting approach of IFRS 2.

The treatment outlined above has the effect that the accounting cost of modifying an already vested award (i.e. the incremental fair value of the modified award) may, at first sight, appear to be lower than the cost of cancelling and replacing it, which requires the full fair value of the new award to be expensed. However, the full fair value of the new replacement award will be reduced by the fair value of the cancelled award that the employee has surrendered as part of the consideration for the new award. This analysis will, in many cases, produce an accounting outcome similar to that of the modification of an unvested award.

8.5 Replacement and ex gratia awards on termination of employment

When an employee's employment is terminated during the vesting period of an award of shares or options, the award will typically lapse in consequence. It is common in such situations, particularly where the employee was part of the senior management, for the entity to make an alternative award, or to allow the employee to retain existing awards, as part of the package of benefits agreed with the employee on termination of employment.

Generally, such an award is an ex gratia award – in other words, it is a voluntary award to which the outgoing employee had no legal entitlement under the terms of the original award. However, a number of plan rules set out, in a ‘good leaver’ clause (see 6.3.8 above), the terms on which any ex gratia award may be made, usually by applying a formula to determine, or limit, how much of the original award can be considered to have vested.

In many cases the award will be made on a fully vested basis, i.e. the employee has full entitlement without further conditions needing to be fulfilled. In other cases, however, an employee will be allowed to retain awards that remain subject to the fulfilment of the original conditions (other than future service). Whichever form the award takes, in accounting terms it will be treated as vesting at the date of termination of employment because any remaining conditions will be accounted for as non-vesting conditions in the absence of an explicit or implied service condition (see 4.2 above).

It has not always been clear whether the termination of employment should be accounted for as a forfeiture or as a cancellation. However, as discussed at 8.4-1-A above, if an employee is unable to satisfy a service condition for any reason, this should be accounted for under IFRS 2 as a forfeiture rather than as a cancellation. It appears appropriate for entities accounting under FRS 102 also to apply forfeiture accounting.

IFRS 2 does not specifically address the accounting for any replacement or ex gratia awards granted on termination of employment. It perhaps follows from the treatment of the termination of employment as a forfeiture to:

  • reverse any expense relating to the forfeited award; and
  • recognise the ex gratia award as a completely new award granted at the date of termination of employment.

However, the guidance is not clear and there might be situations where entities consider it more appropriate to apply modification accounting (recognising the original grant date fair value of the award that would otherwise be forfeited on its original terms (because the service condition would not be met) plus the incremental value of the modified terms). In the absence of clarity, we believe that judgement will be required based on the specific facts and circumstances and the extent to which the changes to the arrangements are considered to be a waiver of existing conditions in connection with the cessation of employment rather than the introduction of a discretionary replacement arrangement on completely new terms.

8.6 Entity's plans for future modification or replacement of award – impact on estimation process at reporting date

As discussed at 7.1.1 and 7.1.2 above, FRS 102 requires an entity to determine a cumulative charge at each reporting date by reference to an estimate of the number of awards that will vest (within the special meaning of that term in FRS 102). The process of estimation at each reporting date should take into account any new information that indicates a change to previous estimates.

In addition to the normal difficulties inherent in any estimation process, it is not entirely clear which anticipated future events should be taken into account in the estimation process and which should not, as illustrated by Example 23.31 below.

In our view, there is no basis in FRS 102 for accounting for an anticipated future change to the terms of an award. The entity must account for those awards in issue at the reporting date, not those that might be in issue in the future. Accordingly we do not consider approach (c) above to be appropriate if any change to the issued awards was simply an intention.

Equally, we struggle to support approach (a) above. FRS 102 requires the entity to use an estimate of the number of awards expected to vest and its best available estimate as at the end of year 1 must be that the unit will be closed, and the employees' employment terminated, in year 2. This view is supported by the fact that, unlike other areas of accounting such as impairment and provisions, accounting for share-based payment transactions does not explicitly prohibit an entity from taking account of the consequences of reorganisations and similar transactions to which it is not yet committed.

Accordingly, we believe that approach (b) should be followed.

The entity's best estimate, at the end of year 1, must be that none of the awards currently in place will vest (because all the employees will be made redundant and so will not meet the service condition before the end of the vesting period). It therefore applies forfeiture accounting at the end of year 1 and reverses any cost previously recorded for the award.

When the terms of the award are changed at the time of the redundancy in year 2 to allow full vesting, the entity will either recognise the full cost of the new award (as all cost relating to the original award has been reversed) or will treat the revised arrangement as a modification of the original award that is beneficial to the employee. In effect, the modification approach is based on a view that the original award is not now going to lapse because it will be modified before employment ceases and the forfeiture crystallises. In our view, in the absence of clarity in the standard, the entity should assess the more appropriate approach based on the particular facts and circumstances.

Either approach will have what many may see as the less than ideal result that the entity will recognise a credit in profit or loss in year 1 and an expense in year 2, even though there has been no change in management's best estimate of the overall outcome. This follows from the analysis, discussed above, that we do not believe that the entity can account, in year 1, for the award on the basis of what its terms may be in year 2.

The best estimate is made as at each reporting date. A change in estimate made in a later period in response to subsequent events affects the accounting expense from that later period only (i.e. there is no restatement of earlier periods presented).

8.7 Share splits and consolidations

It is relatively common for an entity to divide its existing equity share capital into a larger number of shares (share splits) or to consolidate its existing share capital into a smaller number of shares (share consolidations). The impact of such splits and consolidations is not specifically addressed in either FRS 102 or IFRS 2.

Suppose that an employee has options over 100 shares in the reporting entity, with an exercise price of £1. The entity undertakes a ‘1 for 2’ share consolidation – i.e. the number of shares in issue is halved such that, all other things being equal, the value of one share in the entity after the consolidation is twice that of one share before the consolidation.

IFRS 2 is required to be applied to modifications to an award arising from equity restructurings (FRS 102 is silent on this). [IFRS 2.BC24]. In many cases, a share scheme will provide for automatic adjustment so that, following the consolidation, the employee holds options over only 50 shares with an exercise price of £2. As discussed at 6.3-7-A above, all things being equal, it would be expected that the modified award would have the same fair value as the original award and so there would be no incremental expense to be accounted for.

However, it may be that the scheme has no such provision for automatic adjustment, such that the employee still holds options over 100 shares. The clear economic effect is that the award has been modified, since its value has been doubled. It could be argued that, on a literal reading of IFRS 2, no modification has occurred, since the employee holds options over 100 shares at the same exercise price before and after the consolidation. In our view, whilst it seems appropriate to have regard to the substance of the transaction, and treat it as giving rise to a modification, it can be argued that FRS 102 and IFRS 2 as drafted do not require such a treatment.

Sometimes, the terms of an award give the entity discretion to make modifications at a future date in response to more complex changes to the share structure, such as those arising from bonus issues, share buybacks and rights issues where the effect on existing options may not be so clear-cut. These are discussed further at 6.3-7-A above.

9 EQUITY-SETTLED TRANSACTIONS – VALUATION

9.1 Introduction

As noted at 6.1 above, an equity-settled share-based payment transaction is valued either at the fair value of the goods or services received – using the general requirements of FRS 102 for the determination of fair value – or at the fair value of the equity instruments granted – using the specific requirements set out in Section 26. The timing of the fair value measurement, and whether it is based on the goods or services or on the equity instruments, is driven by a number of factors including the relative reliability of measurement and the identity of the counterparty (see 6 above).

In this section we consider the specific requirements in Section 26 for the valuation of shares, share options and equity-settled share appreciation rights. No distinction is drawn between awards to employees and to non-employees and the requirements should therefore be applied to the measurement of employee awards at grant date and non-employee awards at service date.

9.2 Shares

Section 26 requires the fair value of shares (and the related goods or services received) to be determined using the following three-tier measurement hierarchy:

  1. if an observable market price is available for the equity instruments granted, use that price;
  2. if an observable market price is not available, measure the fair value of equity instruments granted using entity-specific observable market data such as:
    1. a recent transaction in the entity's shares; or
    2. a recent independent fair valuation of the entity or its principal assets;
  3. if an observable market price is not available and obtaining a reliable measurement of fair value under (b) is impracticable, indirectly measure the fair value of the shares using a valuation method that uses market data to the greatest extent practicable to estimate what the price of those equity instruments would be on the grant date in an arm's length transaction between knowledgeable, willing parties. The entity's directors should use their judgement to apply a generally accepted valuation methodology for valuing equity instruments that is appropriate to the circumstances of the entity. [FRS 102.26.10].

FRS 102 defines a requirement as ‘impracticable’ when the entity cannot apply it after making every reasonable effort to do so. [FRS 102 Appendix I].

It seems unlikely that the market price referred to in (a), or the entity-specific observable market data referred to in (b), will be available for the measurement of the vast majority of share-based awards granted by unlisted entities. Most entities will therefore be required to apply the approach required by (c) and use an appropriate valuation methodology.

The selection of an appropriate methodology for valuing the equity of an unlisted entity is beyond the scope of this publication but, in many cases of awards of free shares (which are akin to options with a zero strike price), it is likely that an approach similar to that used for valuing share options will be adopted (see 9.3 below).

FRS 102 states that all market conditions and non-vesting conditions should be taken into account when estimating the fair value of the shares or share options at the measurement date (see further discussion at 7.3 and 7.4 above on market conditions and non-vesting conditions). [FRS 102.26.9]. Apart from this, there is no mention of adjusting the market price, or estimated market price, of an entity's shares to take into account the terms and conditions on which they were granted (which would, typically, reduce the value). Many conditions and restrictions attached to awards will be covered by the requirements of paragraph 9. However, this guidance does not specifically address the common situation where the counterparty is not entitled to receive dividends during the vesting period.

Under the requirements of IFRS 2, no adjustment is required to the estimated grant date fair value of shares if the employees are entitled to receive dividends, or dividend equivalents paid in cash, during the vesting period (as they are in no different a position in this respect than if they already held shares). However, where employees are not entitled to receive dividends during the vesting period, IFRS 2 requires the valuation to be reduced by the present value of dividends expected to be paid during the vesting period. [IFRS 2 Appendix B.31, 33-34].

The accounting treatment of awards which give the right to receive dividends during the vesting period is discussed further at 16.3 below.

If an entity is taking approach (c) above in determining a fair value for the equity instruments then it seems appropriate to adjust for all the terms and conditions on which the shares have been awarded (other than those vesting conditions which are not taken into account in the determination of fair value).

Where an entity is using approaches (a) or (b), it might appear that it is required to use an unadjusted market price or other observable price without adjusting for the specific terms and conditions of the share-based payment. However, that seems to be at variance with the requirements of paragraph 9 to take certain conditions into account. In our view, it will generally be more appropriate to adjust the fair value for the terms and conditions on which the right to the equity instrument is granted if the instrument granted is not precisely that for which the market price, or other observable price, is available.

9.3 Share options and equity-settled share appreciation rights

A share option is defined in FRS 102 as ‘a contract that gives the holder the right, but not the obligation, to subscribe to the entity's shares at a fixed or determinable price for a specific period of time’. [FRS 102 Appendix I].

A share appreciation right (SAR) is not specifically defined in FRS 102 but is a grant where the counterparty will become entitled either to shares (or, more commonly, to a future cash payment) based on the increase in the entity's share price or value from a specified level over a period of time (see further discussion at 10 below on cash-settled awards).

Section 26 requires the fair value of share options and equity-settled share appreciation rights (and the related goods or services received) to be determined using the following three-tier measurement hierarchy:

  1. if an observable market price is available for the equity instruments granted, use that price;
  2. if an observable market price is not available, measure the fair value of share options and share appreciation rights granted using entity-specific observable market data such as for a recent transaction in the share options;
  3. if an observable market price is not available and obtaining a reliable measurement of fair value under (b) is impracticable, indirectly measure the fair value of share options or share appreciation rights using an alternative valuation methodology such as an option pricing model. The inputs for an option pricing model (such as the weighted average share price, exercise price, expected volatility, option life, expected dividends and the risk-free interest rate) shall use market data to the greatest extent possible. Paragraph 26.10 provides guidance on determining the fair value of the shares used in determining the weighted average share price. The entity shall derive an estimate of expected volatility consistent with the valuation methodology used to determine the fair value of the shares. [FRS 102.26.11].

The fact that Section 26 does not mandate the use of an option pricing model was identified in earlier versions of FRS 102 as a significant difference between FRS 102 and the IFRS for SMEs on which FRS 102 is based (and is also a change from IFRS 2). However, in practice, it is likely that use of a pricing model will often be a practical basis for determining the fair value of share options and appreciation rights.

The treatment of vesting and non-vesting conditions in the determination of the fair value of share options should be considered in the same way as for the fair value of shares (see 9.2 above) as paragraph 9 of Section 26 refers to both shares and share options.

A discussion of valuation methodology is beyond the scope of this publication. Whilst not addressing the subject of valuation in detail, EY International GAAP 2019 draws on the guidance in Appendix B to IFRS 2 relating to the valuation of share-based payments and addresses some aspects of the pricing of options, particularly with respect to employee awards.

10 CASH-SETTLED TRANSACTIONS

Throughout the discussion in this section, ‘cash’ should be read as including ‘other assets’ in accordance with the definition of a cash-settled share-based payment transaction (see 3.1 above).

10.1 Scope of requirements

Section 26 notes that cash-settled share-based payment transactions include:

  • share appreciation rights (SARs), where employees are entitled to a future cash payment (rather than an equity instrument) based on the increase in an entity's share price from a specified level over a specified period of time; and
  • a right to a future cash payment through a grant of shares (including shares to be issued upon the exercise of share options) that are redeemable, either mandatorily (e.g. upon cessation of employment) or at the employee's option. [FRS 102.26.2].

Another type of cash-settled arrangement frequently encountered in practice is a grant of phantom options, where employees are entitled to a cash payment equivalent to the gain that would have been made by exercising options at a notional price over a notional number of shares and then selling the shares at the date of exercise.

As is clear from the inclusion of certain types of redeemable share as a specific example of a cash-settled share-based payment arrangement, FRS 102 looks beyond the simple issue of whether an award entitles an employee to receive instruments that are in form shares or options to the terms of those instruments. The fact that certain redeemable shares would be treated as a cash-settled, not an equity-settled, award is consistent with the fact that a share with these terms would be regarded as a financial liability rather than an equity instrument of the issuer (based on Section 22).

In some cases the boundary between equity-settled and cash-settled schemes may appear somewhat blurred, so that further analysis may be required to determine whether a particular arrangement is equity-settled or cash-settled. Some examples of such arrangements are discussed at 10.2 below.

10.2 What constitutes a cash-settled award?

There are a number of possible circumstances in which, on, or shortly after, settlement of an equity-settled award either:

  • the entity incurs a cash outflow equivalent to that which would arise on cash-settlement (e.g. because it purchases its own shares to deliver to counterparties); or
  • the counterparty receives cash equivalent to the amount that would arise on cash-settlement (e.g. because the shares are sold for cash on behalf of the counterparty).

Such situations raise the question of whether such schemes are in fact truly equity-settled or cash-settled.

Examples of relatively common mechanisms for delivering the cash-equivalent of an equity-settled award to employees are discussed below. It emerges from the analysis below that, in reality, the accounting for share-based payment transactions is driven by questions of form rather than substance. To put it rather crudely, what matters is often not so much whether the entity has made a cash payment for the fair value of the award, but rather the name of the payee.

The significance of this is that the analysis affects the profit or loss charge for the award, as illustrated by Example 23.32 below.

The analyses below all rely on a precise construction of the definition of a cash-settled share-based payment transaction, i.e. one ‘in which the entity acquires goods or services by incurring a liability to transfer cash or other assets to the supplier of those goods or services for amounts that are based on the price (or value) of equity instruments (including shares and share options) of the entity or another group entity’ (emphasis added). [FRS 102 Appendix I]. Thus, if the entity is not actually required – legally or constructively – to pay cash to the counterparty, there is no cash-settled transaction under FRS 102, even though the arrangement may give rise to an external cash flow and, possibly, another form of recognised liability.

Some have raised the question of whether the entity should recognise some form of liability to repurchase own equity in situations where the entity has a stated policy of settling equity-settled transactions using previously purchased treasury or own shares. In our view, the normal provisions of accounting for financial instruments apply and there would be no question of recognising a liability to repurchase own equity on the basis merely of a declared intention. It is only when the entity enters into a forward contract or a call option with a third party that some accounting recognition of a future share purchase may be required.

An entity might sometimes purchase a number of its own shares shortly after issuing a similar number of shares in settlement of an equity-settled transaction. This raises the question of whether such a scheme would be considered as in substance cash-settled. In our view, further enquiry into the detailed circumstances of the purchase is required in order to determine the appropriate analysis.

Broadly speaking, so long as there is no obligation (explicit or implicit) for the entity to settle in cash with the counterparty, such purchase arrangements will not require a scheme to be treated as cash-settled under Section 26. However, in our view, there might be situations in which post-settlement share purchases are indicative of an obligation to the counterparty, such that treatment as a cash-settled scheme would be appropriate.

For example, if the entity were to create an expectation by employees that any shares awarded can always be liquidated immediately, because the entity will ensure that there is a market for the shares, it could well be appropriate to account for such a scheme as cash-settled. This will often be the case with awards granted to the employees of an unlisted company. The treatment of schemes in which the entity has a choice of settlement, but has created an expectation of cash-settlement, provides a relevant analogy (see 11.1.3 below).

A more extreme example of such a situation would be where the entity has arranged for the shares delivered to the counterparty to be sold on the counterparty's behalf, but has at the same time entered into a contract to purchase those shares. In that situation, in our view, the substance is that:

  • the entity has created an expectation by the counterparty of a right to receive cash; and
  • the intermediate purchaser or broker is no more than an agent paying that cash to the counterparty on behalf of the entity.

Accordingly, it would be appropriate to account for such an arrangement as a cash-settled award.

Similar issues arise in the application of ‘drag along’ and ‘tag along’ rights in the context of an exit event and these are discussed at 16.4.6 below.

10.3 Required accounting for cash-settled share-based payment transactions

10.3.1 Basic accounting treatment

For a cash-settled share-based payment transaction, Section 26 requires an entity to measure the goods or services acquired and the corresponding liability incurred at the fair value of the liability. Until that liability is settled, the entity should remeasure the fair value at each reporting date and at the date of settlement. Any changes in fair value arising from this process of remeasurement should be recognised in profit or loss for the period. [FRS 102.26.14].

It is clear that the ultimate cost of a cash-settled transaction must be the actual cash paid to the counterparty, which will be the fair value at settlement date but the liability is recognised and measured as follows:

  • at each reporting date between grant and settlement the fair value of the award is determined in accordance with the requirements of Section 26;
  • during the vesting period, the liability recognised at each reporting date is the Section 26 fair value of the award at that date multiplied by the expired portion of the vesting period;
  • from the end of the vesting period until settlement, the liability recognised is the full fair value of the liability at the reporting date.

Where the cost of services received in a cash-settled transaction is recognised in the carrying amount of an asset (e.g. inventory) in the entity's statement of financial position, the carrying amount of the asset should not be adjusted for changes in the fair value of the liability.

Although paragraph 14 of Section 26 refers to ‘fair value’ it provides no further guidance about how the fair value of a cash-settled share-based payment liability should be determined. Appendix I to FRS 102 includes a definition of ‘fair value’ as:

‘the amount for which … a liability [could be] settled … between knowledgeable, willing parties in an arm's length transaction. In the absence of any specific guidance provided in the relevant section of this FRS, the guidance in the Appendix to Section 2 – Concepts and Pervasive Principles – shall be used in determining fair value.’

The reference to ‘fair value’ in paragraph 14 is not highlighted as a defined term and so it is not clear whether the defined term in Appendix I to FRS 102 is intended to apply to liabilities for cash-settled share-based payments. Section 26 specifies how fair value should be determined for equity-settled share-based payment transactions (see 9.2 and 9.3 above) but contains no specific guidance for cash-settled share-based payment transactions. In our view, an acceptable approach would be to use the guidance in the Appendix to Section 2 but also to draw on IFRS 2 (using the GAAP hierarchy in Section 10) to provide some more practical guidance on the approach to be taken in fair valuing a cash-settled share-based payment transaction.

The Appendix to Section 2 indicates that an appropriate valuation technique should be used and that this might include an option pricing model. The use of a pricing model is consistent with the requirement in IFRS 2 that fair value be determined by applying an option pricing model, taking into account the terms and conditions on which the cash-settled transaction was granted, and the extent to which the employees have rendered service to date.

10.3.2 Application of the accounting treatment

The treatment required by Section 26 for cash-settled transactions is illustrated by Example 23.33 which is based on IG Example 12 in the implementation guidance to IFRS 2.

Year Fair value Intrinsic value
£ £
1 14.40
2 15.50
3 18.20 15.00
4 21.40 20.00
5 25.00

The entity will recognise the cost of this award as follows:

Year Calculation of liability Calculation of cash paid Liability (£) Cash paid (£) Expense for period (£)*
1 405 employees × 100 SARs × £14.40 × 1/3 194,400 194,400
2 400 employees × 100 SARs × £15.50 × 2/3 413,333 218,933
3 253 employees × 100 SARs × £18.20 150 employees × 100 SARs × £15.00 460,460 225,000 272,127
4 113 employees × 100 SARs × £21.40 140 employees × 100 SARs × £20.00 241,820 280,000 61,360
5 113 employees × 100 SARs × £25.00 282,500 40,680

* Liability at end of period + cash paid in period – liability at start of period

The accounting treatment for cash-settled transactions is therefore (despite some similarities in the methodology) significantly different from that for equity-settled transactions. An important practical issue is that, for a cash-settled transaction, the entity must determine the fair value at each reporting date rather than at grant date (and at the date of any subsequent modification or settlement) as would be the case for equity-settled transactions. As Example 23.33 shows, it is not necessary to determine the fair value of a cash-settled transaction at grant date in order to determine the share-based payment expense.

We discuss in more detail below the following aspects of the accounting treatment of cash-settled transactions:

  • determining the vesting period (see 10.3.2.A below);
  • periodic allocation of cost (see 10.3.2.B below);
  • treatment of non-market vesting conditions (see 10.3.2.C below);
  • treatment of market conditions and non-vesting conditions (see 10.3.2.D below); and
  • treatment of modification, cancellation and settlement (see 10.3.2.E below).
10.3.2.A Determining the vesting period

The rules for determining vesting periods are the same as those applicable to equity-settled transactions, as discussed at 7.1 to 7.4 above. Where an award vests immediately, there is a presumption that, in the absence of evidence to the contrary, the award is in respect of services that have already been rendered, and should therefore be expensed in full at grant date. [FRS 102.26.5].

Where cash-settled awards are made subject to vesting conditions (as in many cases they will be, particularly where payments to employees are concerned), there is a presumption that the awards are a payment for services to be received in the future, during the ‘vesting period’, with the transaction being recognised during that period, as illustrated in Example 23.33 above.

10.3.2.B Periodic allocation of cost

The required treatment for cash-settled transactions is simply to measure the fair value of the liability at each reporting date, [FRS 102.26.14], which might suggest that the full fair value, and not just a time-apportioned part of it, should be recognised at each reporting date – as would be the case for any liability that is a financial instrument measured at fair value.

However, paragraph 14 needs to be read with paragraph 6 which states that if the counterparty is required to complete a specified period of service, the entity ‘shall account for those services as they are rendered during the vesting period, with a corresponding increase in … liabilities’. This indicates that a spreading approach is to be adopted. [FRS 102.26.6].

10.3.2.C Non-market vesting conditions

FRS 102 does not specifically addresses the impact of vesting conditions (other than service conditions) in the context of cash-settled transactions – the provisions relating to vesting conditions are to be found under headings relating to equity-settled share-based payment transactions.

Where a vesting condition is a minimum service period, the liability should be estimated on the basis of the current best estimate of the number of awards that will vest, this estimate being made exactly as for an equity-settled transaction.

As regards other non-market performance conditions, the treatment is unclear. However, in June 2016, the IASB issued an amendment to IFRS 2 to clarify that entities should not reflect non-market performance conditions in the fair value of a cash-settled share-based payment but should apply a similar approach to that used for equity-settled share-based payments.

In the absence of specific guidance in FRS 102, we believe that entities applying FRS 102 will continue to have an accounting policy choice in determining the fair value of the liability (see 2.4 above). We believe that the fair value of the liability until vesting date may either fully take account of the probability of the vesting conditions being achieved or exclude the conditions. If the latter approach is adopted, the liability recognised by the entity would be adjusted at each reporting date to reflect the entity's current best estimate of the outcome of those conditions. This approach analogises to the treatment of service conditions (and to the equity-settled treatment of service and non-market performance conditions).

10.3.2.D Market conditions and non-vesting conditions

There is no specific guidance in FRS 102 as to whether a distinction is to be drawn between the treatment of non-vesting conditions and market conditions and that of other non-market vesting conditions, as would be the case for an equity-settled transaction (see 7.2 to 7.4 above).

As discussed at 10.3-2-C above, this is a matter that has been addressed in a recent amendment to IFRS 2. As well as clarifying the treatment of non-market vesting conditions, the amendment confirms the current approach generally applied in practice that market performance conditions and non-vesting conditions should be taken into account in measuring the fair value of the cash-settled share-based payment. There will be no ultimate cost for an award subject to a market condition or non-vesting condition that is not satisfied as any liability would be reversed.

This differs from the accounting model for equity-settled transactions with market conditions or non-vesting conditions, which can result in a cost being recognised for awards subject to a market or non-vesting condition that is not satisfied (see 7.3 and 7.4 above).

In our view, entities applying FRS 102 should also take market performance conditions and non-vesting conditions into account in measuring the fair value of a cash-settled share-based payment.

10.3.2.E Modification, cancellation and settlement

FRS 102 provides no specific guidance on modification, cancellation and settlement of cash-settled awards. However, as cash-settled awards are accounted for using a full fair value model no such guidance is needed. It is clear that:

  • where an award is modified, the liability recognised at and after the point of modification will be based on its new fair value, with the effect of any movement in the liability recognised immediately;
  • where an award is cancelled the liability will be derecognised, with a credit immediately recognised in profit or loss; and
  • where an award is settled, the liability will be derecognised, and any gain or loss on settlement immediately recognised in profit or loss.

10.4 Modification of award from equity-settled to cash-settled or from cash-settled to equity-settled

As noted at 8.3.5 above, a detailed discussion of this topic is beyond the scope of this publication but is addressed more fully in EY International GAAP 2019.

11 TRANSACTIONS WITH EQUITY AND CASH ALTERNATIVES

Some share-based payment transactions (particularly those with employees) provide either the entity or the counterparty with the choice of settling the transaction either in shares (or other equity instruments) or in cash (or other assets). [FRS 102.26.15].

More detailed guidance is provided as to how that general principle should be applied to transactions:

    • where the entity has choice of settlement (see 11.1 below); and
    • where the counterparty has choice of settlement (see 11.2 below).

A common type of arrangement seen in practice is the ‘matching’ award or deferred bonus arrangement where an employee is offered a share award or a cash alternative to ‘match’ a share award or a cash bonus earned during an initial period. This type of arrangement is discussed further at 16.1 below.

Some share-based payment transactions rather than providing either the entity or the counterparty with a choice between settlement in equity or in cash, offer no choice but instead require an arrangement that will generally be equity-settled to be settled in cash in certain specific and limited circumstances (awards with contingent cash settlement). There will also be situations where there is contingent settlement in equity of an award that is otherwise cash-settled. These types of arrangement are considered in more detail at 11.3 below.

Some awards offer an equity alternative and a cash alternative where the cash alternative is not based on the price or value of the equity instruments. These arrangements are considered at 11.4 below.

11.1 Transactions where the entity has choice of settlement in equity or in cash

Section 26 requires that an entity with a choice of settling a transaction in cash (or other assets) or by transferring equity instruments, should account for the transaction as a wholly equity-settled share-based payment transaction (in accordance with paragraphs 7 to 13 of Section 26) unless:

  1. the choice of settlement in equity instruments has no commercial substance (e.g. because the entity is legally prohibited from issuing shares); or
  2. the entity has a past practice or a stated policy of settling in cash, or generally settles in cash whenever the counterparty asks for cash settlement.

If (a) or (b) applies, the transaction should be accounted for as wholly cash-settled in accordance with paragraph 14 of Section 26. [FRS 102.26.15A].

An important practical effect of the above criteria is that some schemes that may appear at first sight to be equity-settled may in fact have to be treated as cash-settled. For example, if an entity has consistently adopted a policy of granting ex gratia cash compensation to all those deemed to be ‘good’ leavers (or all ‘good’ leavers of certain seniority) in respect of partially vested share options, such a scheme may well be treated as cash-settled for the purposes of FRS 102 to the extent to which there are expected to be such ‘good’ leavers during the vesting period. ‘Good leaver’ arrangements are also discussed at 6.3.8 above.

11.1.1 Accounting at date of settlement for awards where there is a choice of equity- or cash-settlement

FRS 102 contains no guidance about how to account as at the date of settlement for an award that has been accounted for as cash-settled but which is settled in equity, or vice versa. We suggest the following approach based on the requirements of IFRS 2 or practice that has evolved in the application of that standard.

11.1.1.A Settlement of an award treated as cash-settled during vesting period

IFRS 2 gives no specific guidance as to the accounting treatment on settlement where an entity has accounted for an award as cash-settled but it is settled in equity. However, it is clear from other provisions of IFRS 2, including the general rules on settlement and the provisions relating to settlement of an award where the counterparty has the choice of settlement method, that:

  • the liability should be remeasured to fair value through the income statement at settlement date;
  • if cash settlement occurs, the cash paid is applied to reduce the liability; and
  • if equity settlement occurs, the liability is transferred into equity.
11.1.1.B Settlement of an award treated as equity-settled during vesting period

When a transaction that has been accounted for as equity-settled is settled, IFRS 2 specifies the following approach:

  1. subject to (b) below:
    1. if the transaction is cash-settled, the cash is accounted for as a deduction from equity; or
    2. if the transaction is equity-settled, there is a transfer from one component of equity to another (if necessary); and
  2. if the entity chooses the settlement alternative with the higher fair value, as at the date of settlement, the entity recognises an additional expense for the excess value given. [IFRS 2.43].

This is illustrated in Examples 23.34 and 23.35 below.

£ £
Profit or loss (employee costs) 300
Equity 1,700
Cash 2,000
£ £
Profit or loss (employee costs) 300
Equity 300

No further accounting entry is required by IFRS 2. However, there may be a transfer within equity of the £1,300 credited during the vesting period and on settlement.

If the entity settles in cash, no extra expense is recognised, and the accounting entry is:

£ £
Equity 1,700
Cash 1,700

It can be seen in this case that, if the transaction is settled in equity, an additional expense is recognised. If, however, the transaction had simply been an equity-settled transaction (i.e. with no cash alternative), there would have been no additional expense on settlement and the cumulative expense would have been only £1,000 based on the fair value at grant date.

As FRS 102 does not specify the accounting for a settlement – either generally (see 8.4 above) or where there is a settlement choice – it is debatable whether the recognition of an additional expense on remeasurement is required, or whether any difference could be accounted for in equity as would be the case with the repurchase of equity instruments outside a share-based payment transaction. However, in our view, it is appropriate to adopt an approach consistent with that of IFRS 2 given the extent to which the requirements of Section 26 generally, including those relating to modification and cancellation, are derived from those of IFRS 2.

11.1.2 Change in classification of award after grant date

Neither FRS 102 nor IFRS 2 specifies whether a transaction where the entity has a choice of settlement in equity or cash should be assessed as equity-settled or cash-settled only at the inception of the transaction or whether this should also be assessed at each reporting date until the transaction is settled.

FRS 102 states that a transaction should be treated as equity-settled unless either criterion (a) or criterion (b) in paragraph 15A of Section 26 applies (see 11.1 above). As it is not specified that this assessment takes place only at inception of the award, in our view FRS 102 requires an ongoing assessment of the relevance of these criteria.

FRS 102 does not specify how to account for a change in classification resulting from a change in the entity's policy or intention. In our view, the most appropriate treatment is to account for such a change as if it were a modification of the manner of settlement of the award (see 10.4 above). Where the entity is able to choose the manner of settlement, the substance of the situation is the same as a decision to modify the manner of settlement of an award which does not already give the entity a choice. These situations are distinct from those where the manner of settlement depends on the outcome of a contingent event outside the entity's control (see 11.3 below).

11.1.3 Economic compulsion for cash settlement (including unlisted entity awards with a presumption of cash settlement)

Some awards may nominally give the reporting entity the choice of settling in cash or equity, while in practice giving rise to an economic compulsion to settle only in cash. In addition to the examples mentioned at 11.1 above, this will often be the case where an entity that is a subsidiary or owned by a small number of individuals, such as members of the same family, grants options to employees. In such cases there will normally be a very strong presumption that the entity will settle in cash in order to avoid diluting the existing owners' interests. Similarly, where the entity is not listed, there is little real benefit for an employee in receiving a share that cannot be realised except when another shareholder wishes to buy it or there is a change in ownership of the business as a whole.

In our view, such schemes are generally most appropriately accounted for as cash-settled schemes from inception. In any event, once the scheme has been operating for a while, it is likely that there will be a past practice of cash settlement such that the scheme is required to be treated as a liability under the general provisions of FRS 102 summarised above.

A similar conclusion is often reached even where the terms of the agreement do not appear to offer the entity a choice of settling the award in cash but it has established a constructive obligation or a past practice of so doing (see 10.2 above).

11.2 Transactions where the counterparty has choice of settlement in equity or in cash

Where the counterparty has a choice of settlement in either equity instruments or cash, it will generally be the case that the arrangement will be accounted for as a cash-settled share-based payment transaction (see 10 above).

Section 26 requires an entity to account for a transaction where the counterparty has a choice of settlement in cash (or other assets) or in equity instruments as a wholly cash-settled share-based payment transaction (in accordance with paragraph 14), except for when the conditions set out in paragraph 15C of Section 26 are met. [FRS 102.26.15B]. If the choice of settlement in cash (or other assets) has no commercial substance because the cash settlement amount (or value of the other assets) bears no relationship to, and is likely to be lower in value than, the fair value of the equity instruments, the entity should account for the transaction as wholly equity-settled in accordance with paragraphs 7 to 13 of Section 26. [FRS 102.26.15C].

In cases where the fair values of the cash and equity alternatives are similar, the approach required by FRS 102 is broadly consistent with the outcome of the approach required by IFRS 2. IFRS 2 requires a split accounting approach, between liabilities and equity, which mainly has an impact where the fair value of the equity alternative exceeds that of the cash alternative.

FRS 102 has no specific guidance for situations where there is a change of settlement method. The discussions at 11.1.1 and 11.1.2 above may also provide some guidance for transactions where the counterparty has choice of settlement.

11.2.1 Transactions with settlement alternatives of different value

In many share-based payment transactions with a choice of settlement, the value of the share and cash alternatives is equal. The counterparty will have the choice between (say) 1,000 shares or the cash value of 1,000 shares. Under FRS 102, this transaction would be accounted for as a cash-settled transaction.

However, it is not uncommon, particularly in transactions with employees, for the equity-settlement alternative to have more value. For example, an employee might be able to choose at vesting between the cash value of 1,000 shares immediately or 2,000 shares (often subject to further conditions such as a minimum holding period, or a further service period). In such a situation, it will need to be decided whether the arrangement falls within paragraph 15C of Section 26 (see 11.2 above) leading to the entire arrangement being accounted for as an equity-settled transaction.

11.2.2 ‘Backstop’ cash settlement rights

Some schemes may provide cash settlement rights to the holder so as to cover more or less remote contingencies.

If the terms of the award provide the employee with a general right of cash-settlement, FRS 102 requires the award to be treated as cash-settled. This is the case even if the right of cash settlement is extremely unlikely to be exercised (e.g. because it would give rise to adverse tax consequences for the employee as compared with equity settlement). If, however, the right to cash-settlement is exercisable only in specific circumstances, a more detailed analysis may be required (see 11.3 below).

11.3 Awards requiring cash or equity settlement in specific circumstances (awards with contingent cash or contingent equity settlement)

This section is written with a focus on awards with contingent cash settlement. However, similar considerations will apply in a situation where it is the settlement in equity that depends on the outcome of circumstances outside the control of the entity or both the entity and the counterparty.

Rather than giving either the entity or the counterparty a general right to choose between settlement in equity or in cash, some awards require cash settlement in certain specific and limited circumstances, but otherwise will be equity-settled. These arrangements are sometimes referred to as contingent settlement provisions and are driven by the occurrence or non-occurrence of specific outcomes rather than by choice. Questions arise as to whether such an award should be accounted for as equity-settled or cash-settled and whether this should be re-assessed on an ongoing basis during the vesting period.

Neither FRS 102 nor IFRS 2 has specific guidance on the accounting treatment of such arrangements. In advising on the July 2015 amendments to FRS 102, the Accounting Council noted that respondents to the draft amendments to Section 26 pointed out that this is a subject that has recently been discussed in the context of IFRS 2 although no changes have yet been made, or indeed proposed, to the published guidance. The Accounting Council therefore advised that the need for further amendment for situations where settlement in cash depends on the occurrence of an event outside the control of either party to a transaction should be re-considered as part of the next review of FRS 102.2 No further amendments were proposed as part of the Triennial review 2017, most likely as a result of no current amendments being proposed to IFRS 2 by the IASB.

In the absence of specific guidance, we consider some possible accounting analyses at 11.3.1 to 11.3.3 below.

11.3.1 Approach 1 – Treat as cash-settled if contingency is outside entity's control

One approach might be to observe that the underlying principle that determines whether an award is accounted for as equity-settled or cash-settled appears to be whether the reporting entity can unilaterally avoid cash-settlement (see 11.1 and 11.2 above). Under this approach, any award where the counterparty has a right to cash-settlement is always treated as a liability, irrespective of the probability of cash-settlement, unless there is no commercial substance. By contrast, an award where the choice of settlement rests with the entity is accounted for as a liability only where the entity's own actions have effectively put it in a position where it has no real choice but to settle in cash.

Applying this approach, it is first of all necessary to consider whether the event that requires cash-settlement is one over which the entity has control. If the event, however unlikely, is outside the entity's control, then under this approach the award should be treated as cash-settled. However, if the event is within the entity's control, the award should be treated as cash-settled only if the entity has a liability by reference to the criteria summarised in 11.1 above.

Whilst, in our view, this is an acceptable accounting approach, it does not seem entirely satisfactory. For example, it is common for an equity-settled share-based payment award to contain a provision to the effect that, if the employee dies in service, the entity will pay to the employee's estate the fair value of the award in cash. The approach above would lead to the conclusion that the award must be classified as cash-settled, on the basis that it is beyond the entity's control whether or not an employee dies in service. This seems a somewhat far-fetched conclusion, and is moreover inconsistent with the accounting treatment that the entity would apply to any other death-in-service benefit.

11.3.2 Approach 2 – Treat as cash-settled if contingency is outside entity's control and probable

Under US GAAP,3 a cash settlement feature that can be exercised only upon the occurrence of a contingent event that is outside the employee's control (such as an initial public offering) does not give rise to a liability until it becomes probable that that event will occur.

In our view, this approach based on the probability of a contingent event that is outside the control of both the counterparty and the entity is also acceptable in the absence of specific guidance in FRS 102 (and IFRS 2) and has frequently been used in practice by entities applying IFRS 2.

The impact of Approach 1 and Approach 2 can be illustrated by reference to an award that requires cash-settlement in the event of a change of control of the entity (see 11.3.3 below).

11.3.3 Application of Approach 1 and Approach 2 to awards requiring cash settlement on a change of control

It is not uncommon for the terms of an award to provide for compulsory cash-settlement by the entity if there is a change of control of the reporting entity. Such a provision ensures that there is no need for any separate negotiations to buy out all employee options, so as to avoid non-controlling (minority) interests arising in the acquired entity when equity-settled awards are settled after the change of control.

The determination of whether or not a change of control is within the control of the entity is beyond the scope of this publication.

If the facts and circumstances of a particular case indicate that a change of control is within the entity's control, the conclusion under either Approach 1 or Approach 2 above would be that the award should be treated as cash-settled only if the entity has a liability by reference to the criteria summarised at 11.1 above.

If, however, the change of control is not considered to be within the control of the reporting entity, the conclusion will vary depending on whether Approach 1 or Approach 2 is followed. Under Approach 1, an award requiring settlement in cash on a change of control outside the control of the entity would be treated as cash-settled, however unlikely the change of control may be. Under Approach 2 however, an award requiring settlement in cash on a change of control outside the control of the entity would be treated as cash-settled only if a change of control were probable.

A difficulty with Approach 2 is that it introduces rather bizarre inconsistencies in the accounting treatment for awards when the relative probability of their outcome is considered. As noted at 11.2.2 above, an award that gives the counterparty an absolute right to cash-settlement is accounted for as a liability, however unlikely it is that the counterparty will exercise that right (unless the cash settlement option is considered to have no commercial substance). Thus, under this approach, the entity could find itself in the situation where it treats:

  • as a liability: an award with a unrestricted right to cash-settlement for the counterparty, where the probability of the counterparty exercising that right is less than 1%; but
  • as equity: an award that requires cash settlement in the event of a change of control which is assessed as having a 49% probability of occurring.

In our view, an entity may adopt either of these accounting treatments, but should do so consistently and state its policy for accounting for such transactions if material.

It should be noted in the selection of an accounting policy that the IASB had discussions – but did not conclude – on whether an approach based on the ‘probable’ outcome, as set out here, should be applied under IFRS 2 or whether an approach based on the accounting treatment for a compound financial instrument should be used. Any further developments in this area could affect the availability of the alternative treatments in future. The detailed discussions are beyond the scope of this publication but are addressed in EY International GAAP 2019.

There is further discussion at 16.4 below of awards that vest or are exercisable on a flotation or change of control, including the question of whether a cash-settlement obligation rests with the entity itself or with other parties involved in the change of control (see 16.4.6 below).

11.3.4 Accounting for change in manner of settlement where award is contingent on future events outside the control of the entity and the counterparty

When, under Approach 2 above, the manner of settlement of an award changes solely as a consequence of a re-assessment of the probability of a contingent event, there is neither settlement of the award nor modification of its original terms. The terms of the award are such that there have been two potential outcomes, one equity-settled and one cash-settled, running in parallel since grant date. It is as if, in effect, the entity has simultaneously issued two awards, only one of which will vest.

At each reporting date the entity should assess which outcome is more likely and account for the award on an equity- or cash-settled basis accordingly. In our view, any adjustments arising from a switch between the cumulative amount for the cash-settled award and the cumulative amount for the equity-settled award should be taken to profit or loss in the current period. This is similar to the approach for an award with multiple independent vesting conditions (see 7.3.6 above).

When applying an approach where the two outcomes have both been part of the arrangement from grant date, an entity measures the fair value of the equity-settled award only at the original grant date and there is no remeasurement of the equity-settled award on reassessment of the settlement method. As the cash-settled award would be remeasured on an ongoing basis, a switch in the manner of settlement during the period until the shares vest or the award is settled in cash could give rise to significant volatility in the cumulative expense. At the date of vesting or settlement, however, the cumulative expense will equate to either the grant date fair value of the equity-settled approach or the settlement value of the cash-settled approach depending on whether or not the contingent event has happened.

The situation discussed in this section (i.e. an arrangement with two potential outcomes from grant date because the manner of settlement is not within the control of either the entity or the counterparty) is not the same as an award where the manner of settlement is entirely within the entity's control. Where the entity has such control and therefore a choice of settlement, a change in the manner of settlement is treated as a modification with a potential catch-up adjustment through equity (see 10.4 above).

11.4 Cash settlement alternative where the cash sum is not based on share price or value

Some awards may provide a cash-settlement alternative that is not based on the share price. For example, an employee might be offered a choice between 500 shares or £1,000,000 on the vesting of an award. Whilst an award of £1,000,000, if considered in isolation, would obviously not be a share-based payment transaction, in our view it falls within the scope of Section 26 if it is offered as an alternative to a transaction that is within the scope of that Section. FRS 102 has no specific guidance in this area but we draw on the Basis for Conclusions to IFRS 2 which states that the cash alternative may be fixed or variable and, if variable, may be determinable in a manner that is related, or unrelated, to the price of the entity's shares. [IFRS 2.BC256].

Under the requirements of paragraphs 15B and 15C of Section 26, the award will be treated as cash-settled unless the option arrangements do not have commercial substance (see 11.2 above).

12 REPLACEMENT SHARE-BASED PAYMENT AWARDS ISSUED IN A BUSINESS COMBINATION

12.1 Background

It is relatively common for an entity (A) to acquire another (B) which, at the time of the business combination, has outstanding employee share options or other share-based awards. If no action were taken by A, employees of B would be entitled, once any vesting conditions had been satisfied, to shares in B. This is not a very satisfactory outcome for either party: A now has non-controlling (minority) shareholders in subsidiary B, which was previously wholly-owned, and the employees of B are the owners of unmarketable shares in an effectively wholly-owned subsidiary.

The obvious solution, adopted in the majority of cases, is for some mechanism to be put in place such that the employees of B end up holding shares in the new parent A. This can be achieved, for example, by:

  • A granting options over its own shares to the employees of B in exchange for the surrender of the employees' options over the shares of B; or
  • changing the terms of the options so that they are over a special class of shares in B which are mandatorily convertible into shares of A.

FRS 102 contains no guidance about how such a substitution transaction should be accounted for in the consolidated financial statements of A and this area is considered to be beyond the scope of this publication. Under IFRS, the relevant guidance is included in IFRS 3 and the requirements, which are based on accounting for the modification of share-based payments, are addressed in EY International GAAP 2019.

The treatment in the single entity financial statements of B is discussed at 12.2 below.

12.2 Financial statements of the acquired entity

The replacement of an award based on the acquiree's equity with one based on the acquirer's equity appears, from the perspective of the acquired entity, to be a cancellation and replacement. In our view, this should to be accounted for in accordance with the general principles for such transactions (see 8.4 above) but taking into account the specific provisions of Section 26 in respect of group share schemes (see 13 below). Therefore, in addition to considerations about whether this is accounted for as a separate cancellation and new grant or as a modification of the original terms, the acquiree needs to take into account its new status as a subsidiary of the acquirer. If the acquiree's employees are now receiving awards granted by the new parent, the new subsidiary might choose to apply the provisions for groups in paragraph 16 of Section 26 (see 13.2.3.A below) rather than the general approach for an entity receiving goods or services but not obliged to settle the award.

13 GROUP SHARE SCHEMES

In this section we consider various aspects of share-based payment arrangements operated within a group of companies and involving several legal entities. The main areas covered are as follows:

  • typical features of a group share scheme (see 13.1 below);
  • a summary of the accounting treatment of group share schemes (see 13.2 below);
  • EBTs and similar arrangements (see 13.3 below);
  • an example of a group share scheme (based on an equity-settled award satisfied by a purchase of shares) illustrating the accounting by the different entities involved (see 13.4 below);
  • an example of a group share scheme (based on an equity-settled award satisfied by a fresh issue of shares) illustrating the accounting by the different entities involved (see 13.5 below);
  • an example of a group cash-settled transaction where the award is settled by an entity other than the one receiving goods or services (see 13.6 below); and
  • the accounting treatment when an employee transfers between group entities (see 13.7 below).

Associates and joint arrangements do not meet the definition of group entities but there will sometimes be share-based payment arrangements that involve the investor or venturer and the employees of its associate or joint venture. Such arrangements are beyond the scope of this publication but are addressed in EY International GAAP 2019.

13.1 Typical features of a group share scheme

In this section we use the term ‘share scheme’ to encompass any transaction falling within the scope of Section 26, whether accounted for as equity-settled or cash-settled.

It is common practice for a group to operate a single share scheme covering the employees of the parent and/or several subsidiaries but the precise terms and structures of group share schemes are so varied that it is rare to find two completely identical arrangements. From an accounting perspective, however, group share schemes can generally be reduced to a basic prototype, as described below, which will serve as the basis of the following discussion.

A group scheme typically involves transactions by several legal entities:

  • the parent, over whose shares awards are granted and which is often responsible for settling the award (either directly or through a trust);
  • the subsidiary employing an employee who has been granted an award (‘the employing subsidiary’); and
  • in some cases, an employee benefit trust (‘EBT’) that administers the scheme. The accounting treatment of transactions with EBTs is discussed at 13.3 below.

In practice, it might not always be a simple assessment to determine which entity is receiving an employee's services and which entity is responsible for settling the award. For example, the scheme may be directed by a group employee services entity or an individual might be a director of the parent as well as providing services to other operating entities within the group.

Where an employee services company is involved it will be necessary to evaluate the precise group arrangements in order to decide whether the entity is, in substance, the employer. It will often be the case that the services company is simply administering the arrangements on behalf of the parent entity.

A share-based award is often granted to an employee by the parent, or a group employee services entity, which will in turn have an option exercisable against the EBT for the shares that it may be required to deliver to the employee. Less commonly, the trustees of the EBT make awards to the employees and enter into reciprocal arrangements with the parent.

If the parent takes the view that it will satisfy any awards using existing shares it will often seek to fix the cash cost of the award by arranging for the EBT to purchase, on the day that the award is made, sufficient shares from existing shareholders to satisfy all or part of the award. This will be funded by external borrowings, a loan from the parent, a contribution from the employing subsidiary, or some combination. The cash received from the employee on exercise of the option can be used by the EBT to repay any borrowings.

If the parent takes the view that it will satisfy the options with a fresh issue of shares, these will be issued to the EBT, either:

  1. at the date on which the employee exercises his option (in which case the EBT will subscribe for the new shares using the cash received from the employee together with any non-refundable contribution made by the employing subsidiary – see below). Such arrangements are generally referred to as ‘simultaneous funding’;
  2. at some earlier date (in which case the EBT will subscribe for the new shares using external borrowings, a loan from the parent or a contribution from the employing subsidiary, or some combination. The cash received from the employee on exercise of the option may then be used by the EBT to repay any borrowings). Such arrangements are generally referred to as ‘pre-funding’; or
  3. some shares will be issued before the exercise date as in (b) above, and the balance on the exercise date as in (a) above.

As noted in (a) above, the employing subsidiary often makes a non-refundable contribution to the EBT in connection with the scheme, so as to ensure that employing subsidiaries bear an appropriate share of the overall cost of a group-wide share scheme.

13.2 Accounting treatment of group share schemes – summary

13.2.1 Background

From a financial reporting perspective, it is generally necessary to consider the accounting treatment in:

  • the group's consolidated financial statements;
  • the parent's separate financial statements; and
  • the employing subsidiary's financial statements.

We make the assumption throughout this section on group share schemes that the subsidiary is directly owned by the parent company. In practice, there will often be one or more intermediate holding companies between the ultimate parent and the subsidiary. The intermediate parent company generally will not be the entity granting the award, receiving the goods or services or responsible for settling the award. Therefore, under Section 26, we believe that there is no requirement for the intermediate company to account for the award in its separate financial statements.

The accounting entries to be made in the various financial statements will broadly vary according to:

  • whether the award is satisfied using shares already held or a fresh issue of shares;
  • whether any charge is made to the employing subsidiary for the cost of awards to its employees;
  • whether an EBT is involved. The accounting treatment of transactions undertaken with and by EBTs is discussed in more detail at 13.3 below; and
  • the tax consequences of the award. For the purposes of the discussion and illustrative examples below, tax effects are ignored. A more general discussion of the tax effects of share-based payment transactions may be found at 15 below.

The sections below largely discuss the application of the basic requirements of Section 26 to share-based payment transactions within a group of entities. However, in addition to the application of those requirements, Section 26 allows an alternative treatment based on the allocation of a group share-based payment expense to group entities on a reasonable basis (see 13.2.3.A below).

13.2.2 Scope of Section 26 for group share schemes

By virtue of the definition of a ‘share-based payment transaction’ (see 3.1 and 3.2.1 above), a group share-based payment transaction is in the scope of Section 26 for:

  • the consolidated financial statements of the group (the accounting for which follows the general principles set out in 4 to 11 above);
  • the separate or individual financial statements of the entity in the group that receives goods or services (see 13.2.3 below); and
  • the separate or individual financial statements of the entity in the group (if different from that receiving the goods or services) that settles the transaction with the counterparty. This entity will typically, but not necessarily, be the parent (see 13.2.4 below).

As discussed at 3 above, the scope paragraphs of Section 26, together with the definitions in Appendix I to FRS 102, indicate whether transactions are to be accounted for as equity-settled or as cash-settled in most group situations including:

  • transactions settled in the equity of the entity, or in the equity of its parent (see 13.2.5 below); and
  • cash-settled transactions settled by a group entity other than the entity receiving the goods or services (see 13.2.6 below).

At 3.2-1-A above, we consider seven scenarios commonly found in practice and outline the approach required by Section 26 in the consolidated and separate or individual financial statements of group entities depending on whether the award is settled in cash or shares and which entity grants the award, has the obligation to settle the award and receives the goods or services. These scenarios do not reflect the alternative treatment for group plans in Section 26 (see 13.2.3.A below).

It is common practice in a group share scheme to require each participating entity in the group to pay a charge, either to the parent or to an EBT, in respect of the cost of awards made under the scheme to employees of that entity. This is generally done either as part of the group's cash-management strategy, or in order to obtain tax relief under applicable local legislation. The amount charged could in principle be at the discretion of the group, but is often based on either the fair value of the award at grant date or the fair value at vesting, in the case of an award of free shares, or exercise, in the case of an award of options.

Neither FRS 102 nor IFRS 2 directly addresses the accounting treatment of such intragroup management charges and other recharge arrangements, which is discussed further at 13.2.7 below. [IFRS 2 Appendix B.46].

Worked examples illustrating how these various principles translate into accounting entries are given at 13.4 to 13.6 below.

13.2.3 Entity receiving goods or services

The entity in a group receiving goods or services in a share-based payment transaction determines whether the transaction should be accounted for as equity-settled or cash settled in its separate or individual financial statements. It does this by assessing the nature of the awards granted and its own rights and obligations.

The entity accounts for the transaction as equity-settled when either the awards granted are the entity's own equity instruments, or the entity has no obligation to settle the share-based payment transaction. Otherwise, the entity accounts for the transaction as cash-settled. Where the transaction is accounted for as equity-settled it is remeasured after grant date only to the extent permitted or required by Section 26 for equity-settled transactions generally, as discussed at 4 to 7 above.

A possible consequence of these requirements is that the amount recognised by the entity may differ from the amount recognised by the consolidated group or by another group entity settling the share-based payment transaction. This is discussed further at 13.6 below.

The cost recognised by the entity receiving goods or services is calculated according to the principles set out above unless the group applies the alternative treatment for group plans in Section 26 (see 13.2.3.A below). The cost under Section 26 is not adjusted for any intragroup recharging arrangements, the accounting for which is discussed at 13.2.7 below.

13.2.3.A Alternative treatment for group plans

As an alternative to the accounting treatment in paragraphs 3 to 15C of Section 26 (discussed in sections 4 to 11 and 13 of this chapter), in a share-based payment arrangement granted by an entity to the employees of one or more group entities, those group entities are permitted to measure the share-based payment expense on the basis of a reasonable allocation of the group expense. [FRS 102.26.16].

Prior to the Triennial review 2017 it was not clear in Section 26 whether this alternative treatment is intended only to apply in situations where the group expense is calculated on a basis consistent with the requirements of FRS 102. However, the Triennial review 2017 clarified that the alternative treatment is permitted where the group expense is calculated in accordance with FRS 102, IFRS 2 or on an equivalent basis. [FRS 102.26.16].

13.2.4 Entity settling the transaction

As noted at 3.2.1 above, Section 26 was clarified in the Triennial review 2017 by specifying the accounting treatment when the entity settling the transaction does not receive the goods or services. An entity settling a share-based payment transaction when another entity in the group receives the goods or services should recognise the transaction as an equity-settled share-based payment transaction only if it is settled in its own equity instruments, otherwise, the transaction is recognised as a cash-settled share-based payment transaction. [FRS 102.26.2A].

The above requirements relate only to the credit entry – the classification of the transaction as equity- or cash-settled, and its measurement. They do not specify the debit entry, which is therefore subject to the general requirement of IFRS 2 (and Section 26) that a share-based payment transaction should normally be treated as an expense, unless there is the basis for another treatment (see 4 above).

In our view, the settling entity is not always required to treat the transaction as an expense. Instead:

  • Where the settling entity is a parent (direct or indirect) of the entity receiving the goods or services and is accounting for the transaction as equity-settled, it will generally account for the settlement of the award as an addition to the cost of its investment in the employing subsidiary (or of that holding company of the employing subsidiary which is the settling entity's directly-held subsidiary). It may then be necessary to review the carrying value of that investment to ensure that it is not impaired.
  • Where the settling entity is a parent (direct or indirect) of the entity receiving the goods or services and is accounting for the transaction as cash-settled (whereas the subsidiary will be accounting for the transaction as equity-settled), in our view it has an accounting policy choice for the treatment of the remeasurement of the cash-settled liability. Either:
    • it accounts for the entire award as part of the contribution to the subsidiary and therefore as an addition to the cost of its investment in the employing subsidiary (or of that holding company of the employing subsidiary which is the settling entity's directly-held subsidiary); or
    • after the initial capitalisation of the grant date fair value of the liability, it remeasures the liability through profit or loss.

      Whichever policy is chosen, it may then be necessary to review the carrying value of the investment to ensure that it is not impaired.

  • In other cases (i.e. where the settling entity is a subsidiary (direct or indirect) or fellow subsidiary of the entity receiving the goods or services), it should treat the settlement as a distribution, and charge it directly to equity. Whether or not such a settlement is a legal distribution is a matter of law.

We adopt the approach of full capitalisation by the parent entity in the worked examples set out at 13.4 to 13.6 below.

13.2.5 Transactions settled in equity of the entity or its parent

13.2.5.A Awards settled in equity of subsidiary

Where a subsidiary grants an award to its employees and settles it in its own equity, the subsidiary accounts for the award as equity-settled. [FRS 102.26.1, FRS 102 Appendix I].

The parent accounts for the award as equity-settled in its consolidated financial statements. In its separate financial statements, the parent does not account for the award under FRS 102 because the Parent receives no goods or services, nor does it settle the transaction (see 3.2.1 above). In both cases, the transaction may have implications for other aspects of the financial statements, since its settlement results in the partial disposal of the subsidiary.

Where the parent is responsible for settling the award, it accounts for the transaction as equity-settled in its consolidated financial statements. In its separate financial statements, however, it accounts for the award as cash-settled, since it is settled not in its own equity, but in the equity of the subsidiary (see 3.2.1 and 13.2.4 above). From the perspective of the parent's separate financial statements, the equity of a subsidiary is a financial asset.

13.2.5.B Awards settled in equity of the parent

Where the parent grants an award directly to the employees of a subsidiary and settles it in its own equity, the subsidiary accounts for the award as equity-settled, with a corresponding increase in equity as a contribution from the parent. [FRS 102.26.1, 1A].

The parent accounts for the award as equity-settled in both its consolidated and separate financial statements (see 3.2.1 above). FRS 102.26.2A]

Where a subsidiary grants an award of equity in its parent to its employees and settles the award itself, it accounts for the award as cash-settled, since it is settled not in its own equity, but in the equity of its parent. From the perspective of the subsidiary's separate or individual financial statements, the equity of the parent is a financial asset. [FRS 102.26.1].

This requirement potentially represents something of a compliance burden. For the purposes of the parent's consolidated financial statements the fair value of the award needs to be calculated once, at grant date. For the purposes of the subsidiary's financial statements, however, the basic requirements of Section 26 require the award to be accounted for as cash-settled, with the fair value recalculated at each reporting date. In some cases, the rather unclear wording of paragraph 16 of Section 26 might mean that the arrangements are considered to meet the criteria for the alternative accounting treatment for group schemes. If this were the case, the subsidiary could, in effect, account on an equity-settled basis until the point of settlement (see 13.2.3.A above).

However this approach, which results in equity-settled accounting in the consolidated financial statements and cash-settled accounting in the subsidiary financial statements, applies only when a subsidiary ‘grants’, and is therefore obliged to settle, such an award. In some jurisdictions, including the UK, it is normal for grants of share awards to be made by the parent, or an employee service company or EBT, rather than by the subsidiary, although the subsidiary may well make recommendations to the grantor of the award as to which of its employees should benefit.

In those cases, the fact that the subsidiary may communicate the award to the employee does not necessarily mean that the subsidiary itself has granted the award. It may simply be notifying the employee of an award granted by another group entity and which the other group company has the obligation to settle. In that case the subsidiary should apply the normal requirement of Section 26 to account for the award as equity-settled.

13.2.6 Cash-settled transactions not settled by the entity receiving goods or services

The scope section of Section 26 (see 3 above) considers arrangements in which the parent has an obligation to make cash payments to the employees of a subsidiary linked to the price of either:

  • the subsidiary's equity instruments, or
  • the parent's equity instruments.

In both cases, the subsidiary has no obligation to settle the transaction. Therefore, unless the alternative accounting rules are applied (see below), the subsidiary accounts for the transaction as equity-settled, recognising a corresponding credit in equity as a contribution from its parent. [FRS 102.26.1-1A].

The subsidiary subsequently remeasures the cost of the transaction only for any changes resulting from non-market vesting conditions not being met in accordance with the normal provisions of Section 26 discussed at 4 to 7 above. Section 26 does not specifically make the point – made in IFRS 2 – that this will differ from the measurement of the transaction as cash-settled in the consolidated financial statements of the group. [IFRS 2 Appendix B.56-57].

The parent has an obligation to settle the transaction in cash, paragraph 2A of Section 26 requires the parent to account for the transaction as cash-settled in both its consolidated and separate financial statements as the settling entity. [FRS 102.26.1, 2A].

The requirement for the subsidiary to measure the transaction as equity-settled is somewhat controversial. The essential rationale for requiring the subsidiary to record the cost of a share-based payment transaction settled by its parent is to reflect that the subsidiary is effectively receiving a capital contribution from its parent.

Using the alternative accounting treatment for group plans set out in Section 26 (see 13.2.3.A above), it appears that the subsidiary in this situation could base its expense either on an equity-settled calculation or on an allocation of the group cash-settled expense.

13.2.7 Intragroup recharges and management charges

As noted at 13.2.2 above, neither FRS 102 nor IFRS 2 deals specifically with the accounting treatment of intragroup recharges and management charges that may be levied on the subsidiary that receives goods or services, the consideration for which is equity or cash of another group entity.

The accounting requirements of FRS 102 for group share schemes derive from requirements in IFRS 2 which evolved, via an Interpretation, from an exposure draft (D17) published in 2005.4 In the absence of more specific guidance, we suggest that the treatment outlined below is applied to recharge arrangements in place between entities applying FRS 102. For entities applying the Companies Act 2006, the accounting treatment under D17 is also addressed in Section 7 of TECH 02/17BL. [TECH 02/17BL.7.53-56].

D17 proposed that any such payment made by a subsidiary should be charged directly to equity, on the basis that it represents a return of the capital contribution recorded as the credit to equity required by IFRS 2 (see 13.2.3 and 13.2.6 above) up to the amount of that contribution, and a distribution thereafter.

In our view, whilst IFRS 2 and FRS 102 as currently drafted clearly do not explicitly require this treatment, this is likely to be the more appropriate analysis for most cases where the amount of the recharge or management charge to a subsidiary is directly related to the value of the share-based payment transaction. Indeed, the only alternative, ‘mechanically’ speaking, would be to charge the relevant amount to profit or loss. This would result in a double charge (once for the FRS 102 charge, and again for the management charge or recharge) which we consider less appropriate in cases where the amounts are directly related. Accordingly, in the examples at 13.4 to 13.6 below, we apply the treatment originally proposed in D17 to any payments made by the subsidiary for participation in the group scheme.

Many intragroup recharge arrangements are based directly on the value of the underlying share-based payment – typically at grant date, vesting date or exercise date. In other cases, a more general management charge might be levied that reflects not just share-based payments but also a number of other arrangements or services provided to the subsidiary by the parent. Where there is a more general management charge of this kind, we believe that it is more appropriate for the subsidiary to recognise a double charge to profit or loss rather than debiting the management charge to equity as would be the case for a direct recharge.

IFRS 2 and FRS 102 also do not address how the parent should account for a recharge or management charge received. In our view, to the extent that the receipt represents a return of a capital contribution made to the subsidiary, the parent may choose whether to credit:

  • the carrying amount of its investment in the subsidiary; or
  • profit or loss (with a corresponding impairment review of the investment).

Even if part of the recharge received is credited to the carrying amount of the investment, any amount received in excess of the capital contribution previously debited to the investment in subsidiary should be accounted for as a distribution from the subsidiary and credited to the income statement of the parent. Where applicable, the illustrative examples at 13.4 to 13.6 below show the entire amount as a credit to the income statement of the parent rather than part of the recharge being treated as a credit to the parent's investment in its subsidiary.

A further issue that arises in practice is the timing of recognition of the recharge by the parties to the arrangement. In the absence of a contractual agreement, the treatment adopted might depend on the precise terms and whether there are contractual arrangements in place, but two approaches generally result in practice:

  • to account for the recharge when it is actually levied or paid (which is consistent with accounting for a distribution); or
  • to accrue the recharge over the life of the award or the recharge agreement even if, as is commonly the case, the actual recharge is only made at vesting or exercise date.

An entity should choose the more appropriate treatment for its particular circumstances. The first approach is often the more appropriate in a group context where recharge arrangements might be rather informal and therefore not binding until such time as a payment is made. It is also consistent with the overall recognition of the arrangement through equity. The second approach, which is likely to be the more appropriate approach when a liability is considered to exist in advance of the payment date, is closer in some aspects to the accounting treatment of a provision or financial liability but would reflect changes in the liability through equity rather than profit or loss and would build up the liability over the life of the award rather than recognising it in full when a present obligation has been identified.

Whichever accounting treatment is adopted, any adjustments to the amount to be recognised as a recharge, whether arising from a change in the Section 26 expense or other changes, should be recognised in the current period and previous periods should not be restated.

Where applicable, the examples at 13.4 to 13.6 below illustrate the first of the two treatments outlined above and recognise the recharge only when it becomes payable at the date of exercise.

13.3 Employee benefit trusts (‘EBTs’) and similar arrangements

13.3.1 Background

For some time entities have established trusts and similar arrangements for the benefit of employees. These are known by various names but, for the sake of convenience, in this section we will use the term ‘EBT’ (‘employee benefit trust’) to cover all such vehicles by whatever name they are actually known.

The commercial purposes of using such vehicles vary from employer to employer but may include the following:

  • An EBT, in order to achieve its purpose, needs to hold shares that have either been issued to it by the entity or been bought by the EBT on the open market.
  • In the case of longer-term benefits the use of an EBT may ‘ring fence’ the assets set aside for the benefit of employees in case of the insolvency of the entity.
  • The use of an EBT may be necessary in order to achieve a favourable tax treatment for the entity or the employees, or both.

The detailed features of an EBT will again vary from entity to entity but typical features often include the following:

  • The EBT provides a warehouse for the shares of the sponsoring entity, for example by acquiring and holding shares that are to be sold or transferred to employees in the future. The trustees may purchase the shares with finance provided by the sponsoring entity (by way of cash contributions or loans), or by a third-party bank loan, or by a combination of the two. Loans from the entity are usually interest-free. In other cases, the EBT may subscribe directly for shares issued by the sponsoring entity or acquire shares in the market.
  • Where the EBT borrows from a third party, the sponsoring entity will usually guarantee the loan, i.e. it will be responsible for any shortfall if the EBT's assets are insufficient to meet its debt repayment obligations. The entity will also generally make regular contributions to the EBT to enable the EBT to meet its interest payments, i.e. to make good any shortfall between the dividend income of the EBT (if any) and the interest payable. As part of this arrangement the trustees may waive their right to dividends on the shares held by the EBT.
  • Shares held by the EBT are distributed to employees through an employee share scheme. There are many different arrangements – these may include:
    • the purchase of shares by employees when exercising their share options under a share option scheme;
    • the purchase of shares by the trustees of an approved profit-sharing scheme for allocation to employees under the rules of the scheme; or
    • the transfer of shares to employees under some other incentive scheme.
  • The trustees of an EBT may have a legal duty to act at all times in accordance with the interests of the beneficiaries under the EBT. However, most EBTs (particularly those established as a means of remunerating employees) are specifically designed so as to serve the purposes of the sponsoring entity, and to ensure that there will be minimal risk of any conflict arising between the duties of the trustees and the interest of the entity.

13.3.2 Accounting forEBTs

The requirement to treat an EBT as an extension of the entity is included in Section 9 (see Chapter 8 at 4.5). [FRS 102.9.35-37]. This treatment has the following broad consequences for the consolidated and separate financial statements of the reporting entity:

  • Until such time as the entity's own shares held by the EBT vest unconditionally in employees any consideration paid for the shares should be deducted in arriving at shareholders' equity.
  • Other assets and liabilities (including borrowings) of the EBT should be recognised as assets and liabilities in the financial statements of the sponsoring entity.
  • No gain or loss should be recognised in profit or loss or other comprehensive income on the purchase, sale, issue or cancellation of the entity's own shares. Consideration paid or received for the purchase or sale of the entity's own shares in an EBT should be shown separately from other purchases and sales of the entity's own shares (‘true’ treasury shares held by the reporting entity) in the statement of changes in equity.
  • Any dividend income arising on own shares should be excluded from profit or loss and deducted from the aggregate of dividends paid. In our view, the deduction should be disclosed if material.
  • Finance costs and any administration expenses should be charged as they accrue and not as funding payments are made to the EBT.

The discussion above, and in the remainder of 13 below, focuses on arrangements where the EBT holds unallocated shares of the reporting entity and/or shares that have been allocated to employees in connection with share awards but where the awards have not yet vested. There will also be situations in practice in which an EBT reaches the stage where, or is designed so that, it only holds shares to which employees have full entitlement (i.e. the shares are fully vested). In this situation the shares are beneficially owned and controlled by the individual employees but might remain in trust for tax or other reasons in the period following vesting. Where an EBT does not hold any unvested shares and there are no other assets or liabilities in the EBT over which the entity continues to exercise control, there will be nothing left in the EBT to incorporate into the entity's financial statements by extension.

13.3.3 Illustrative Examples – awards satisfied by shares purchased by, or issued to, an EBT

The following Examples show the interaction of accounting for the EBT with the requirements of Section 26. Example 23.36 illustrates the treatment where an award is satisfied using shares previously purchased by the EBT. Example 23.37 illustrates the treatment where freshly issued shares are used.

£ £
1 January
Own shares (equity) 250,000
Cash 250,000
To record purchase of 100,000 £1 shares at £2.50/share
1 May – 31 December
Profit or loss 52,500
Equity 52,500
To record cost of vested 350,000 options at £0.15/option
1 September
Own shares (equity) 795,000
Cash 795,000
To record purchase of 300,000 £1 shares at £2.65/share
31 December
Cash 945,000
Equity†1 945,000
Receipt of proceeds on exercise of 350,000 options at £2.70/share
Equity 914,375
Own shares (equity)2 914,375
Release of shares from EBT to employees

1 This reflects the fact that the entity's resources have increased as a result of a transaction with an owner, which gives rise to no gain or loss and is therefore credited direct to equity.

2 It is necessary to transfer the cost of the shares ‘reissued’ by the EBT out of own shares, as the deduction for own shares would otherwise be overstated. The total cost of the pool of 400,000 shares immediately before vesting was £1,045,000 (£250,000 purchased on 1 January and £795,000 purchased on 1 September), representing an average cost per share of £2.6125. £2.6125 × 350,000 shares = £914,375.

These amounts should all be accounted for in the profit and loss reserve or, until the awards are exercised, a separate reserve for share-based payments.

Example 23.36 illustrates the importance of keeping the accounting for the cost of the shares completely separate from that for the cost of the share-based payment award. In cash terms, ABC has made a ‘profit’ of £30,625, since it purchased 350,000 shares with a weighted average cost of £914,375 and issued them to the executives for £945,000. However, this ‘profit’ is accounted for entirely within equity, whereas a calculated expense of £52,500 is recognised in profit or loss.

£ £
1 January
Equity†1 250,000
Share capital 100,000
Share premium 150,000
To record issue of 100,000 £1 shares to EBT at £2.50/share
1 May – 31 December
Profit or loss 52,500
Equity 52,500
To record cost of vested 350,000 options at £0.15/option
1 September
Equity†1 795,000
Share capital 300,000
Share premium 495,000
To record issue of 300,000 £1 shares at £2.65/share
31 December
Cash 945,000
Equity2† 945,000
Receipt of proceeds on exercise of 350,000 options at £2.70/share

1 This entry is required to reconcile the legal requirement to record an issue of shares with the fact that, in reality, there has been no increase in the resources of the reporting entity. All that has happened is that one member of the reporting group (the EBT) has transferred cash to another (the parent entity). In our view, this amount should not strictly be accounted for within any ‘Own shares reserve’ in equity, which should be restricted to shares acquired from third parties, although it is increasingly common in practice to see an entry in ‘own shares’ to reflect such a holding of shares by an EBT.

2 This reflects the fact that the entity's resources have increased as a result of a transaction with an owner, which gives rise to no gain or loss and is therefore credited direct to equity.

These amounts should all be accounted for in the profit and loss reserve (subject to note 1 above) or, until the awards are exercised, a separate reserve for share-based payments.

13.3.4 Financial statements of the EBT

The EBT may be required to prepare financial statements in accordance with requirements imposed by local law or by its own trust deed. The form and content of such financial statements are beyond the scope of this publication.

13.4 Illustrative example of group share scheme – equity-settled award satisfied by purchase of shares

The discussion in 13.4.1 to 13.4.3 below is based on Example 23.38 and addresses the accounting treatment for three distinct aspects of a group share scheme – a share-based payment arrangement involving group entities (see 13.2 above), the use of an EBT (see 13.3 above) and a group recharge arrangement (see 13.2.7 above).

This illustrative example treats the recharge by the parent to the subsidiary as an income statement credit in the individual accounts of the parent and recognises the recharge when it is paid. In some situations, entities might consider it appropriate to apply alternative accounting treatments (see 13.2.7 above).

13.4.1 Consolidated financial statements

So far as the consolidated financial statements are concerned, the transactions to be accounted for are:

  • the purchase of the shares by the EBT and their eventual transfer to the employee; and
  • the cost of the award.

Transactions between H plc or S Limited and the EBT are ignored since the EBT is treated as an extension of H plc (see 13.3 above). The accounting entries required are set out below. As in other examples in this chapter, an entry to equity is not allocated to a specific reserve as this will vary between entities (although the most common for an entity complying with the Companies Act 2006 will be the profit and loss reserve or a separate ‘other reserve’ for share-based payments).

£ £
y/e 31.12.20x1 Profit or loss (employee costs)* 500
Equity 500
1.1.20x2 Own shares (equity) 6,000
Cash 6,000
y/e 31.12.20x2 Profit or loss (employee costs)* 1,000
Equity 1,000
y/e 31.12.20x3 Profit or loss (employee costs)* 1,000
Equity 1,000
y/e 31.12.20x4 Profit or loss (employee costs)* 500
Equity 500
1.9.20x6 Cash (option proceeds) 4,500
Equity 1,500
Own shares (equity)** 6,000

* Total cost £3,000 (3000 options × £1) spread over 36 months. Charge for period to December 20x1 is 6/36 × £3,000 = £500, and so on. In practice, where options are granted to a group of individuals, or with variable performance criteria, the annual charge will be based on a continually revised cumulative charge (see further discussion at 7.1 to 7.4 above).

3,000 options at £1.50 each.

This reflects the fact that the overall effect of the transaction for the group in cash terms has been a ‘loss’ of £1,500 (£6,000 original cost of shares less £4,500 option proceeds received). However, under FRS 102 this is an equity transaction, not an expense.

**£6,000 cost of own shares purchased on 1 January 20x2 now transferred to the employee. In practice, it is more likely that the appropriate amount to be transferred would be based on the weighted average price of shares held by the EBT at the date of exercise, as in Example 23.36 at 13.3.3 above. In such a case there would be a corresponding adjustment to the debit to equity marked with ‡ above.

13.4.2 Parent

13.4.2.A Accounting by parent where the subsidiary company is the employing company

The parent accounts for the share-based payment transaction under FRS 102 as an equity-settled transaction since the parent settles the award by delivering its own equity instruments to the employees of the subsidiary (see 13.2.4 above). However, as discussed at 13.2.4 above, instead of recording an expense, as in its consolidated financial statements, the parent records an increase in the carrying value of its investment in subsidiary. It might then be necessary to consider whether the ever-increasing investment in subsidiary is supportable or is in fact impaired. As this is a matter to be determined in the light of specific facts and circumstances, it is not considered in this example. Any impairment charge would be recorded in profit or loss.

In addition to accounting for the share-based payment transaction, the parent records the transactions of the EBT and the purchase of shares.

This gives rise to the following entries:

£ £
y/e 31.12.20x1 Investment in subsidiary* 500
Equity 500
1.1.20x2 Own shares (equity) 6,000
Cash 6,000
y/e 31.12.20x2 Investment in subsidiary* 1,000
Equity 1,000
y/e 31.12.20x3 Investment in subsidiary* 1,000
Equity 1,000
y/e 31.12.20x4 Investment in subsidiary* 500
Equity 500
1.9.20x6 Cash 6,000
Equity 1,500
Profit or loss§ 1,500
Own shares** (equity) 6,000

* Total increase in investment £3,000 (3000 shares × £1 fair value of each option) spread over 36 months. Increase during period to December 20x1 is 6/36 × £3,000 = £500, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual adjustment would be based on a continually revised cumulative adjustment (see further discussion at 7.1 to 7.4 above).

£4,500 option exercise proceeds from employee plus £1,500 contribution from S Limited.

This is essentially a balancing figure representing the fact that the entity is distributing own shares with an original cost of £6,000, but has treated £1,500 of the £6,000 of the cash it has received as income (see § below) rather than as payment for the shares.

§ The £1,500 contribution by the subsidiary to the EBT has been treated as a distribution from the subsidiary (see 13.2.7 above) and recorded in profit or loss. It might then be necessary to consider whether, as a result of this payment, the investment in the subsidiary had become impaired. As this is a matter to be determined in the light of specific facts and circumstances, it is not considered in this example. Any impairment charge would be recorded in profit or loss.

** £6,000 cost of own shares purchased on 1 January 20x2 now transferred to employee. In practice, it is more likely that the appropriate amount to be transferred would be based on the weighted average price of shares held by the EBT at the date of exercise, as in Example 23.36 at 13.3.3 above.

13.4.2.B Parent company as employing company

If, in Example 23.38, the employing entity were the parent rather than the subsidiary, it would record an expense under FRS 102. It would also normally waive £1,500 of its £6,000 loan to the EBT (i.e. the shortfall between the original loan and the £4,500 option proceeds received from the employee).

As the EBT is treated as an extension of the parent, the accounting entries for the parent would be the same as those for the group, as set out at 13.4.1 above.

13.4.3 Employing subsidiary

The employing subsidiary is required to account for the FRS 102 expense and the contribution to the EBT on exercise of the award. This gives rise to the accounting entries set out below. The entries to reflect the expense are required by FRS 102 (see 13.2.3 above). The treatment of the contribution to the EBT as a distribution is discussed at 13.2.7 above.

£ £
y/e 31.12.20x1 Profit or loss* 500
Equity 500
y/e 31.12.20x2 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x3 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x4 Profit or loss* 500
Equity 500
1.9.20x6 Equity 1,500
Cash 1,500

* Total cost £3,000 (3000 options × £1) spread over 36 months. Charge for period to December 20x1 is 6/36 × £3,000 = £500, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 7.1 to 7.4 above).

This should be treated as a reduction of whatever component of equity was credited with the £3,000 quasi-contribution from the parent in the accounting entries above.

13.5 Illustrative example of a group share scheme – equity-settled award satisfied by fresh issue of shares

The discussion in 13.5.1 to 13.5.3 below is based on Example 23.39 and addresses the accounting treatment for three distinct aspects of a group share scheme – a share-based payment arrangement involving group entities (see 13.2 above), the use of an EBT (see 13.3 above) and a group recharge arrangement (see 13.2.7 above). The Example assumes that the share-based payment arrangement is settled by a fresh issue of shares.

This illustrative example treats the recharge by the parent to the subsidiary as an income statement credit in the individual accounts of the parent and recognises the recharge when it is paid. In some situations, entities might consider it appropriate to apply alternative accounting treatments (see 13.2.7 above).

13.5.1 Consolidated financial statements

The consolidated financial statements need to deal with:

  • the charge required by FRS 102 in respect of the award; and
  • the issue of shares.

Transactions between H plc or S Limited and the EBT are ignored since the EBT is treated as an extension of H plc (see 13.3 above). The accounting entries required are set out below. As in other examples in this chapter, an entry to equity is not allocated to a specific reserve as this will vary between entities (although the most common for an entity complying with the Companies Act 2006 will be the profit and loss reserve or a separate ‘other reserve’ for share-based payments).

£ £
y/e 31.12.20x1 Profit or loss* 500
Equity 500
y/e 31.12.20x2 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x3 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x4 Profit or loss* 500
Equity 500
1.9.20x6 Cash 4,500
Other equity
Share capital / premium
6,000 10,500

* Total cost £3,000 (3000 options × £1) spread over 36 months. Charge for period to December 20x1 is 6/36 × £3,000 = £500, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 7.1 to 7.4 above).

From the point of view of the consolidated group, the issue of shares results in an increase in net assets of only £4,500 (i.e. the exercise price received from the employee), since the £6,000 contribution from the employing subsidiary to the EBT is an intragroup transaction. However, an entity applying the Companies Act 2006 is required to increase its share capital and share premium accounts by the £10,500 legal consideration for the issue of shares. The £6,000 consideration provided from within the group is effectively treated as a bonus issue.

13.5.2 Parent

13.5.2.A Accounting by parent where subsidiary is the employing company

The parent accounts for the share-based payment transaction under FRS 102 as an equity-settled transaction since the parent settles the award by delivering its own equity instruments via its EBT to the employees of the subsidiary (see 13.2.4 above). However, as discussed at 13.2.4 above, instead of recording an expense, as in its consolidated financial statements, the parent records an increase in the carrying value of its investment in subsidiary. It might then be necessary to consider whether the ever-increasing investment in subsidiary is supportable or is in fact impaired. As this is a matter to be determined in the light of specific facts and circumstances, it is not considered in this example. Any impairment charge would be recorded in profit or loss.

In addition to accounting for the share-based payment transaction, the parent records the transactions of the EBT and the issue of shares.

£ £
y/e 31.12.20x1 Investment in subsidiary* 500
Equity 500
y/e 31.12.20x2 Investment in subsidiary* 1,000
Equity 1,000
y/e 31.12.20x3 Investment in subsidiary* 1,000
Equity 1,000
y/e 31.12.20x4 Investment in subsidiary* 500
Equity 500
1.9.20x6 Cash 10,500
Equity 6,000
Profit or loss** 6,000
Share capital/premium 10,500

* Total increase in investment £3,000 (3000 shares × £1 fair value of each option) spread over 36 months. Increase during period to December 20x1 is 6/36 × £3,000 = £500, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual adjustment would be based on a continually revised cumulative adjustment (see further discussion at 7.1 to 7.4 above).

£4,500 option exercise proceeds from employee plus £6,000 contribution from the subsidiary.

This assumes that local law requires the entity to record share capital and share premium of £10,500, as in 13.5.1 above. However, FRS 102 prima facie requires the £6,000 cash received by the EBT from the subsidiary to be treated as income (see ** below) rather than as part of the proceeds of the issue of shares. In order, in effect, to reconcile these conflicting analyses, £6,000 of the £10,500 required by law to be capitalised as share capital and share premium has been treated as an appropriation out of other equity.

** The £6,000 contribution by the subsidiary to the EBT has been treated as a distribution from the subsidiary (see 13.2.7 above) and recorded in profit or loss. It might then be necessary to consider whether, as a result of this payment, the investment in the subsidiary had become impaired. As this is a matter to be determined in the light of specific facts and circumstances, it is not considered in this Example. Any impairment charge would be recorded in profit or loss.

13.5.2.B Parent company as employing company

If, in Example 23.39, the employing entity were the parent rather than the subsidiary, it would clearly have to record an expense under FRS 102. It would also have to fund the £6,000 shortfall between the option exercise proceeds of £4,500 and the £10,500 issue proceeds of the shares.

As the EBT is treated as an extension of the parent, the accounting entries for the parent would be the same as those for the group, as set out in 13.5.1 above.

13.5.3 Employing subsidiary

The employing subsidiary is required to account for the FRS 102 expense and the contribution to the EBT on exercise of the award. This gives rise to the accounting entries set out below. The entries to reflect the expense are required by FRS 102 (see 13.2.3 above). The treatment of the contribution to the EBT as a distribution is discussed at 13.2.7 above.

£ £
y/e 31.12.20x1 Profit or loss* 500
Equity 500
y/e 31.12.20x2 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x3 Profit or loss* 1,000
Equity 1,000
y/e 31.12.20x4 Profit or loss* 500
Equity 500
1.9.20x6 Equity 6,000
Cash 6,000

* Total cost £3,000 (3000 options × £1) spread over 36 months. Charge for period to December 20x1 6/36 × £3,000 = £500, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 7.1 to 7.4 above).

£3,000 of this payment should be treated as a reduction of whatever component of equity was credited with the £3,000 quasi-contribution from the parent in the accounting entries above. The remaining £3,000 would be treated as a distribution and deducted from any appropriate component of equity.

13.6 Illustrative example – cash-settled transaction not settled by the entity receiving goods or services

The discussion in 13.6.1 to 13.6.3 below is based on Example 23.40.

Date Fair value
£
1.7.20x1 1.50
31.12.20x1 1.80
31.12.20x2 2.70
31.12.20x3 2.40
31.12.20x4 2.90
31.12.20x5 3.30
1.9.20x6 3.50

If the award had been equity-settled (i.e. the employee had instead been granted a right to 3,000 free shares), the grant date fair value of the award would have been £1.50 per share.

H plc and its subsidiaries have a 31 December year end.

13.6.1 Consolidated financial statements

The group has entered into a cash-settled transaction which is accounted for using the methodology discussed at 10.3 above. This gives rise to the following accounting entries:

£ £
y/e 31.12.20x1 Profit or loss* 900
Liability 900
y/e 31.12.20x2 Profit or loss* 3,150
Liability 3,150
y/e 31.12.20x3 Profit or loss* 1,950
Liability 1,950
y/e 31.12.20x4 Profit or loss* 2,700
Liability 2,700
y/e 31.12.20x5 Profit or loss* 1,200
Liability 1,200
y/e 31.12.20x6 Profit or loss* 600
Liability 600
1.9.20x6 Liability 10,500
Cash 10,500

* Charge for period to 31 December 20x1 is 6/36 × 3000 × £1.80 [reporting date fair value] = £900. Charge for year ended 31 December 20x2 is 18/36 × 3000 × £2.70 = £4,050 less £900 charged in 20x1 = £3,150 and so on (refer to Example 23.33 at 10.3.2 above). In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 10 above).

13.6.2 Parent company

The parent accounts for the share-based payment transaction under FRS 102 as a cash-settled transaction, since the parent settles the award by delivering cash to the employees of the subsidiary (see 13.2.4 above). However, as discussed at 13.2.4 above, instead of recording a cost, as in its consolidated financial statements, the parent records an increase in the carrying value of its investment in subsidiary. It might then be necessary to consider whether the ever-increasing investment in subsidiary is supportable or is in fact impaired. As this is a matter to be determined in the light of specific facts and circumstances, it is not considered in this example. Any impairment charge would be recorded in profit or loss.

This would result in the following accounting entries:

£ £
y/e 31.12.20x1 Investment in subsidiary* 900
Liability 900
y/e 31.12.20x2 Investment in subsidiary* 3,150
Liability 3,150
y/e 31.12.20x3 Investment in subsidiary* 1,950
Liability 1,950
y/e 31.12.20x4 Investment in subsidiary* 2,700
Liability 2,700
y/e 31.12.20x5 Investment in subsidiary* 1,200
Liability 1,200
y/e 31.12.20x6 Investment in subsidiary* 600
Liability 600
1.9.20x6 Liability 10,500
Cash 10,500

* Increase in investment to 31 December 20x1 is 6/36 × 3000 × £1.80 [reporting date fair value] = £900. Increase for year ended 31 December 20x2 is 18/36 × 3000 × £2.70 = £4,050 less £900 charged in 20x1 = £3,150 and so on (refer to Example 23.33 at 10.3.2 above). In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 10 above).

Where the parent entity was also the employing entity (and therefore receiving goods or services), it would apply the same accounting treatment in its separate financial statements as in its consolidated financial statements (see 13.6.1 above).

13.6.3 Employing subsidiary

The employing subsidiary accounts for the transaction as equity-settled, since it receives services, but incurs no obligation to its employees (see 13.2.3 and 13.2.6 above). This gives rise to the following accounting entries:

£ £
y/e 31.12.20x1 Profit or loss* 750
Equity 750
y/e 31.12.20x2 Profit or loss* 1,500
Equity 1,500
y/e 31.12.20x3 Profit or loss* 1,500
Equity 1,500
y/e 31.12.20x4 Profit or loss* 750
Equity 750

* Charge for period to 31 December 20x1 is 6/36 × 3000 × £1.50 [grant date fair value] = £750, and so on. In practice, where options were granted to a group of individuals, or with variable performance criteria, the annual charge would be based on a continually revised cumulative charge (see further discussion at 7.1 to 7.4 above).

The effect of this treatment is that, while the group ultimately records a cost of £10,500, the subsidiary records a cost of only £4,500.

However, there may be cases where the subsidiary records a higher cost than the group. This would happen if, for example:

  • the award vests, but the share price has fallen since grant date, so that the value of the award at vesting (as reflected in the consolidated financial statements) is lower than the value at grant (as reflected in the subsidiary's financial statements); or
  • the award does not actually vest because of a failure to meet a market condition and/or a non-vesting condition (so that the cost is nil in the consolidated financial statements) but is treated by FRS 102 as vesting in the subsidiary's financial statements, because it is accounted for as equity-settled (see 7.3 and 7.4 above).

13.7 Employee transferring between group entities

It is not uncommon for an employee to be granted an equity-settled share-based payment award while in the employment of one subsidiary in the group, but to transfer to another subsidiary in the group before the award is vested, with the entitlement to the award remaining unchanged.

Section 26 does not specifically address the accounting in such cases. For entities applying the special rules for group plans in paragraph 16 of Section 26, that paragraph appears to support an appropriate allocation of the group expense between the employing entities (see 13.2.3.A above). In other cases, we suggest that group entities adopt an approach based on that in IFRS 2. Under IFRS 2, each subsidiary measures the services received from the employee by reference to the fair value of the equity instruments at the date those rights to equity instruments were originally granted, and the proportion of the vesting period served by the employee with each subsidiary. [IFRS 2 Appendix B.59]. In other words, for an award with a three-year vesting period granted to an employee of subsidiary A, who transfers to subsidiary B at the end of year 2, subsidiary A will (cumulatively) record an expense of 2/3, and subsidiary B 1/3, of the fair value at grant date. However, any subsidiary required to account for the transaction as cash-settled in accordance with the general principles discussed at 13.2 above accounts for its portion of the grant date fair value and also for any changes in the fair value of the award during the period of employment with that subsidiary. [IFRS 2 Appendix B.60].

After transferring between group entities, an employee may fail to satisfy a vesting condition other than a market condition, for example by leaving the employment of the group. In this situation each subsidiary adjusts the amount previously recognised in respect of the services received from the employee in accordance with the general principles of FRS 102 and IFRS 2 (see 7.1 to 7.4 above). [IFRS 2 Appendix B.61].

14 DISCLOSURES

The disclosure requirements of Section 26 fall into three main categories:

  • the nature and extent of share-based payment arrangements (see 14.1 below);
  • the measurement of share-based payment arrangements (see 14.2 below); and
  • the effect on the financial statements of share-based payment transactions (see 14.3 below).

The requirements apply to all entities applying FRS 102 although a ‘qualifying entity’, as defined in Section 1 – Scope – of FRS 102, may take advantage in its individual financial statements of an exemption from the requirements of paragraphs 18(b), 19 to 21 and 23 of Section 26 provided the following criteria are met:

  • if the qualifying entity is a subsidiary, the share-based payment arrangement concerns equity instruments of another group entity;
  • if the qualifying entity is an ultimate parent, the share-based payment arrangement concerns its own equity instruments and its separate financial statements are presented alongside the consolidated financial statements of the group;

and, in both cases, provided that the equivalent disclosures required by FRS 102 are included in the consolidated financial statements of the group in which the entity is consolidated. [FRS 102.1.8-12].

14.1 Nature and extent of share-based payment arrangements

IFRS 2 contains a general requirement that an entity should ‘disclose information that enables users of the financial statements to understand the nature and extent of share-based payment arrangements that existed during the period’ [IFRS 2.44] and then lists the minimum disclosures required to meet the overall requirement.

FRS 102 does not include the overall requirement from IFRS 2 but picks up some of the detailed disclosures and requires an entity to ‘disclose the following information about the nature and extent of share-based payment arrangements that existed during the period: [FRS 102.26.18]

  1. A description of each type of share-based payment arrangement that existed at any time during the period, including the general terms and conditions of each arrangement, such as vesting requirements, the maximum term of options granted, and the method of settlement (e.g. whether in cash or equity). An entity with substantially similar types of share-based payment arrangements may aggregate this information.
  2. The number and weighted average exercise prices of share options for each of the following groups of options:
    1. outstanding at the beginning of the period;
    2. granted during the period;
    3. forfeited during the period;
    4. exercised during the period;
    5. expired during the period;
    6. outstanding at the end of the period; and
    7. exercisable at the end of the period.’

The reconciliation in (b) above should, in our view, reflect all changes in the number of equity instruments outstanding. Therefore, in addition to awards with a grant date during the period, the reconciliation should include subsequent additions to earlier grants, e.g. options or shares added to the award in recognition of dividends declared during the period (where this is part of the original terms of the award), and changes to the number of equity instruments as a result of share splits or consolidations and other similar changes.

As drafted, the requirements in (b) above appear to apply only to share options. However, since there is little distinction between the treatment of an option with a zero exercise price and the award of a free share, in our view the disclosures should not be restricted to awards of options.

14.2 Measurement of share-based payment arrangements

IFRS 2 contains a general requirement that an entity should ‘disclose information that enables users of the financial statements to understand how the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period was determined’ [IFRS 2.46] and then lists the minimum disclosures required to meet the overall requirement.

FRS 102 contains its own general disclosure requirements for equity-settled, cash-settled, modified and group share-based payment arrangements but does not mandate the disclosure of specific details other than as set out at 14.2.1 to 14.2.4 below.

14.2.1 Equity-settled arrangements

For equity-settled share-based payment arrangements, FRS 102 requires an entity to ‘disclose information about how it measured the fair value of goods or services received or the value of the equity instruments granted. If a valuation methodology was used, the entity shall disclose the method and the reason for choosing it’. [FRS 102.26.19].

Unlike IFRS 2, FRS 102 has no specific requirement to disclose the inputs to an option pricing model and other assumptions made in the determination of fair value.

The requirement in FRS 102 to disclose the reason for choosing the valuation methodology used is not found in IFRS 2 but is consistent with the fact that FRS 102 allows directors to select an appropriate method of valuation rather than requiring the use of an option-pricing model (as is the case in IFRS 2 when market price information is not available).

14.2.2 Cash-settled arrangements

FRS 102 includes a requirement to disclose information about how the liability for a cash-settled arrangement was measured but does not expand on this general requirement. [FRS 102.26.20]. There is no direct correlation between this requirement and the disclosure requirements of IFRS 2 as the latter do not specifically address the measurement of cash-settled arrangements. The FRS 102 requirement is therefore potentially more onerous.

14.2.3 Modification of share-based payment arrangements

Where share-based payment arrangements have been modified during the accounting period, FRS 102 requires an explanation of those modifications [FRS 102.26.21] although, unlike IFRS 2, there is no specific requirement to disclose the incremental fair value or information about how that incremental value was measured.

14.2.4 Group share-based payment arrangements

If the reporting entity is part of a group share-based payment arrangement and it measures its share-based payment expense on the basis of a reasonable allocation of the expense for the group (in accordance with paragraph 16 of Section 26 – see 13.2.3.A above), then disclosure is required of that fact and of the basis for the allocation. [FRS 102.26.22].

14.3 Effect of share-based payment transactions on financial statements

IFRS 2 contains a general requirement that an entity should ‘disclose information that enables users of the financial statements to understand the effect of share-based payment transactions on the entity's profit or loss for the period and on its financial position’ [IFRS 2.50] and then lists the minimum disclosures required to meet the overall requirement.

FRS 102 does not include such a general requirement but picks up some of the detailed disclosures and requires an entity to ‘disclose the following information about the effect of share-based payment transactions on the entity's profit or loss for the period and on its financial position:

  1. the total expense recognised in profit or loss for the period; and
  2. the total carrying amount at the end of the period for liabilities arising from share-based payment transactions’. [FRS 102.26.23].

15 TAXES RELATED TO SHARE-BASED PAYMENT TRANSACTIONS

15.1 Income tax deductions for the entity

The particular issues raised by the accounting treatment for income taxes on share-based payment transactions are discussed in Chapter 26 at 7.7.

15.2 Employment taxes of the employer

An employing entity is required to pay National Insurance on share options and other share-based payment transactions with employees, just as if the employees had received cash remuneration. This raises the question of how such taxes should be accounted for as FRS 102 contains no specific guidance in this area.

The previous version of UK GAAP included UITF Abstract 25: National Insurance contributions on share option gains and, in our view, entities should continue to apply the requirements of this interpretation in the absence of more specific guidance. Therefore a provision should be made for National Insurance (‘NI’) contributions on outstanding share options (and similar awards) that are expected to be exercised. The provision should be:

  • calculated at the latest enacted NI rate applied to the difference between the market value of the underlying shares at the reporting date and the option exercise price;
  • allocated over the period from grant date to the end of the vesting period, after which it should be updated using the current market value of the shares; and
  • expensed through profit or loss unless the options form part of capitalised staff costs.

In some situations the entity may require employees to reimburse the amount of NI paid. This should be treated in accordance with the general rules in Section 21 – Provisions and Contingencies – for the reimbursement of the expenditure required to settle a provision.

15.3 Sale or surrender of shares by employee to meet employee's tax liability (‘sell to cover’ and net settlement)

An award of shares or options to an employee may give rise to a personal tax liability for the employee, often related to the fair value of the award when it vests or, in the case of an option, is exercised. In order to meet this tax liability, employees may wish to sell or surrender as many shares as are needed to raise proceeds equal to the tax liability (sometimes described respectively as ‘sell to cover’ or ‘net settlement’).

This in itself does not, in our view, require the scheme to be considered as cash-settled, any more than if the employee wished to liquidate the shares in order to buy a car or undertake home improvements. However, if the manner in which the cash is passed to, or realised for, the employee gives rise to a legal or constructive obligation for the employer, then the scheme might well be cash-settled (see 10.2 above), to the extent of any such obligation.

Where employees must pay income tax on share awards, the tax is often initially collected from the employer, but with eventual recourse by the tax authorities to the employee for tax not collected from the employer. Such tax collection arrangements mean that even an equity-settled award results in a cash cost for the employer for the income tax.

In such a situation, the employer may require the employee, as a condition of taking delivery of any shares earned, to indemnify the entity against the tax liability, for example by:

  • direct payment to the entity;
  • authorising the entity to deduct the relevant amount from the employee's salary; or
  • surrendering as many shares to the entity as have a fair value equal to the tax liability.

If the entity requires the employee to surrender the relevant number of shares, in our view the scheme must be treated as cash-settled to the extent of the indemnified amount, as explained in Example 23.41 below.

£ £
Employee costs (based on 60 shares at grant date fair value) 180
Equity 180
Employee costs (based on 40% of vesting date value) 200
Employment tax liability 200

The award is then satisfied by the delivery of 60 shares by the entity to the employee.

If, instead of being required to surrender the shares needed to settle the tax liability, the employee has a free choice as to how to indemnify the employer, the employer will have recorded the following entries by the end of the vesting period:

£ £
Employee costs (based on 100 shares at grant date fair value) 300
Equity 300
Receivable from employee (based on 40% of vesting date value) 200
Employment tax liability 200

The award is then satisfied by the delivery of 100 shares to the employee and the employee indicates that he wishes to surrender 40 shares to discharge his obligation to the employer under the indemnity arrangement. The entity therefore receives 40 shares from the employee in settlement of the £200 receivable from him.

In practice, this would almost certainly be effected as a net delivery of 60 shares, but in principle there are two transactions:

  • a release of 100 shares to the employee; and
  • the re-acquisition of 40 of those shares at £5 each from the employee.

The entity then settles the tax liability:

£ £
Employment tax liability 200
Cash 200

Even in this case, however, some might take the view that the substance of the arrangement is that the employee has the right to put 40 shares to the employer, and accordingly 40% of the award should be accounted for as cash-settled, resulting in essentially the same accounting as when the employee is required to surrender 40 shares, as set out above. An entity should therefore make a careful assessment of the appropriate accounting treatment based on the terms of a particular arrangement.

An amendment to IFRS 2, issued in June 2016, introduced an exception to the requirement to split an award into an equity-settled element and a cash-settled element where certain specified criteria relating to an entity's tax withholding obligations are met. The exception means that net-settled arrangements that meet the criteria will be accounted for as entirely equity-settled under IFRS. There is no corresponding exception to the requirements of Section 26 and so the requirement to consider whether an award has an equity-settled portion and a cash-settled portion, and to account accordingly, will continue to apply.

16 OTHER PRACTICAL ISSUES

We consider below the application of Section 26 to the following types of arrangement encountered in practice:

  • matching share awards (including deferred bonuses delivered in shares) (see 16.1 below);
  • loans to employees to purchase shares (limited recourse and full recourse loans) (see 16.2 below);
  • awards entitled to dividends or dividend equivalents during the vesting period (see 16.3 below); and
  • awards vesting or exercisable on an exit event or change of control (flotation, trade sale etc.) (see 16.4 below).

16.1 Matching share awards (including deferred bonuses delivered in shares)

As noted in the discussion at 11.2.1 above, in our view the rules in Section 26 for awards where there is a choice of equity- or cash-settlement do not fully address awards where the equity and cash alternatives may have significantly different fair values and vesting periods. A matching share award is an example of the type of scheme giving rise to such issues.

Under a matching share award, the starting point is usually that an employee is awarded a bonus for a one year performance period. At the end of that period, the employee may then be either required or permitted to take all or part of that bonus in shares rather than cash. To the extent that the employee takes shares rather than cash, the employing entity may then be required or permitted to make a ‘matching’ award of an equal number of shares (or a multiple or fraction of that number). The matching award will typically vest over a longer period.

Whilst such schemes can appear superficially similar, the accounting analysis may vary significantly, according to whether:

  • the employee has a choice, or is required, to take some of the ‘base’ bonus in shares and whether any such shares have to be retained by the employee in order for the matching shares to vest; and/or
  • the employer has a choice, or is required, to match any shares taken by the employee.

The detailed accounting for such arrangements is beyond the scope of this publication but is addressed in EY International GAAP 2019. The requirements of FRS 102 and IFRS 2 are not identical for awards where there is a choice of settlement but are closely aligned (see 11 above). However, it is expected that many companies with a matching share scheme will be part of a larger group arrangement and will potentially be able to recognise an expense based on the group expense in accordance with paragraph 16 of Section 26 (see 13.2.3.A above).

16.2 Loans to employees to purchase shares (limited recourse and full recourse loans)

Share awards to employees are sometimes made by means of so-called ‘limited recourse loan’ schemes. The detailed terms of such schemes vary, but typical features include the following:

  • the entity makes an interest-free loan to the employee which is immediately used to acquire shares to the value of the loan on behalf of the employee;
  • the shares may be held by the entity, or a trust controlled by it (see 13.3 above), until the loan is repaid;
  • the employee is entitled to dividends, except that these are treated as paying off some of the outstanding loan;
  • within a given period (say, five years) the employee must either have paid off the outstanding balance of the loan, at which point the shares are delivered to the employee, or surrendered the shares. Surrender of the shares by the employee is treated as discharging any outstanding amount on the loan, irrespective of the value of the shares.

The effect of such an arrangement is equivalent to an option exercisable within five years with an exercise price per share equal to the share price at grant date less total dividends since grant date. There is no real loan at the initial stage. The entity has no right to receive cash or another financial asset, since the loan can be settled by the employee returning the (fixed) amount of equity ‘purchased’ at grant date.

Indeed, the only true cash flow in the entire transaction is any amount paid at the final stage if the employee chooses to acquire the shares at that point. The fact that the exercise price is a factor of the share price at grant date and dividends paid between grant date and the date of repayment of the ‘loan’ is simply an issue for the valuation of the option. The fair value of the option will generally need to be based on the employee's implicit right to buy the shares at a future date rather than being the share price at grant date (the face value of the loan).

The loan arrangement might have a defined period during which the employee must remain in service (five years in the example above) and during which there might also be performance conditions to be met. Where this is the case, the FRS 102 expense will be recognised by the entity over this period. However, where, as is frequently the case, such an award is subject to no future service or performance condition, i.e. the ‘option’ is, in effect, immediately exercisable by the employee should he choose to settle the ‘loan’, the cost will need to be recognised in full at grant date (see 7.1 above).

Under more complex arrangements, the loan to the employee to acquire the shares is a full recourse loan (i.e. it cannot be discharged simply by surrendering the shares and there can be recourse to other assets of the employee). However, the amount repayable on the loan is reduced not only by dividends paid on the shares, but also by the achievement of performance targets, such as the achievement of a given level of earnings.

The appropriate analysis of such awards is more difficult, as they could be viewed in two ways:

  • either the employer has made a loan (which the employee has chosen to use to buy a share), accounted for as a financial asset, and has then entered into a performance-related cash bonus arrangement with the employee, accounted for as an employee benefit; or
  • the transaction is a share option where the exercise price varies according to the satisfaction of performance conditions and the amount of dividends on the shares, accounted for under Section 26.

The different analyses give rise to potentially significantly different expenses. This will particularly be the case where one of the conditions for mitigation of the amount repayable on the loan is linked to the price of the employer's equity. As this is a market condition, the effect of accounting for the arrangement under Section 26 may be that an expense is recognised in circumstances where no expense would be recognised if the arrangement were treated as an employee benefit under Section 28.

Such awards need to be carefully analysed, in the light of their particular facts and circumstances, in order to determine the appropriate treatment. Factors that could suggest that Section 26 is the more relevant would, in our view, include:

  • the employee can use the loan only to acquire shares;
  • the employee cannot trade the shares until the loan is discharged; or
  • the entity has a practice of accepting (e.g. from leavers) surrender of the shares as full discharge for the amount outstanding on the loan and does not pursue any shortfall between the fair value of the shares and the amount owed by the employee. This would tend to indicate that, in substance, the loan is not truly full recourse.

16.3 Awards entitled to dividends or dividend equivalents during the vesting period

Some awards entitle the holder to receive dividends on unvested shares (or dividend equivalents on options) during the vesting period.

For example, an entity might award shares that are regarded as fully vested for the purposes of tax legislation (typically because the employee enjoys the full voting and dividend rights of the shares), but not for accounting purposes (typically because the shares are subject to forfeiture if a certain minimum service period is not achieved). In practice, the shares concerned are often held by an EBT until the potential forfeiture period has expired.

Another variant of such an award that is sometimes seen is where an entity grants an employee an option to acquire shares in the entity which can be exercised immediately. However, if the employee exercises the option but leaves within a certain minimum period from the grant date, he is required to sell back the share to the entity (typically either at the original exercise price, or the lower of that price or the market value of the share at the time of the buy-back).

Such awards do not fully vest for the purposes of Section 26 until the potential forfeiture or buy-back period has expired. The cost of such awards should therefore be recognised over this period.

This raises the question of the accounting treatment of any dividends paid to employees during the vesting period. Conceptually, it could be argued that such dividends cannot be dividends for financial reporting purposes since the equity instruments to which they relate are not yet regarded as issued for financial reporting purposes. This would lead to the conclusion that dividends paid in the vesting period should be charged to profit or loss as an employment cost.

However, the charge to be made for the award under Section 26 will already take account of the fact that the recipient is entitled to receive dividends during the vesting period. Thus, it could be argued that also to charge profit or loss with the dividends paid is a form of double counting. Moreover, whilst the relevant shares may not have been fully issued for financial reporting purposes, the basic Section 26 accounting does build up an amount in equity over the vesting period. It could therefore be argued that – conceptually, if not legally – any dividend paid relates not to an issued share, but rather to the equity instrument represented by the cumulative amount that has been recorded for the award as a credit to equity, and can therefore appropriately be shown as a deduction from equity.

However, this argument is valid only to the extent that the credit to equity represents awards that are expected to vest. It cannot apply to dividends paid to employees whose awards are either known not to have vested or treated as expected not to vest when applying Section 26 (since there is no credit to equity for these awards). Accordingly, we believe that the most appropriate approach is to analyse the dividends paid so that, by the date of vesting, cumulative dividends paid on awards treated by Section 26 as vested are deducted from equity and those paid on awards treated by Section 26 as unvested are charged to profit or loss. The allocation for periods prior to vesting should be based on a best estimate of the final outcome, as illustrated by Example 23.42 below.

Year Calculation of cumulative expense Cumulative expense (£) Expense for period (£)
1 100 shares × 425 employees × £15 × 1/3 212,500 212,500
2 100 shares × 440 employees × £15 × 2/3 440,000 227,500
3 100 shares × 443 × £15 × 3/3 664,500 224,500

On the assumption that all employees who leave during a period do so on the last day of that period (and thus receive dividends paid in that period), in our view the dividends paid on the shares should be accounted for as follows:

£ £
Year 1 Dr. Profit or loss (employee costs)1 7,500
Dr. Equity1 42,500
Cr. Cash2 50,000
Year 2 Dr. Profit or loss (employee costs)3 3,300
Dr. Equity3 54,300
Cr. Cash4 57,600
Year 3 Dr. Profit or loss (employee costs)5 1,590
Dr. Equity5 67,110
Cr. Cash6 68,700

1 20 employees have left and a further 55 are anticipated to leave. Dividends paid to those employees (100 shares × 75 employees × £1 = £7,500) are therefore recognised as an expense. Dividends paid to other employees are recognised as a reduction in equity.

2 100 shares × 500 employees × £1.

3 22 further employees have left and a further 18 are anticipated to leave. The cumulative expense for dividends paid to leavers and anticipated leavers should therefore be £10,800 (100 shares × 20 employees × £1 = £2,000 for leavers in year 1 + 100 shares × 40 employees × [£1 + £1.20] for leavers and anticipated leavers in year 2 = £8,800). £7,500 was charged in year 1, so the charge for year 2 should be £10,800 – £7,500 = £3,300. This could also have been calculated as charge for leavers and expected leavers in current year £4,800 (100 shares × 40 [22 + 18] employees × £1.20) less reversal of expense in year 1 for reduction in anticipated final number of leavers £1,500 (100 shares × 15 [75 – 60] employees × £1.00). Dividends paid to other employees are recognised as a reduction in equity.

4 100 shares × 480 employees in employment at start of year × £1.20.

5 15 further employees have left. The cumulative expense for dividends paid to leavers should therefore be £12,390 (£2,000 for leavers in year 1 (see 3 above) + 100 shares × 22 employees × [£1 + £1.20] = £4,840 for leavers in year 2 + 100 shares × 15 employees × [£1 + £1.20 + £1.50] = £5,550 for leavers in year 3). A cumulative expense of £10,800 (see 3 above) was recognised by the end of year 2, so the charge for year 3 should be £12,390 – £10,800 = £1,590. This could also have been calculated as charge for leavers in current year £2,250 (100 shares × 15 employees × £1.50) less reversal of expense in years 1 and 2 for reduction in final number of leavers as against estimate at end of year 2 £660 (100 shares × 3 [60 – 57] employees × [£1.00 + £1.20]). Dividends paid to other employees are recognised as a reduction in equity.

6 100 shares × 458 employees in employment at start of year × £1.50.

16.4 Awards vesting or exercisable on an exit event or change of control (flotation, trade sale etc.)

Entities frequently issue awards connected to a significant event such as a flotation, trade sale or other change of control of the business. It may be that an award that would otherwise be equity-settled automatically becomes cash-settled if such an event crystallises and the entity has no choice as to the method of settlement (as discussed at 11.3 above).

However, it may also be the case that an award vests only on such an event, which raises various issues of interpretation, as discussed below.

The sections below should be read together with the more general discussions elsewhere in this chapter (as referred to in the narrative below) on topics such as grant date, vesting period, vesting and non-vesting conditions and classification as equity-settled or cash-settled. References to flotation should be read as also including other exit events.

16.4.1 Grant date

Sometimes awards are structured so that they will vest on flotation, or so that they will vest on flotation subject to further approval at that time. For awards in the first category, grant date as defined in FRS 102 will be the date on which the award is first communicated to employees (subject to the normal requirements of Section 26 relating to a shared understanding, offer and acceptance, as discussed at 6.3 above). For awards in the second category, grant date will be at or around the date of flotation, when the required further approval is given.

This means that the cost of awards subject to final approval at flotation will generally be significantly higher than that of awards that do not require such approval. Moreover, as discussed further at 6.3 above, it may well be the case that employees begin rendering service for such awards before grant date (e.g. from the date on which the entity communicates its intention to make the award in principle). In that case, the entity would need to consider making an initial estimate of the value of the award for the purpose of recognising an expense from the date services have been provided, and continually re-assess that value up until the actual grant date. As with any award dependent on a non-market vesting condition, an expense would be recognised only to the extent that the award is considered likely to vest. The classification of a requirement to float as a non-market vesting condition is discussed further at 16.4.3 below.

16.4.2 Vesting period

Many awards that vest on flotation have a time limit – in other words, the award lapses if flotation has not occurred on or before a given future date. In principle, as discussed at 7.2.3 above, when an award has a variable vesting period due to a non-market performance condition, the reporting entity should make a best estimate of the likely vesting period at each reporting date and calculate the Section 26 charge on the basis of that best estimate.

In practice, the likely timing of a future flotation is notoriously difficult to assess months, let alone years, in advance. In such cases, it would generally be acceptable simply to recognise the cost over the full potential vesting period until there is real clarity that a shorter period may be more appropriate. However, in making the assessment of the likelihood of vesting, it is important to take the company's circumstances into account. The likelihood of an exit event in the short- to medium-term is perhaps greater for a company owned by private equity investors seeking a return on their investment than for a long-established family-owned company considering a flotation.

It is worth noting that once an exit event becomes likely, the Section 26 expense will in some cases need to be recognised over a shorter vesting period than was originally envisaged as the probability of the exit event occurring will form the basis at the reporting date of the estimate of the number of awards expected to vest (see also the discussion at 8.6 above).

16.4.3 Is flotation or sale a vesting condition or a non-vesting condition?

There was debate in the past about whether a requirement for a flotation or sale to occur in order for an award to vest was a vesting condition or a non-vesting condition. The argument for it being a non-vesting condition was that flotation or sale may occur irrespective of the performance of the entity. The counter-argument was essentially that the price achieved on flotation or sale, which typically affects the ultimate value of the award (see 16.4.4 below), reflects the performance of the entity and is therefore a non-market performance condition (provided there is an associated service condition).

On the basis of discussions on the interpretation of IFRS 2 by the IASB and the IFRS Interpretations Committee, it appears appropriate to treat a requirement to float or be sold as a performance vesting condition rather than as a non-vesting condition, provided there is also a service condition for the duration of the performance condition (see 4.2 above). If the service period is not at least as long as the duration of the flotation or sale condition, the condition will need to be accounted for as a non-vesting condition.

Even though the condition is deemed to relate to the entity's own operations and therefore generally classified as a performance condition, it will sometimes be concluded that fulfilment of the condition is outside the control of both the entity and the counterparty. The settlement of an award in equity or cash might depend on the outcome of the condition i.e. there might be either cash- or equity-settlement that is entirely contingent on the exit event. Such contingent arrangements are discussed at 11.3 above.

16.4.4 Awards requiring achievement of a minimum price on flotation or sale

Some awards with a condition contingent on flotation (or another similar event) vest only if a minimum price per share is achieved. For example, an entity might grant all its employees share options, the vesting of which is contingent upon a flotation or sale of the shares at a price of at least £5 per share within five years, and the employee still being in employment at the time of the flotation or sale.

Taken alone, the requirement for a flotation or sale to occur is a non-market performance condition (see further below and at 16.4.3 above). However, if a minimum market price has to be achieved, the question arises as to whether, in addition to the service requirement, such an award comprises:

  • a single market performance condition (i.e. float or sell within five years at a share price of at least £5); or
  • two conditions:
    • a market performance condition (share price at time of flotation or sale of at least £5); and
    • a non-market performance condition (flotation or sale achieved within five years).

The significance of this is the issue discussed at 7.3 above, namely that an expense must always be recognised for all awards with a market condition, if all the non-market vesting conditions are satisfied, even if the market condition is not. In either case, however, there is a market condition which needs to be factored into the valuation of the award.

If the view is that ‘flotation or sale at £5 within five years’ is a single market condition, the entity will recognise an expense for the award for all employees still in service at the end of the five year period, since the sole non-market vesting condition (i.e. service) will have been met. Note that this assumes that the full five-year period is considered the most likely vesting period at grant date (see 16.4.2 above).

If, on the other hand, the view is that ‘flotation or sale within five years’ and ‘flotation or sale share price £5’ are two separate conditions, and no flotation or sale occurs, no expense will be recognised since the performance element of the non-market vesting condition (i.e. ‘flotation or sale within five years’) has not been satisfied. However, even on this second analysis, if a sale or flotation is achieved at a price less than £5, an expense must be recognised, even though the award does not truly vest, since the non-market condition (i.e. ‘flotation or sale within five years’ with its associated service requirement) will have been met.

In our view, the appropriate analysis is to regard ‘flotation or sale within five years’ and ‘flotation or sale share price £5’ as two separate conditions.

The example above assumes that there is a service condition equal in duration to the other condition attached to the award and hence the analysis above only considers vesting conditions. If the fact pattern were such that there was no service condition, or a service condition that was of a shorter duration than the other conditions, then those conditions would need to be treated as non-vesting conditions rather than as performance vesting conditions.

16.4.5 Awards ‘purchased for fair value’

As noted at 3.4.3 above, entities that are contemplating a flotation or trade sale may invite employees to subscribe for shares (often a special class of share) for a relatively nominal amount. In the event of a flotation or trade sale occurring, these shares may be sold or will be redeemable at a substantial premium. It is often argued that the initial subscription price paid represents the fair value of the share at the time, given the inherent high uncertainty as to whether a flotation or trade sale will in fact occur.

The premium paid on the shares in the event of a flotation or trade sale will typically be calculated in part by reference to the price achieved. The question therefore arises as to whether such awards fall within the scope of Section 26. It might be argued for example that, as the employee paid full fair value for the award at issue, there has been no share-based payment and, accordingly, the award is not within the scope of Section 26.

In our view, in order to determine whether the arrangement falls within the scope of Section 26, it is necessary to consider whether the award has features that would not be expected in ‘normal’ equity transactions – in particular, a requirement for the holder of the shares to remain in employment until flotation or sale and/or individual buyback arrangements. If this is the case, regardless of the amount subscribed, the terms suggest that the shares are being awarded in connection with, and in return for, employee services and hence that the award is within the scope of Section 26. This may mean that, even if the award has no material fair value once the subscription price has been taken into account (and therefore gives rise to no FRS 102 expense), it may be necessary to make the disclosures required by Section 26.

Moreover, even if the amount paid by the employees can be demonstrated to be fair value for tax or other purposes, that amount would not necessarily meet the valuation requirements of Section 26. Specifically, a ‘true’ fair value would take into account non-market vesting conditions (such as a requirement for the employee to remain in employment until flotation or a trade sale occurs). However, a valuation for Section 26 purposes would not take such conditions into account (see 6.5 and 7.2.1 above) and would therefore typically be higher than the ‘true’ fair value.

If the arrangement relates to a special class of share rather than ordinary equity shares, the underlying shares might well be classified under FRS 102 as a liability rather than as equity. However, if the redemption amount is linked to the flotation price of the ‘real’ equity, the arrangement will be a cash-settled share-based payment transaction under Section 26 (see 3.4.1 above).

It is common in such situations for the cost of satisfying any obligations to the holders of the special shares to be borne by shareholders rather than by the entity itself. This raises a number of further issues, which are discussed at 3.2.1 above and at 16.4.6 below.

16.4.6 ‘Drag along’ and ‘tag along’ rights

An award might be structured to allow management of an entity to acquire a special class of equity at fair value (as in 16.4.5 above), but (in contrast to 16.4.5 above) with no redemption right on an exit event. However, rights are given:

  • to any buyer of the ‘normal’ equity also to buy the special shares (sometimes called a ‘drag along’ right);
  • to a holder of the special shares to require any buyer of the ‘normal’ equity also to buy the special shares (sometimes called a ‘tag along’ right).

Such schemes are particularly found in entities where the ‘normal’ equity is held by a provider of venture capital, which will generally be looking for an exit in the medium term.

It may well be that, under the scheme, the entity itself is required to facilitate the operation of the drag along or tag along rights, which may involve the entity collecting the proceeds from the buyer and passing them on to the holder of the special shares.

This raises the issue of whether such an arrangement is equity-settled or cash-settled. The fact that, in certain circumstances, the entity is required to deliver cash to the holder of a share suggests that the arrangement is an award requiring cash settlement in specific circumstances, the treatment of which is discussed at 11.3 above.

However, if the terms of the award are such that the entity is obliged to pass on cash to the holder of the share only if, and to the extent that, proceeds are received from an external buyer, in our view the arrangement may be economically no different to the ‘broker settlement’ arrangements typically entered into by listed entities.

Under such broker settlement arrangements, the entity may either sell employees' shares in the market on the employees' behalf or, more likely, arrange for a third party broker to do so. A sale of shares on behalf of an employee is undertaken by the entity as agent and does not give rise to an increase in equity and an expense, although a share-based payment expense will be recognised for the award of shares. Such an arrangement does not of itself create a cash-settled award, provided that the entity has not created any obligation to the employees. If, however, the entity has either created an expectation among employees that it will step in to make good any lack of depth in the market, or has indeed itself contracted to repurchase the shares in question, it may well mean that analysis as a cash-settled scheme is more appropriate. However, as the entity may enter into much the same transaction with a broker whether it is selling shares on its own behalf or on behalf of its employees, the challenge is for the entity to be able to demonstrate the true economic nature of the transaction.

Following on from the approach to broker settlement arrangements outlined above, an arrangement where the employees' shares are being sold to an external buyer could be regarded as equity-settled because the entity's only involvement as a principal is in the initial delivery of shares to employees. However, consideration must be given to all the factors that could suggest that the scheme is more appropriately regarded as cash-settled.

In making such an assessment, care needs to be taken to ensure that the precise facts of an arrangement are considered. For example, a transaction where the entity has some discretion over the amount of proceeds attributable to each class of shareholder might indicate that it is inappropriate to treat the entity simply as an agent in the cash payment arrangement. It might also be relevant to consider the extent to which, under relevant local law, the proceeds received can be ‘ring fenced’ so as not to be available to settle other liabilities of the entity.

It is also the case that arrangements that result in employees obtaining similar amounts of cash can be interpreted very differently under Section 26 depending on how the arrangement is structured and whether, for example:

  • the entity is required to pay its employees cash on an exit (having perhaps held shares itself via a trust and those shares having been subject to ‘drag along’ rights); or
  • the employees themselves have held the right to equity shares on a restricted basis with vesting – and ‘drag along’ rights – taking effect on a change of control and the employees receiving cash for their shares.

The appropriate accounting treatment in such cases requires a significant amount of judgement based on the precise facts and circumstances.

17 FIRST-TIME ADOPTION AND TRANSITIONAL PROVISIONS

17.1 Transitional provisions on first-time adoption of FRS 102

Section 35 sets out the transitional provisions for first-time adoption of FRS 102 and is discussed in Chapter 32. Issues arising from the specific requirements of Section 35 in relation to share-based payment transactions are discussed below.

Subject to the special provisions outlined below, a first-time adopter is not required to apply Section 26:

  • to equity instruments (including the equity component of share-based payment transactions previously treated as compound instruments) that were granted before the date of transition to FRS 102; or
  • to liabilities arising from share-based payment transactions that were settled before the date of transition to FRS 102. [FRS 102.35.10(b)].

There are special provisions for first-time adopters of FRS 102 that have previously applied IFRS 2, which are discussed further below. The transitional provisions from previous UK GAAP (FRS 20 and the FRSSE) are not covered as entities would have transitioned to FRS 102 some years back.

Where a first-time adopter has previously applied IFRS 2, it should ‘apply either IFRS 2 (as applicable) or Section 26 of this FRS at the date of transition’ to equity instruments (including the equity component of share-based payment transactions previously treated as compound instruments) granted before the date of transition to FRS 102. Therefore, unlike the full exemption from accounting for pre-transition grants given to those first-time adopters that have not previously accounted for share-based payments, those who have previously applied IFRS 2 are required to continue accounting for ongoing awards either under the previous standard or under Section 26. [FRS 102.35.10(b)]. In our view, the intention is simply that an entity may complete the accounting for a pre-transition grant using the original grant date fair value and it is not intended that the application of Section 26 to such grants should necessarily result in a remeasurement. However, there is nothing in paragraph 10(b) of Section 35 to prohibit such a remeasurement (for example, as a result of applying the group allocation arrangements of paragraph 16 of Section 26).

FRS 102 and IFRS 2 are not identical for awards where there is a choice of settlement but are closely aligned (see 11 above), therefore it is less likely that the classification of a share-based payment transaction as equity-settled or cash-settled will differ depending on whether an entity is applying FRS 102 or IFRS 2. If a classification difference does still result from adoption of FRS 102, it appears that an entity could continue with the IFRS 2 classification for existing awards, even if new grants would be classified differently under FRS 102.

There is a lack of clarity in relation to certain other aspects of the requirements for those entities with share-based payments to which IFRS 2 has previously been applied but where the accounting treatment of such arrangements differs, or could differ, under Section 26. For example, it is unclear whether a company which has recognised an expense for a transaction for which no apparent consideration has been received has a choice as to whether it carries on doing so (given that there is no general equivalent of paragraph 13A of IFRS 2 (see 3.2.3 above)).

17.2 Modification of awards following transition

Section 35 does not address the treatment of equity-settled awards granted before the date of transition but modified at a later date. Therefore a first-time adopter (other than one who has previously applied FRS 20 or IFRS 2) could potentially avoid a charge for a new award by modifying (or cancelling or settling) an out of scope old award instead. However, in practice, the potential to do this is likely to be limited to those entities previously applying the FRSSE which, in most cases, are unlikely to have had extensive equity-settled share-based payment arrangements in place prior to transition to FRS 102.

18 SUMMARY OF GAAP DIFFERENCES

The differences between FRS 102 and IFRS are set out below.

FRS 102 IFRS 2
Scope:
Definitions and transactions within scope (see 2.1 above)
FRS 102 does not provide guidance or examples in areas such as:
  1. the meaning of ‘goods’ in ‘goods and services’ when used in the definition of a share-based payment transaction;
  2. vested transactions;
  3. transactions with shareholders as a whole;
  4. business combinations; or
  5. interaction with accounting for financial instruments.
IFRS 2 has specific guidance or examples in these areas.
Recognition:

Accounting after the vesting date (see 2.2.1 above)

FRS 102 includes no guidance on accounting for awards after vesting. IFRS 2 specifically prohibits a reversal of the expense once awards have vested.
Measurement of equity-settled transactions:

Non-vesting conditions (see 2.3.1 above)

FRS 102 contains no definition of conditions that are not vesting conditions, but the example provided is similar to that provided for non-vesting conditions in IFRS 2. IFRS 2 does not include a definition of a ‘non-vesting condition’ but includes examples of such conditions as part of the Implementation Guidance.
Employees and others providing similar services (see 2.3.2 above) FRS 102 offers no additional guidance on the meaning of ‘others providing similar services’. This term is explained/defined in Appendix A to IFRS 2.
Valuation methodology (see 2.3.3 above) FRS 102 draws a more explicit distinction than IFRS 2 between the valuation of shares and the valuation of options and appreciation rights. It does not mandate use of an option pricing model in the absence of market price information. IFRS 2 requires the use of a market price or an option pricing model for the valuation of equity-settled transactions. The standard includes guidance in Appendix B about the selection and application of option pricing models that is not reproduced in FRS 102.
Awards where fair value cannot be measured reliably (see 2.3.4 above) FRS 102 contains no specific requirements and assumes that it will always be possible to fair value an award. IFRS 2 includes an approach based on intrinsic value to be used in ‘rare cases’ where an entity is unable to measure fair value reliably.
Cancellation of awards (see 2.3.5 above) FRS 102 contains no specific requirements to mirror those in IFRS 2. IFRS 2 makes clear that an award may be cancelled either by the entity or the counterparty and also that a failure to meet non-vesting conditions should, in certain situations, be considered cancellation of an award.
Settlement of awards (see 2.3.6 above) FRS 102 states that settlement of an unvested award should be treated as an acceleration of vesting but does not specify the treatment when the settlement value exceeds the fair value of the award being cancelled.
Similarly, there is no specific guidance on the repurchase of vested equity instruments.
Under IFRS 2, any incremental fair value is expensed at the date of settlement but any settlement value up to the fair value of the cancelled award is debited to equity.
When vested equity instruments are repurchased, IFRS 2 requires any incremental fair value to be expensed at the date of repurchase.
Replacement awards following a cancellation or settlement (see 2.3.7 above) FRS 102 includes no guidance on the accounting treatment of equity-settled awards to replace a cancelled award. Under IFRS 2 replacement awards may be accounted for on the basis of their incremental fair value rather than being treated as a completely new award.
Measurement of cash-settled transactions:

Treatment of non-market performance conditions in measurement of fair value (see 2.4 above)

FRS 102 does not make it explicitly clear whether service and non-market performance conditions should be incorporated into the determination of fair value or whether they should be taken into account in estimating the number of awards expected to vest. The June 2016 amendment to IFRS 2 clarifies that non-market performance conditions should be taken into account in estimating the number of awards expected to vest rather than being reflected in the determination of fair value.
Share-based payment transactions with cash alternatives:

Counterparty has choice of settlement in equity or cash (see 2.5.1 above)

FRS 102 requires cash-settled accounting unless there is no commercial substance to the amount of the cash settlement alternative. IFRS 2 requires a split accounting approach, splitting the arrangement into equity-settled and cash-settled components.
Settlement in cash of award accounted for as equity-settled (or vice versa) (see 2.5.2 above) There is no guidance in FRS 102 on how to account for the settlement in cash of an award accounted for as equity-settled or vice versa. IFRS 2 specifically addresses the accounting for a basis of settlement that differs from the accounting basis.
Group plans:

Accounting by group entity with obligation to settle an award when another group entity receives goods or services (see 2.6.1 above)

FRS 102 makes clear that an entity receiving goods or services, but with no obligation to settle the transaction, accounts for the transaction as equity-settled. However, prior to the Triennial review 2017although explicitly within scope, the accounting in the entity settling the transaction was not specified. This is now clarified and consistent with IFRS 2. IFRS 2 makes clear when the settling entity should treat an award as equity-settled and when as cash-settled.
Alternative accounting treatment for group plans (see 2.6.2 above) Where a share-based payment award is granted by an entity to the employees of one or more group entities, those group entities are permitted – as an alternative to the measurement requirements of FRS 102 – to recognise the share-based payment expense on the basis of a reasonable allocation of the group expense. IFRS 2 has no corresponding alternative treatment.
Unidentifiable goods or services (see 2.7.1 above) The Triennial review 2017 clarified the scope of the section, where in the absence of specifically identifiable goods or services, other circumstances may indicate that goods or services have been (or will be) received, which is consistent with IFRS 2. But Section 26 then appears to restrict the requirements for certain government-mandated plans where the goods or services received or receivable are not identifiable, and requires the award to be valued on the basis of the equity instruments rather than the goods or services. Under IFRS 2, the scope is not restricted to government-mandated plans.
Net settlement of awards for tax withholding obligations (see 2.8 above) There is no exception comparable to that added to IFRS 2 and entities will need to continue to assess whether a net-settled arrangement has an equity-settled element and a cash-settled element. The June 2016 amendment to IFRS 2 introduced an exception for arrangements that are net-settled solely to meet an entity's withholding tax obligation in respect of an employee's tax liability. Entities meeting the criteria will account for the net-settled award as equity-settled in its entirety.
Where the criteria for the exception are not met, entities will need to continue to assess whether an arrangement has an equity-settled element and a cash-settled element.
Disclosures (see 2.9 above) The disclosure requirements of FRS 102 are generally derived from, but less extensive than, those of IFRS 2. However, there are certain specific requirements that are not found in IFRS 2.There are disclosure exemptions for certain entities. There are no exemptions from disclosure under IFRS 2.

References

  1.   1 For convenience, throughout this chapter we refer to the recognition of a cost for share-based payments. In some cases, however, a share-based payment transaction may initially give rise to an asset (e.g. where employee costs are capitalised as part of the cost of PP&E or inventories).
  2.   2 FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland, September 2015, para Accounting Council Advice (SE).39.
  3.   3 FASB Staff Position 123(R)-4, Classification of Options and Similar Instruments Issued as Employee Compensation That Allow for Cash Settlement upon the Occurrence of a Contingent Event.
  4.   4 D17 – IFRS 2 – Group and Treasury Share Transactions, IASB, 2005, para. IE5.
..................Content has been hidden....................

You can't read the all page of ebook, please click here login for view all page.
Reset